Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGRP,Agouti-related protein,40516,0.196750511705062,0.0045642625154651,0.187804557174751,0.205696466235374,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN1,CCN family member 1,40280,0.292716129874678,0.00664544463317184,0.279691058393661,0.305741201355695,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.145956039415241,0.00261514507631899,0.140830355065655,0.151081723764826,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,0.0812551278083111,0.0018841896347642,0.0775621161241733,0.0849481394924489,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LDLR,Low-density lipoprotein receptor,40356,0.342848016722767,0.00386470739137073,0.33527319023568,0.350422843209854,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPY,Pro-neuropeptide Y,40489,0.267738494374837,0.00563264806886549,0.25669850415986,0.278778484589813,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.197995498541402,0.00235957072505025,0.193370739920303,0.2026202571625,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROC,Vitamin K-dependent protein C,40372,0.0919335293276629,0.00215744796491474,0.08770493131643,0.0961621273388958,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFPI,Tissue factor pathway inhibitor,40309,0.133054123473105,0.00260383047581997,0.127950615740498,0.138157631205712,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.196806488483349,0.00517853375406075,-0.206956414641308,-0.18665656232539,1.76218319717166e-302
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,0.135079729112132,0.00364388550432702,0.127937713523651,0.142221744700613,1.27791403082156e-288
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFGE8,Lactadherin,40332,0.135149265871489,0.00365345695599801,0.127988490237733,0.142310041505245,2.06458858424438e-287
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F7,Coagulation factor VII,40376,0.0938621038134387,0.00259650681652333,0.088772950453053,0.0989512571738245,4.37113320741463e-275
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,40489,0.0985357138016154,0.00287321880683706,0.0929042049402147,0.104167222663016,8.36138683182643e-249
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,0.220306385558624,0.00653976866024588,0.207488438984542,0.233124332132706,6.10011501213732e-239
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APCS,Serum amyloid P-component,37882,0.103894392769228,0.00311997877660101,0.0977792343670904,0.110009551171366,1.07959342421407e-233
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAMR1,Inactive serine protease PAMR1,40332,0.0798325331522083,0.00244005587822408,0.0750500236308891,0.0846150426735275,2.87043411140657e-227
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL27,C-C motif chemokine 27,40359,0.168671426503003,0.00519766751676102,0.158483998170152,0.178858854835855,9.53929268594561e-224
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFP,Properdin,38013,0.06129510207498,0.00190530776787476,0.0575606988499455,0.0650295053000146,6.84739716867543e-219
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,0.0529341520027556,0.00165831570630106,0.0496838532184055,0.0561844507871056,9.41334299927913e-217
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,40424,0.1272576507771,0.00403497767646371,0.119349094531231,0.135166207022969,7.61301006193311e-212
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0707321286349813,0.00227130259593441,0.0662803755469498,0.0751838817230127,8.76698927287371e-207
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOM,Apolipoprotein M,40372,0.0720547975258799,0.00234573305008823,0.067457160747707,0.0766524343040528,2.38587500498049e-201
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0981014078022603,0.00321761963289099,0.091794873321794,0.104407942282727,1.69634352229934e-197
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL23,C-C motif chemokine 23,40422,0.10915786097139,0.00359432143952001,0.102112990949931,0.116202730992849,5.30000274156724e-197
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TTR,Transthyretin,37871,0.0674131774454032,0.00223494672105213,0.0630326818721411,0.0717936730186654,1.90909816431592e-193
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FURIN,Furin,40411,0.0871953041775319,0.00295962137048682,0.0813944462913778,0.0929961620636861,8.1178800089707e-186
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GHR,Growth hormone receptor,37671,0.0738448503111937,0.00252726406139694,0.0688914127508557,0.0787982878715317,6.27038510172463e-182
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.263761303679276,0.0090634525225625,0.245996936735053,0.281525670623498,1.91636156910156e-181
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,P4HB,Protein disulfide-isomerase,40266,0.0956975495776938,0.00340346278270598,0.0890267625235901,0.102368336631798,8.68626809612435e-170
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPL,Lipoprotein lipase,40359,-0.11347438063938,0.00404000140199186,-0.121392783387284,-0.105555977891476,1.83843036217264e-169
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINF2,Alpha-2-antiplasmin,37755,0.0331966467477467,0.00119436253601906,0.0308556961771493,0.035537597318344,2.55139679535983e-165
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CES1,Liver carboxylesterase 1,40352,0.185688222679779,0.0067104867347196,0.172535668679728,0.198840776679829,1.19852828008775e-164
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCHE,Cholinesterase,37748,0.068714234870491,0.00248770602862306,0.0638383310543898,0.0735901386865922,2.39315498138518e-163
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,39980,0.194901894576039,0.00708580044066011,0.181013725712346,0.208790063439733,1.14857074568496e-162
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN3,Contactin-3,40332,0.0846091777348345,0.0030834150959084,0.0785656841468541,0.090652671322815,5.34754941976219e-162
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLKB1,Plasma kallikrein,37721,0.0606555669414586,0.00221859104329627,0.0563071284965979,0.0650040053863193,3.75646823662883e-160
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROS1,Vitamin K-dependent protein S,38013,0.0603647172481931,0.00220959989438223,0.0560339014552039,0.0646955330411823,5.15894613306065e-160
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,40305,0.210201516509436,0.00774988293606655,0.195011745954746,0.225391287064127,2.11604034036721e-158
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTH,Parathyroid hormone,37572,0.188193848027965,0.0069430100100613,0.174585548408245,0.201802147647685,1.76648321140272e-157
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA5,Plasma serine protease inhibitor,37835,0.0780963920596841,0.00289767214545343,0.0724169546545954,0.0837758294647728,7.63241635924549e-156
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYAP1,Synapse-associated protein 1,37671,0.133745853981132,0.00497495953283504,0.123994933296776,0.143496774665489,4.81587985647037e-155
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL6,C-X-C motif chemokine 6,40516,0.182967654843809,0.00686337300555446,0.169515443752923,0.196419865934696,3.01372567824872e-153
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRP1,Neuropilin-1,40424,-0.0660493027716454,0.00248691984690308,-0.0709236656715754,-0.0611749398717154,4.02284551791142e-152
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA4,Kallistatin,37781,0.0558743021333805,0.00211076902427414,0.0517371948458032,0.0600114094209578,1.56872298792138e-150
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNCA,Alpha-synuclein,37671,0.265577969645275,0.0100328058196773,0.245913670238708,0.285242269051843,1.68997452711088e-150
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INHBC,Inhibin beta C chain,40332,0.0988762220302519,0.00376280778191449,0.0915011187776995,0.106251325282804,5.25396320864421e-149
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,0.243495367145688,0.00926635990767076,0.225333301726653,0.261657432564723,5.30414900619925e-149
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFH,Complement factor H,37301,0.0535995615617902,0.00203561918870711,0.0496097479519243,0.0575893751716562,7.28689680513121e-149
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,0.0425275216582805,0.00163379931685866,0.0393252749972376,0.0457297683193235,3.19400111728422e-146
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.062082290691771,0.00240497166602338,0.0573685462263652,0.0667960351571769,5.4796692972411e-144
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOC1,Apolipoprotein C-I,37981,0.082090490746166,0.00320040474228464,0.0758176974512881,0.0883632840410439,1.00285415973512e-141
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATRN,"Attractin, Isoform 2",38013,0.037036888230225,0.0014445137331982,0.0342056413131565,0.0398681351472934,1.26921640795179e-141
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPIND1,Heparin cofactor 2,37981,0.061816795991282,0.00241540923941229,0.0570825938820339,0.0665509981005301,4.08149079735405e-141
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,40411,0.0568548958189256,0.00223574585921238,0.0524728339348694,0.0612369577029819,7.07659753500716e-140
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFI,Complement factor I,38013,0.0449869277578178,0.00177494874097623,0.0415080282255044,0.0484658272901312,1.64685151123409e-138
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC39A5,Zinc transporter ZIP5,40341,0.119802384489598,0.00473803889640653,0.110515828252641,0.129088940726554,2.48817695080276e-138
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,0.0772671458869347,0.00307228073217836,0.0712454756518651,0.0832888161220043,6.31706680003368e-137
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,0.1760718780005,0.00700465559973574,0.162342753025018,0.189801002975982,9.35333538114238e-137
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,40359,-0.0877891427729929,0.00350811560043671,-0.0946650493498488,-0.0809132361961369,1.36659934775499e-135
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHMP6,Charged multivesicular body protein 6,37990,0.123368261419808,0.00492391276197877,0.113717392406329,0.133019130433286,1.83721065471874e-135
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOST,Sclerostin,40330,0.0851835952603006,0.00342174603879771,0.0784769730242571,0.0918902174963441,3.13679202732312e-134
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F10,Coagulation factor X,37987,0.0568853987469867,0.00229485433265162,0.0523874842549895,0.0613833132389839,1.06910009093874e-132
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSG2,Desmoglein-2,40332,-0.0583810625543192,0.00238730083659486,-0.0630601721940451,-0.0537019529145932,1.10635693662056e-129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD4,T-cell surface glycoprotein CD4,40309,0.0659289541853045,0.00270435903307015,0.060628410480487,0.071229497890122,6.69867558575432e-129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPB2,Carboxypeptidase B2,37981,0.0481569960205234,0.00197788910554299,0.0442803333736591,0.0520336586673876,3.44883297516324e-128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,40141,0.318277706485987,0.0131271074395475,0.292548575904474,0.3440068370675,1.60571869843156e-127
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDHR5,Cadherin-related family member 5,40359,0.0818684421833411,0.00345307229922425,0.0751004204768616,0.0886364638898207,3.80363034305727e-122
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL22,C-C motif chemokine 22,40204,0.107634210091593,0.00456406219508019,0.098688648189236,0.11657977199395,7.09883619033587e-121
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,0.141033326085265,0.00599288629332811,0.129287268950341,0.152779383220188,2.1313240151829e-120
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,39980,0.226934784885974,0.00964136979573677,0.20803770008633,0.245831869685618,2.13661553224634e-120
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAB2,Stabilin-2,37998,0.0581807218408164,0.00247604274481976,0.0533276780609696,0.0630337656206631,1.05710778940976e-119
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORT1,Sortilin,40330,0.0755220694144808,0.00322186911456052,0.0692072059499421,0.0818369328790194,1.75365282545979e-119
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,40355,0.0751369265130319,0.00322104761754429,0.0688236731826451,0.0814501798434187,2.2808319755095e-118
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,0.287638393338743,0.0123649724963334,0.263403047245929,0.311873739431556,2.18294893402944e-117
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,0.151654064368183,0.00657421711124284,0.138768598830147,0.164539529906219,7.94702403658458e-116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPM,Carboxypeptidase M,40415,0.0700108249731976,0.00304110581516375,0.0640502575754767,0.0759713923709186,2.13564991364616e-115
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.0420700703856669,0.00183653658846859,0.0384704586722684,0.0456696820990653,2.79758879097888e-114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLAT,Tissue-type plasminogen activator,40490,0.0995355305572295,0.00435292585448916,0.0910037958824308,0.108067265232028,6.61663776119725e-114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FN1,Fibronectin,38013,0.0532221665299599,0.00232574968477158,0.0486636971478076,0.0577806359121122,9.47499890537218e-114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,0.105655258191839,0.0046336590227363,0.096573286507276,0.114737229876402,2.78574931996841e-113
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.0524718857948727,0.00230170841585682,0.0479605372997933,0.056983234289952,7.39519518942383e-113
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,37598,0.170392002226484,0.00748465847154515,0.155722071622255,0.185061932830712,1.49109191934111e-112
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCS1,Neuronal calcium sensor 1,40489,0.0573289085240047,0.00253902713258264,0.0523524153441427,0.0623054017038667,3.73650765832148e-111
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.0484792601347671,0.00215536028924939,0.0442547539678383,0.0527037663016959,2.53768118320129e-110
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGR3,Anterior gradient protein 3,39963,0.118732778216855,0.00528730659805111,0.108369657284675,0.129095899149035,6.25053854927093e-110
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,40377,0.0790556858147073,0.00354268929221266,0.0721120148019705,0.0859993568274441,1.21140239356967e-108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRIP2,Cysteine-rich protein 2,40228,0.0717273368422089,0.00321472773207823,0.0654264704873356,0.0780282031970823,1.34111355161879e-108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCN2,Ficolin-2,40291,0.0811841163344685,0.00364800694229849,0.0740340227275634,0.0883342099413735,4.60992644903214e-108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,37900,0.133907969785193,0.00602603344521682,0.122096944232568,0.145718995337818,1.80661700305082e-107
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUMB,Protein numb homolog,37598,0.164179646331763,0.00741193447190442,0.149652254766831,0.178707037896696,9.11156028080616e-107
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAA80,N-alpha-acetyltransferase 80,37572,0.2334487174288,0.0105615104741305,0.212748156899504,0.254149277958096,2.50936740772375e-106
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL17,C-X-C motif chemokine 17,40516,0.0811779727681585,0.00368168176873776,0.0739618765014325,0.0883940690348845,3.6362975021825e-106
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADIPOQ,Adiponectin,38013,-0.12946438440873,0.00590390632697393,-0.141036040809599,-0.117892728007861,9.08024912555142e-105
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,0.163295137688965,0.00748238892170814,0.148629655402417,0.177960619975512,4.93461947167134e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRP,Gastrin-releasing peptide,37628,0.105527212214968,0.004833274830017,0.0960539935481348,0.115000430881801,7.65443133119248e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,0.040635138587119,0.00186529522395026,0.0369791599481764,0.0442911172260615,1.0256993156374e-103
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,0.0411538278198189,0.00188753115804887,0.0374542667500431,0.0448533888895947,1.43717928064373e-103
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAPIN,SNARE-associated protein Snapin,37959,0.110791358144333,0.0050928914947876,0.100809290814549,0.120773425474117,3.69074367086831e-103
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAT2,Linker for activation of T-cells family member 2,40305,0.236282408255911,0.0108806259869715,0.214956381321447,0.257608435190375,4.59123171313028e-103
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCG,Pro-glucagon,39980,0.240716702982402,0.0110850387505321,0.218990027031359,0.262443378933444,4.97277827104285e-103
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AFM,Afamin,38013,0.035901162544543,0.00165709929265041,0.0326532479309482,0.0391490771581378,2.36251129187282e-102
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENO3,Beta-enolase,37628,0.108561228308176,0.00504371303137768,0.098675550766676,0.118446905849676,5.04242411173801e-101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,40443,0.0589085195064759,0.0027427723179316,0.05353268576333,0.0642843532496218,6.67272458251018e-101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS15,Enteropeptidase,40305,0.175933779130746,0.00819439956222801,0.159872755988779,0.191994802272713,8.06548641156461e-101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KYNU,Kynureninase,40516,0.0846267609413559,0.00396886522586108,0.0768477850986681,0.0924057367840436,1.66825867328902e-99
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,0.127843189436745,0.00599476118006056,0.116093457523827,0.139592921349664,1.739460123226e-99
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,40280,0.048604057267893,0.00228066944725314,0.0441339451512768,0.0530741693845091,2.21188981960782e-99
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,0.0739927209159328,0.00348055521400576,0.0671708326964815,0.0808146091353841,6.24266667847851e-99
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F9,Coagulation factor IX,40372,0.0339803064533169,0.00159873142541712,0.0308467928594993,0.0371138200471344,7.04970239521233e-99
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EEF1D,Elongation factor 1-delta,37990,0.172004542725748,0.00814527140746941,0.156039810767108,0.187969274684388,2.04678373303635e-97
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,37900,0.148662974731147,0.00708794090303339,0.134770610561202,0.162555338901093,3.88881362314519e-96
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR37,Prosaposin receptor GPR37,40042,0.12470863550305,0.00598097781495209,0.112985918985744,0.136431352020356,2.97468955305607e-95
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTYMK,Thymidylate kinase,37990,0.128485070253983,0.00615962542778959,0.116412204415516,0.140557936092451,3.91413158312333e-95
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.0539067520062324,0.00259257271582557,0.0488253094832143,0.0589881945292505,8.88549189878081e-95
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAP29,Synaptosomal-associated protein 29,40411,0.168435939004014,0.00811981979879255,0.15252109219838,0.184350785809647,2.44185083150738e-94
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,0.108078329404049,0.0052187578623786,0.097849563993787,0.118307094814311,5.27210565703432e-94
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,0.0534760902982303,0.00258348410606188,0.048412461450349,0.0585397191461116,9.89235392183854e-94
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL17,C-C motif chemokine 17,40333,0.166513493293201,0.00806111218485947,0.150713713410876,0.182313273175525,1.44765574206337e-93
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTD,Biotinidase,38013,0.0380000713539297,0.00183924936571242,0.0343951425971333,0.041605000110726,2.1355604307414e-93
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTA3,Glutathione S-transferase A3,39980,0.138670997175579,0.00674026644189306,0.125460074949469,0.15188191940169,8.165512418755e-93
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,0.0379408661995889,0.00184701127949799,0.0343207240917729,0.041561008307405,1.50903975749964e-92
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MLN,Promotilin,40341,0.162204878382528,0.00790709682714076,0.146706968601332,0.177702788163724,2.53704331874808e-92
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUSB,Beta-glucuronidase,40419,0.106688898548052,0.00520526676504405,0.0964865756885656,0.116891221407538,3.55451835746088e-92
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTA1,Glutathione S-transferase A1,40333,0.150598499303384,0.00736613768445803,0.136160869441846,0.165036129164922,1.01246299548423e-91
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YES1,Tyrosine-protein kinase Yes,40305,0.206613881294817,0.0101168512581282,0.186784852828886,0.226442909760748,1.57664983455314e-91
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EHBP1,EH domain-binding protein 1,37990,0.135129102767747,0.00664391811360508,0.122107023265081,0.148151182270413,1.31165644861188e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.0516212903305424,0.00254878904739557,0.0466256637976471,0.0566169168634377,4.40659775159471e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TJAP1,Tight junction-associated protein 1,40411,0.148292360649805,0.00735499941911183,0.133876561788346,0.162708159511264,2.72005788833998e-89
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THPO,Thrombopoietin,40042,0.068514130475176,0.00340468988939182,0.0618409382919681,0.075187322658384,6.17807533656296e-89
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,40305,0.121865256182711,0.00605941407257554,0.109988804600463,0.133741707764959,7.45868622309071e-89
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,40359,0.0535187337287437,0.00266285292267518,0.0482995420003003,0.058737925457187,9.63408446470877e-89
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,0.0719478639364787,0.00357922334060765,0.0649325861888877,0.0789631416840696,1.41081340229842e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,0.15895054337272,0.00792874638344997,0.143410200461158,0.174490886284282,2.68045011106837e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.17493080344293,0.00874942228759617,-0.192079671126618,-0.157781935759241,7.52290663530926e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,40411,0.038053273317627,0.00190655539310932,0.0343164247471327,0.0417901218881213,1.45689910437939e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F2,Prothrombin,38013,0.0260917964942821,0.00131221336896674,0.0235198582911073,0.0286637346974569,9.63148771414145e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,40341,0.0757612064109208,0.00382897559089504,0.0682564142527665,0.0832659985690751,4.24301706202684e-86
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF9,Protein turtle homolog A,37990,0.140196816425566,0.00708930649046026,0.126301775704264,0.154091857146868,7.79473251911937e-86
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,0.0526443161317141,0.00266756170235221,0.0474158951951037,0.0578727370683244,1.74129934214758e-85
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDHR2,Cadherin-related family member 2,40305,0.135169953508594,0.00685763184513688,0.121728995092126,0.148610911925062,1.83151952353444e-85
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GHRL,Appetite-regulating hormone,40359,0.138233749380625,0.00703370221005344,0.124447693048921,0.15201980571233,5.53525406690491e-85
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YTHDF3,YTH domain-containing family protein 3,40044,0.148017696734931,0.00755853002361684,0.133202977888642,0.16283241558122,2.2298068298911e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FYB1,FYN-binding protein 1,40311,0.159470040500803,0.00814937617146096,0.143497263204739,0.175442817796866,2.83212671682225e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYH9,Myosin-9,37998,0.195878288611109,0.010006480678798,0.176265586480665,0.215490990741553,3.65154903465496e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,0.165406641382201,0.00849652752620886,0.148753447430831,0.18205983533357,1.93646119702398e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEG1,Protein HEG homolog 1,37671,0.0458067010770414,0.00235552511618016,0.0411898718493283,0.0504235303047545,4.49808561132637e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SARG,Specifically androgen-regulated gene protein,37931,0.187458180444492,0.00968057398842929,0.168484255427171,0.206432105461814,2.02386809892332e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAB2,Disabled homolog 2,40489,0.190035445340153,0.00983331723522476,0.170762143559112,0.209308747121194,2.8126337950748e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL16,Pro-interleukin-16,40516,0.0695859121154034,0.00360162112797898,0.0625267347045646,0.0766450895262422,3.07804086254577e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1S,Complement C1s subcomponent,38013,0.0357231482281487,0.00185110037012755,0.0320949915026987,0.0393513049535987,6.92640965836512e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,40332,-0.0697117169915445,0.00362763355309273,-0.0768218787556063,-0.0626015552274828,2.24121354852403e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CES2,Cocaine esterase,40305,0.0917801527383335,0.00478051715764259,0.082410339109354,0.101149966367313,3.16012254283129e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,37671,0.126576568785364,0.00659052655515606,0.113659136737259,0.13949400083347,4.19416198777365e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKK1,Dickkopf-related protein 1,40471,0.101998352414264,0.00532162519689309,0.091567967028354,0.112428737800175,5.64686082739472e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPD52L2,Tumor protein D54,37671,0.184666425587815,0.00962622406511776,0.165799026420184,0.203533824755445,6.35030053115829e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPC5,Glypican-5,40228,0.0957658451079012,0.00500540517697244,0.0859552509610352,0.105576439254767,1.10899676979701e-80
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL5,C-X-C motif chemokine 5,40309,0.19538668993407,0.010240416211559,0.175315474159414,0.215457905708725,2.93473893980779e-80
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,0.142562915194093,0.00749773035142561,0.127867363705299,0.157258466682887,1.42169017211596e-79
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CREG1,Protein CREG1,40145,0.0610999412413664,0.00321970496999012,0.0547893195001858,0.0674105629825471,2.04994499827554e-79
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300LG,CMRF35-like molecule 9,40332,-0.0637549155277118,0.00336449958596042,-0.0703493347161942,-0.0571604963392294,3.34280626990177e-79
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINC1,Antithrombin-III,37981,0.0249290755290948,0.00131471900010794,0.0223522262888833,0.0275059247693064,3.75804064631376e-79
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UPB1,Beta-ureidopropionase,37990,0.153875811407486,0.00814639355982008,0.137908880030239,0.169842742784734,1.43885319091589e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP5,Retinol-binding protein 5,40305,0.09318471420843,0.00494167396519622,0.0834990332366454,0.102870395180215,1.85945525598438e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,0.0914599394157282,0.00485036817334942,0.0819532177959634,0.100966661035493,1.89901368610863e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MINK1,Misshapen-like kinase 1,37942,0.155865501796108,0.00826149186888186,0.1396729777331,0.172058025859116,2.18931274216281e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,37990,0.180019645626165,0.00955016825703543,0.161301315842376,0.198737975409955,2.94960172506605e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,39961,0.132668711265645,0.00705031561758089,0.118850092655186,0.146487329876103,4.02642162211057e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,0.0912337829535839,0.00486365546382136,0.081701018244494,0.100766547662674,1.18485776615252e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KAZN,Kazrin,37901,0.173879219725453,0.00926196430120392,0.155725769695093,0.192032669755813,1.2198949994485e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLA,Alpha-galactosidase A,37642,0.0606487117651642,0.00323035382592984,0.0543172182663417,0.0669802052639867,1.24791383271763e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,40192,0.0398257714862931,0.00212632025766327,0.0356581837812731,0.0439933591913131,1.95973387405821e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINF1,Pigment epithelium-derived factor,37790,0.0433152940548931,0.00231433124469484,0.0387792048152912,0.047851383294495,3.553367393904e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,40283,0.0537652554078071,0.00287759515559802,0.048125168902835,0.0594053419127792,4.49356002146985e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,0.139712433322915,0.00747719619274166,0.125057128785141,0.154367737860688,6.1244425940805e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,0.186006450943031,0.00995570042470326,0.166493278110613,0.205519623775449,6.54210634504816e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GDF2,Growth/differentiation factor 2,40359,0.0595224363019632,0.00319143319291126,0.0532672272438571,0.0657776453600692,8.21163913388252e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,0.159411210683879,0.00854478377227175,0.142663434490226,0.176158986877531,1.03675133550187e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OTUD7B,OTU domain-containing protein 7B,37959,0.105007293972672,0.00563817731054761,0.0939564664439982,0.116058121501345,1.84525649791835e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,40471,0.136236925705436,0.00733074971890922,0.121868656256374,0.150605195154498,2.72679782027316e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEFTY2,Left-right determination factor 2,40453,0.0861857413324257,0.00463889474128818,0.0770935076395009,0.0952779750253505,3.01366094294151e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,0.177971253294738,0.00957492565240716,0.15920439901602,0.196738107573456,3.63467716631639e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.0447484691530143,0.00241446417915104,0.0400161193618783,0.0494808189441504,7.03903733141681e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,37628,0.119618782365368,0.00645420035337113,0.106968549672761,0.132269015057976,1.0141382542949e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,37959,0.188363328481871,0.0101727808971448,0.168424677923467,0.208301979040275,1.31002052387025e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AXIN1,Axin-1,40341,0.155158563330379,0.00839296348054909,0.138708354908503,0.171608771752255,1.63349818330692e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,0.139359814397815,0.00753163849695379,0.124597802943786,0.154121825851845,1.75267236111524e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRAP1,Proline-rich acidic protein 1,37998,0.0698810640342168,0.00377818494987202,0.0624758215324677,0.077286306535966,1.88606548615812e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMBP,Protein AMBP,40470,0.0329854169229283,0.00178744035956509,0.0294820338181807,0.0364888000276759,2.91603862496889e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,40536,-0.0569600859917037,0.00308920630400351,-0.0630149303475506,-0.0509052416358569,3.83868484738077e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,0.136798866882895,0.00741564889724777,0.122264195044289,0.151333538721501,4.7796530577888e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,40341,0.0454604180769103,0.0024711565926783,0.0406169511552609,0.0503038849985598,8.38474243019488e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,0.109850587849899,0.00598100732972058,0.0981278134836471,0.121573362216152,1.49669453606896e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F13B,Coagulation factor XIII B chain,37934,0.0423532416983175,0.00230677236960472,0.0378319678538922,0.0468745155427427,2.1934605119664e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,37901,0.156034983160433,0.00850842889019463,0.139358462535652,0.172711503785215,3.24422027460534e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,40422,0.204330893965257,0.0111563183653619,0.182464509969147,0.226197277961366,3.58950413122409e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,40497,-0.103821310326887,0.00567340088029802,-0.114941176052272,-0.0927014446015034,4.71413442643708e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,0.158954045183686,0.00868673579584382,0.141928043023832,0.17598004734354,4.91614488765243e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,40341,0.172718818664952,0.00946917006570659,0.154159245336167,0.191278391993737,1.39559224788258e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.051858968159054,0.00284499133233551,0.0462827851476764,0.0574351511704316,1.71469022845952e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD63,CD63 antigen,40203,0.0849538738443984,0.00466178311702614,0.0758167789350272,0.0940909687537696,1.90871058307998e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATG16L1,Autophagy-related protein 16-1,37901,0.13781326116879,0.00755742943413275,0.123000699477889,0.15262582285969,2.06442748890381e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXNA4,Plexin-A4,40341,0.134180938209294,0.00737468911057048,0.119726547552576,0.148635328866012,3.14129982487815e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,0.168270913545763,0.00926097801958992,0.150119396627366,0.186422430464159,4.9017935388878e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5E,5'-nucleotidase,40411,0.0939571318175457,0.00517159164573116,0.0838208121919127,0.104093451443179,5.03845771533537e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXLNA,Alpha-taxilin,40228,0.144558603779653,0.00797020113254195,0.128937009559871,0.160180197999435,8.85789312193652e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AAMDC,Mth938 domain-containing protein,37628,0.0866377341606775,0.00479201985710949,0.0772453752407429,0.0960300930806121,3.4328330758914e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,40192,0.118240895968979,0.00655933609608088,0.10538459722066,0.131097194717297,6.39411729432232e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP20,Centrosomal protein 20,39980,0.118157678184844,0.00657807135946715,0.105264658320288,0.1310506980494,2.02718936337234e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLIN1,Perilipin-1,39961,0.0569850640860816,0.0031724957477236,0.0507669724205433,0.0632031557516198,2.03628010243916e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,0.073000329189132,0.0040651447276478,0.0650326455229423,0.0809680128553217,2.13112666239449e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0975457589269942,0.00543453217175664,0.0868940758703512,0.108197441983637,2.4616363644833e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFC,Vascular endothelial growth factor C,40411,0.0893652341459842,0.00499105919863496,0.0795827581166597,0.0991477101753087,5.32623756711778e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,37628,0.164453435199683,0.00918170994327443,0.146457283710865,0.182449586688501,6.69386714505548e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORD,Sorbitol dehydrogenase,40417,0.106885156924183,0.00597424315455589,0.0951756403412538,0.118594673507113,6.81866636507052e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM20A,Pseudokinase FAM20A,37990,0.045133545316748,0.00252653235445127,0.0401815419020235,0.0500855487314725,1.45382490727802e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F11,Coagulation factor XI,37810,0.0483161987118516,0.00270783423696864,0.0430088436073931,0.0536235538163101,2.14095752687281e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTSS2,Protein MTSS 2,37900,0.156022133216583,0.00878461078174886,0.138804296084355,0.17323997034881,8.88326106552187e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDC4,Syndecan-4,40359,0.0717280687052526,0.0040436740614982,0.0638024675447161,0.0796536698657891,9.94882045722289e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,37920,0.131956729308512,0.00743581437292445,0.11738253313758,0.146530925479444,1.14509508616173e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,37900,0.0810237274788665,0.00456674854070637,0.072072900339082,0.089974554618651,1.23086528301014e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPY30,Protein dpy-30 homolog,40414,0.0941534683985695,0.00531289803889927,0.0837401882423269,0.104566748554812,1.32346583787238e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELN,Elastin,37990,0.0556097824267848,0.00314115128958056,0.0494531258992069,0.0617664389543627,2.3732735271351e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,40471,0.151913147928078,0.00860625871220663,0.135044880852153,0.168781415004003,4.46659371058003e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CMIP,C-Maf-inducing protein,37900,0.12959151644486,0.00733760000399651,0.115209820437026,0.143973212452693,5.0030032397938e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAS6,Growth arrest-specific protein 6,40429,-0.0405585608281324,0.00229876417184006,-0.0450641386049389,-0.0360529830513259,5.13774981305649e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,0.107623193096623,0.00609341111702078,0.0956801073072618,0.119566278885983,5.15235836559719e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,40434,0.114131721548523,0.00647033037839412,0.101449874006871,0.126813569090176,5.54253751962827e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXNB3,Plexin-B3,40310,0.0735111386661272,0.00416926191166332,0.0653393853192671,0.0816828920129873,6.39220207372891e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTSS1,Protein MTSS 1,37901,0.174578485978483,0.00989334054898085,0.155187538502481,0.193969433454486,6.51166034107422e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,40312,0.0320340644609067,0.00181740897118483,0.0284719428773844,0.035596186044429,7.02627395799385e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTBDN,Retbindin,40305,0.0461423419116205,0.00261943046509732,0.0410082582000298,0.0512764256232113,8.48133442730707e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,40044,0.0637538203362906,0.00362339123143684,0.0566519735226744,0.0708556671499068,1.23671011497034e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCTN3,Tectonic-3,37990,0.0457195920310713,0.00260898479856908,0.0406059818258759,0.0508332022362667,5.29299498479393e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F11R,Junctional adhesion molecule A,40332,0.0884479604024981,0.00505180947471803,0.0785464138320508,0.0983495069729454,5.39825910716127e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOK2,Docking protein 2,40359,0.188676108351093,0.0107846694619174,0.167538156205735,0.209814060496451,6.77506491844661e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,0.117072159392128,0.006686785435027,0.103966059939475,0.130178258844781,7.28908311067434e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK10,Kallikrein-10,40354,0.0614176343219143,0.00351496154764361,0.0545283096885328,0.0683069589552958,9.83703226328548e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELP,P-selectin,40403,0.0899894231488369,0.00515158073995397,0.0798923248985271,0.100086521399147,1.06528865027756e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,0.0648238379047123,0.00371385854069719,0.0575446751649458,0.0721030006444788,1.36090170556684e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",39961,0.0854501376627206,0.00489831007148436,0.0758494499226113,0.0950508254028299,1.66123240628146e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,37942,0.138143840738589,0.00792035152356466,0.122619951752402,0.153667729724776,2.18340532049269e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD6,T-cell differentiation antigen CD6,40502,0.0826714235909837,0.00475200547365631,0.0733574928626173,0.0919853543193501,3.58098949470521e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18R1,Interleukin-18 receptor 1,40516,0.0506323747884132,0.00291141663756265,0.0449259981787904,0.056338751398036,3.97665182718256e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USO1,General vesicular transport factor p115,40305,0.140896100569327,0.00810923013899721,0.125002009496892,0.156790191641762,5.34510917177685e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL13,C-X-C motif chemokine 13,40471,0.0983737766815743,0.0056683088959066,0.0872638912455973,0.109483662117551,7.38162831373079e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFC,Platelet-derived growth factor C,39980,0.046080618885625,0.00265641079736053,0.0408740537227983,0.0512871840484516,8.85764686828401e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,0.141067011132926,0.00812841184975559,0.125135323907405,0.156998698358447,9.66173918230303e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CES3,Carboxylesterase 3,40305,0.10638144760344,0.00614089361291657,0.0943452961221236,0.118417599084757,1.28464866738476e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARF6,ADP-ribosylation factor 6,37901,0.162808162124508,0.00939306937574827,0.144397746148041,0.181218578100974,1.40522262513318e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,0.0417686896117261,0.0024103324935631,0.0370444379243424,0.0464929412991098,1.49856038766937e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R9B,Neurabin-2,40516,0.145253219558712,0.00839247083918818,0.128803976713903,0.161702462403521,1.65378170574768e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,37942,0.072076989368632,0.00416666714712832,0.0639103217602605,0.0802436569770035,2.50555515094387e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBIN,Erbin,40305,0.158223872755133,0.00916600261103204,0.14025850763751,0.176189237872755,3.65555249647884e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACY1,Aminoacylase-1,40359,0.0917414185916941,0.00531747144642279,0.0813191745567055,0.102163662626683,4.25502742258539e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCR,Breakpoint cluster region protein,40341,0.140202344178407,0.00814152376873431,0.124244957591687,0.156159730765126,7.35883414403727e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,0.107637329096786,0.00625861270993429,0.0953704481853149,0.119904210008257,1.10970024173257e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,0.167402131038855,0.00973353919058878,0.148324394225301,0.186479867852409,1.36869125168028e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP10,Stromelysin-2,40341,-0.0920472198561993,0.00535952809797129,-0.102551894928223,-0.0815425447841756,1.60819163641384e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,0.163192881908891,0.00949717187254901,0.144578425038695,0.181807338779087,1.80808264835835e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,37671,0.126410495405062,0.007357749709822,0.11198930597381,0.140831684836313,1.90291650210865e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BPIFB1,BPI fold-containing family B member 1,40261,-0.0945519701410925,0.00551023806125217,-0.105352036741147,-0.0837519035410383,2.09283269131197e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL3,C-X-C motif chemokine 3,40350,0.142616608108596,0.00832323637247985,0.126303064818536,0.158930151398657,3.14576792271402e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOMO1,Nodal modulator 1,40332,0.0362689559372658,0.0021171475084743,0.0321193468206561,0.0404185650538754,3.35388309702021e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,40341,0.171083107873079,0.00999598121268098,0.151490984696224,0.190675231049934,4.37937109205861e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BECN1,Beclin-1,37628,0.0933765990759787,0.00545094864885112,0.0826927397242306,0.104060458427727,4.45828401872898e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL16,C-C motif chemokine 16,40536,0.0807861498682648,0.00472980493398105,0.071515732197662,0.0900565675388677,7.76700655340066e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,40228,0.090576048441931,0.00530395324770867,0.080180300076422,0.10097179680744,8.39973523567624e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD99L2,CD99 antigen-like protein 2,40332,0.0362976913539106,0.00212717207809444,0.0321284340808455,0.0404669486269757,1.04075095562272e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,0.105328717350424,0.00617290115838522,0.0932298310799892,0.117427603620859,1.07966677879389e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,0.165363393705827,0.0096886366008883,0.146373665968086,0.184353121443568,1.24008110743667e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,40303,0.07379289314294,0.0043324671812701,0.0653012574676506,0.0822845288182294,1.76470137478208e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A4,Protein S100-A4,40411,0.087964137814726,0.00516473314334953,0.0778412608537609,0.0980870147756911,1.77411236941519e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTN1,Dynactin subunit 1,40489,0.100080100048454,0.0058808521630387,0.0885536298088986,0.11160657028801,2.21980171455997e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,37901,0.0601154205529228,0.003543699460658,0.0531697696100331,0.0670610714958125,6.98929109690322e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCK2,Cytoplasmic protein NCK2,40422,0.157783307045006,0.00934019690275504,0.139476521115606,0.176090092974406,1.80367206111024e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCBP2,Poly(rC)-binding protein 2,37959,0.108481496509318,0.00641819047002973,0.0959018431880598,0.121061149830576,1.9428922061778e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,37990,0.136089812017873,0.00805179517903769,0.120308293466959,0.151871330568787,1.94909479524646e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCLY,Selenocysteine lyase,40434,0.0718706910822655,0.00426440954357926,0.0635124483768502,0.0802289337876809,3.46614839135402e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,37959,-0.0683045747494659,0.00405216187148546,-0.0762468120175774,-0.0603623374813544,4.15777546590488e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RILPL2,RILP-like protein 2,37990,0.146567872039702,0.00870349093315066,0.129509029810726,0.163626714268677,5.41935232056274e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,0.143223588443301,0.00852858810646401,0.126507555754631,0.15993962113197,9.43459055532628e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLSCR3,Phospholipid scramblase 3,37919,0.0898458808118551,0.00535576383782377,0.0793485836897205,0.10034317793399,1.58703365047238e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,40042,0.0515498651707398,0.00307755691247687,0.0455178536222851,0.0575818767191944,1.98042923909064e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,37557,0.126658915640621,0.007561910398159,0.11183757126023,0.141480260021013,2.5322808651226e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IKBKG,NF-kappa-B essential modulator,40341,0.137548152249735,0.00822803355178018,0.121421206488246,0.153675098011224,3.34847485237643e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,37990,0.0975410080963406,0.00583785299485006,0.0860988162264345,0.108983199966247,4.75936881971336e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGCC,Regulator of cell cycle RGCC,37959,0.111851124377638,0.00669790167715,0.0987232370904243,0.124979011664852,5.53019482440529e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLA2,Src-like-adapter 2,37959,0.153888265001966,0.00922213297495049,0.135812884371063,0.171963645632869,6.79932051051814e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGFR,Epidermal growth factor receptor,40536,0.024407730139518,0.00146538726263249,0.0215355711047583,0.0272798891742777,8.98455759447864e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINH1,Serpin H1,37714,0.191905239594874,0.0115154179811887,0.169335020351744,0.214475458838003,9.97093515860383e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THOP1,Thimet oligopeptidase,40288,0.0446059984946985,0.00267973155706958,0.0393537246428421,0.0498582723465549,1.08682988117703e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS1,Galectin-1,40359,0.0500745544932545,0.00301100369422641,0.0441729872525708,0.0559761217339383,1.38685145530687e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,40305,0.204914867208727,0.0123307774243794,0.180746543456943,0.229083190960511,1.70520837700962e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,0.148611091062499,0.00894680804642429,0.131075347291508,0.166146834833491,1.90312705533702e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KHK,Ketohexokinase,37628,0.0957845907855522,0.0057643658444607,0.0844864337304092,0.107082747840695,2.22102870965049e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.068602387871638,0.00413239649526381,0.0605028907409209,0.0767018850023551,2.86341158004626e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,37987,0.0401883888439979,0.00242325606998628,0.0354388069468248,0.044937970741171,3.61969700160972e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APPL2,DCC-interacting protein 13-beta,37671,0.165705931968298,0.00999052058793018,0.146124511615955,0.185287352320641,3.6285749233461e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUCB2,Nucleobindin-2,40447,0.0550730884590675,0.00332394948604754,0.0485581474664143,0.0615880294517207,3.80032095442232e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BID,BH3-interacting domain death agonist,40341,0.0993202711641422,0.00599459427486035,0.0875708663854159,0.111069675942868,3.84638874141231e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,40357,0.0415417889800419,0.0025102941562311,0.036621612433829,0.0464619655262549,5.30320830293565e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,0.0681728664054131,0.0041209552150475,0.06009579418392,0.0762499386269062,5.89570167360038e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN2,CCN family member 2,40358,0.0848174009512479,0.00515151233170473,0.0747204367811067,0.0949143651213892,2.08339160447544e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFX1,Transcriptional repressor NF-X1,37562,0.100283195440895,0.00608982616807026,0.088347136151477,0.112219254730312,2.53754158122335e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP85,Centrosomal protein of 85 kDa,39980,0.0926576779229303,0.00563765015926736,0.0816078836107662,0.103707472235094,3.43179442180787e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAP23,Synaptosomal-associated protein 23,40359,0.127759654473454,0.00777820498122997,0.112514372710244,0.143004936236665,3.9373609614846e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C4BPB,C4b-binding protein beta chain,40411,0.0606533696666731,0.00369579617881952,0.0534096091561868,0.0678971301771593,4.91323907507909e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP5,Fatty acid-binding protein 5,40432,0.101518051526051,0.0061866729188946,0.0893921726050176,0.113643930447084,5.09203393021443e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,40357,0.0738619570096651,0.00450279698232648,0.0650364749243052,0.082687439095025,5.60288201976353e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL5,C-C motif chemokine 5,40403,0.146968847018793,0.00896176046068719,0.129403796515847,0.16453389752174,5.96049930046529e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,0.15061025118735,0.00918372048338554,0.132610159039915,0.168610343334786,7.31645721095855e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA5,Integrin alpha-5,40332,0.0365003590429968,0.00222883293852304,0.0321318464834916,0.040868871602502,8.70496391015706e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLG,Plasminogen,37705,0.0328536788036758,0.0020068905026614,0.0289201734184594,0.0367871841888921,1.19565180199904e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,0.16987084267871,0.0103858089276319,0.149514657180551,0.190227028176869,1.2124103509458e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,37900,0.167301455310365,0.0102231121709004,0.1472641554554,0.187338755165329,1.27976217908822e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,0.151544786564963,0.00928375462825318,0.133348627493587,0.16974094563634,2.02812433710761e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEP,Leptin,40359,0.0932414875302732,0.00571669169024947,0.0820367718173842,0.104446203243162,2.5219744201763e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,0.0775922687268044,0.00475661249173415,0.0682693082430054,0.0869152292106033,2.97741189562023e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCXR,L-xylulose reductase,40411,0.0761662402763414,0.00467951423396691,0.0669943923777663,0.0853380881749166,4.33300607828139e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IST1,IST1 homolog,37812,0.145923978560962,0.00896406255984467,0.128354415943667,0.163493541178258,5.15820679831574e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,0.0940011458887445,0.00577866533072022,0.0826749618405329,0.105327329936956,6.13140477920839e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,37950,0.0288557906375788,0.00177702842947624,0.0253728149158054,0.0323387663593522,9.74209949946131e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP4,Dipeptidyl peptidase 4,40068,0.043467770551375,0.00267901273162119,0.0382169055973974,0.0487186355053525,1.00932471520515e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,0.0332970762950823,0.0020530985823738,0.0292730030736296,0.0373211495165349,1.11464693565688e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,39980,0.0719318831422504,0.00444055941147836,0.0632283866957528,0.080635379588748,1.55102365137716e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.0386170609737821,0.00238632322640947,0.0339398674500196,0.0432942544975447,1.95446579390656e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL13,C-C motif chemokine 13,40483,0.100847318548164,0.00624226423502257,0.0886124806475198,0.113082156448808,2.9919630467877e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,37959,0.109564850007075,0.0067829622115103,0.0962702440725153,0.122859455941636,3.79222020859012e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,0.129253898711407,0.00800389505573679,0.113566264402163,0.144941533020651,4.06780271085322e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,0.107382347138161,0.00665352588490551,0.0943414364037459,0.120423257872576,4.90128115736338e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPON2,Spondin-2,40267,-0.0498119525124493,0.00309281087062101,-0.0558738618188665,-0.0437500432060321,6.71450706225143e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEC31A,Protein transport protein Sec31A,37628,0.11037712620953,0.00684908922482692,0.0969529113288694,0.123801341090191,7.08060782517522e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBPL,FK506-binding protein-like,37901,0.0850248242379881,0.0052791983552722,0.0746775954616545,0.0953720530143216,8.08389872573111e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBCC,Tubulin-specific chaperone C,40228,0.117193429558746,0.00728332548311251,0.102918111611845,0.131468747505646,8.5549957210031e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,0.102592839531581,0.00637914657842386,0.0900897122378701,0.115095966825292,1.19083732902871e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMOX2,Heme oxygenase 2,39961,0.0656979100107238,0.00409059703962352,0.0576803398130617,0.0737154802083859,1.4008841936362e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOXO1,Forkhead box protein O1,40341,0.12159060408627,0.00757561934014658,0.106742390179583,0.136438817992957,1.61241008711794e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,37598,0.140467487908133,0.00876292822314849,0.123292148590762,0.157642827225504,2.76230620177235e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,0.0820763297398445,0.00512112869405281,0.072038917499501,0.092113741980188,2.87643057558123e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGRN,Agrin,40422,0.047561710642031,0.00297018248545426,0.0417401529705407,0.0533832683135214,2.89094913936037e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,37598,0.127385038491167,0.00795079098227819,0.111801488165902,0.142968588816433,3.13703088090124e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0588269102047996,0.00367532552242371,0.0516232721808491,0.06603054822875,3.28783718948852e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,37863,0.0621673550124964,0.00388848502387453,0.0545459243657023,0.0697887856592905,5.24367059352101e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLTP,Phospholipid transfer protein,40461,-0.0489144508139796,0.00306246335113255,-0.0549168789821994,-0.0429120226457598,5.49531373444454e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBC1D23,TBC1 domain family member 23,40305,0.127809707332933,0.0080335018906444,0.11206404362727,0.143555371038596,1.48921687901678e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,0.153251314996725,0.00964453706152476,0.134348022356136,0.172154607637313,2.40765424758108e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTBS,Di-N-acetylchitobiase,37819,0.0385609746481813,0.00242714944717909,0.0338037617317103,0.0433181875646523,2.538729672981e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,0.0445060380943387,0.00280180823552208,0.0390144939527154,0.0499975822359619,2.68923958010208e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRPK2,SRSF protein kinase 2,40341,0.117522465938167,0.00740580277247728,0.103007092504112,0.132037839372223,2.81167295992685e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHBG,Sex hormone-binding globulin,37987,-0.076572728481346,0.00483292999168996,-0.0860452712650583,-0.0671001856976337,4.93181377892369e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNPY4,Protein canopy homolog 4,40305,0.106067532399486,0.00670248930053545,0.0929306533704367,0.119204411428536,5.60225182540001e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,0.134149098134385,0.00848727159562483,0.117514045806961,0.15078415046181,7.59676165639681e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,40516,0.0791568824648092,0.00500979407895792,0.0693376860700517,0.0889760788595668,8.1333505288911e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,40422,0.147602106395786,0.00934560301993063,0.129284724476722,0.16591948831485,9.07829868347443e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,0.10284755141513,0.00651859442636729,0.0900711063394497,0.115623996490809,1.1694110125189e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPPC,C-type natriuretic peptide,40341,0.0609244018263287,0.00386227554282018,0.0533543417624011,0.0684944618902563,1.23716810690253e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MITD1,MIT domain-containing protein 1,40228,0.13645919471689,0.00866449091750193,0.119476792518586,0.153441596915193,1.83835571376764e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,0.0972888301584042,0.00617536199670853,0.0851851206448554,0.109392539671953,1.99850293292683e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,0.141638543701302,0.00900430690429485,0.123990102168884,0.15928698523372,2.45987688235833e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,0.0708289293509414,0.00450702368047963,0.0619951629372013,0.0796626957646815,3.17158627083267e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,0.157323234846663,0.010012431778368,0.137698868561061,0.176947601132264,3.24769867136747e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,37959,0.166460098054064,0.0105988446239618,0.145686362591099,0.187233833517029,4.25764246418667e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF21,Fibroblast growth factor 21,40453,0.164513530469603,0.0104895112356149,0.143954088447798,0.185072972491408,5.02838764248188e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA11,Annexin A11,40312,0.0945444601179604,0.0060359306113943,0.0827140361196276,0.106374884116293,6.91389648306156e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,0.127772675269705,0.00815190523771761,0.111794941003779,0.143750409535632,6.94415771839754e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLK1,Protein delta homolog 1,40536,0.074242530056444,0.00474717247140342,0.0649380720124934,0.0835469881003947,9.93954337338746e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,40305,0.0453817267827673,0.0029052342298939,0.0396874676921752,0.0510759858733593,1.34364416171055e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,0.128911408924071,0.0082563111315964,0.112729039106142,0.145093778742,1.5205133398678e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPOCK1,Testican-1,40228,0.0352374942137851,0.00225856157905427,0.0308107135188387,0.0396642749087315,1.80798111875093e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPING1,Plasma protease C1 inhibitor,37981,0.0260376577586101,0.00166890209963324,0.022766609643329,0.0293087058738913,2.11092237768133e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VNN1,Pantetheinase,37987,0.101189961425782,0.00648968877165853,0.0884701714333317,0.113909751418233,2.43248015098927e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP3B1,AP-3 complex subunit beta-1,37901,0.106641170628589,0.00684076578075536,0.0932332696983082,0.120049071558869,2.57881304176219e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAXX,Protein PAXX,37671,0.0632870145975191,0.00406094084640318,0.0553275705385688,0.0712464586564693,2.82657192660195e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,0.101320285546359,0.00650457948006631,0.0885713097654294,0.114069261327289,3.09379032812396e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BACH1,Transcription regulator protein BACH1,40341,0.101182784463498,0.00650487926063792,0.0884332211126478,0.113932347814348,3.69580129718315e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEXIM1,Protein HEXIM1,40341,0.113795252496623,0.00731906380206387,0.0994498874445774,0.128140617548668,4.12339477564953e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNMBP,Dynamin-binding protein,40228,0.0858857577021401,0.0055258302546971,0.0750551304029338,0.0967163850013464,4.49504001313131e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,0.116825539223045,0.00751938616383639,0.102087542341926,0.131563536104164,4.89373440628251e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD2AP,CD2-associated protein,40359,0.0889374841295971,0.00572602679025387,0.0777144716206995,0.100160496638495,5.2386999482532e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,0.0733899193088358,0.0047221204895302,0.0641345631493566,0.082645275468315,5.41497382035142e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,0.0912899812916767,0.00588062555127009,0.0797639552111873,0.102816007372166,6.98251480916572e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GH1,Somatotropin,40330,-0.243246196691727,0.0156837756710273,-0.273986397006941,-0.212505996376514,7.43854040330407e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OPHN1,Oligophrenin-1,37942,0.148403909152969,0.00957407167068418,0.129638728678428,0.16716908962751,9.97957421829786e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,37671,0.109645149667999,0.00707397173255055,0.0957801650722,0.123510134263798,1.03237368383286e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.0334788125072333,0.00216330948924614,0.0292387259083109,0.0377188991061557,1.24616889891668e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,0.106624896177144,0.00688853816433842,0.0931233613750409,0.120126430979247,1.39513424181065e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD1,Sushi domain-containing protein 1,40042,0.0682869158254661,0.00441484563930958,0.0596338183724193,0.0769400132785129,1.43580518607516e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,0.144150705245484,0.00934378085872733,0.125836894762378,0.16246451572859,2.61506438429295e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EZR,Ezrin,40471,0.0326881252201619,0.00212009621559069,0.0285327366376041,0.0368435138027197,2.978164210757e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,39961,0.0933946571370596,0.00606185975393427,0.0815134120193484,0.105275902254771,3.64065460733279e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD22,B-cell receptor CD22,40516,0.0565258630107754,0.00367347901784132,0.0493258441358064,0.0637258818857443,4.74155186148689e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,0.0872450262385021,0.00566604526685709,0.0761395775154622,0.098350474961542,4.87964147402026e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,40228,0.0404465316267119,0.00263063025616247,0.0352904963246335,0.0456025669287904,5.8110479836845e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NIT2,Omega-amidase NIT2,37936,0.104058200113624,0.00676938511880184,0.0907902052807724,0.117326194946476,7.09245262835848e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL10,C-X-C motif chemokine 10,40422,0.0926874841978215,0.00604627664707037,0.0808367819695635,0.104538186426079,1.14854689397219e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPL,N-acetylneuraminate lyase,37990,0.0591507063231621,0.00386462131417963,0.05157604854737,0.0667253640989542,1.92423234882568e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM13A,Protein FAM13A,37901,0.0923040812837161,0.00603668770463157,0.0804721733826382,0.104135989184794,2.43581145570069e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STK11,Serine/threonine-protein kinase STK11,40042,0.0999035108017752,0.00653818591319544,0.0870886664119122,0.112718355191638,2.48810181112806e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.120307049890398,0.00788471811590043,0.104853002383233,0.135761097397562,3.38792672225675e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,METAP2,Methionine aminopeptidase 2,40453,0.0804059581955742,0.00527500181382712,0.070066954640473,0.0907449617506754,4.26688504235143e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,37671,0.171200764617459,0.0112241732217784,0.149201385102773,0.193200144132145,4.37192850334346e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDHD2,Phospholipase DDHD2,37959,0.0903977499122053,0.00592938328151015,0.0787761586804454,0.102019341143965,4.76420570163297e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD36,Platelet glycoprotein 4,37598,0.0606963301597077,0.0039818371940475,0.0528919292593746,0.0685007310600408,5.07698035583318e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,0.131638332667314,0.00864898159222386,0.114686328746556,0.148590336588073,6.14435569350133e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,40044,0.0950463871686968,0.00624615562521657,0.0828039221432723,0.107288852194121,6.45813628704048e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUOM,Fucose mutarotase,37671,0.0851549966036592,0.005593027893415,0.0741926619325658,0.0961173312747526,6.62705337107527e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,40422,0.116626773337825,0.00767475233935253,0.101584258752694,0.131669287922956,8.63331648816957e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,0.0619573479028638,0.00407743527274705,0.0539655747682796,0.069949121037448,1.04079760151903e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AZI2,5-azacytidine-induced protein 2,37959,0.0748953982717939,0.00493631975632877,0.0652202115493895,0.0845705849941983,1.43469664057231e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP43,Centrosomal protein 43,39934,0.0937633878239544,0.00618363880956475,0.0816434557572075,0.105883319890701,1.45510854552532e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,40305,0.115795600466286,0.00765012015834054,0.100801364955939,0.130789835976634,2.12921188822884e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA3F,Semaphorin-3F,40359,0.0350526596268103,0.00231740826627778,0.0305105394249058,0.0395947798287147,2.49019964899459e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA4D,Semaphorin-4D,40471,0.0404507584185129,0.00267452683580468,0.0352086858203357,0.0456928310166901,2.52657181355836e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYDGF,Myeloid-derived growth factor,37990,0.13605962614239,0.00899906044291473,0.118421467674277,0.153697784610503,3.16295915408865e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAG1,Dystroglycan,40422,0.0640265826894566,0.00423952950505505,0.0557171048595487,0.0723360605193645,3.52931298970836e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASAH2,Neutral ceramidase,40228,0.0711650081991244,0.00471505134623528,0.0619235075605032,0.0804065088377455,4.08556775421833e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRKL,Crk-like protein,40374,0.143931694067586,0.00953945866581502,0.125234355082588,0.162629033052583,4.37765890989264e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,0.10832076608422,0.00718309778371276,0.0942418944281427,0.122399637740297,4.94775174234175e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,0.0856286847788747,0.00568242661664273,0.074491128610255,0.0967662409474945,5.93312111190624e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,0.0466321478198912,0.00309514662125,0.0405656604422412,0.0526986351975412,6.05218710535895e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C2,Complement C2,40372,0.0323757436942984,0.002148941975502,0.0281638174223145,0.0365876699662823,6.09276128370443e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRADD,Death domain-containing protein CRADD,40192,0.103454593972039,0.00687218894003928,0.0899851036495623,0.116924084294516,7.33205659047104e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF19,Fibroblast growth factor 19,40422,0.103319916778849,0.00686589037433672,0.0898627716451486,0.116777061912549,7.90231982147225e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CKB,Creatine kinase B-type,37998,-0.0817381335793804,0.00542878734315264,-0.0923785567719596,-0.0710977103868013,8.07026246535547e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYTL4,Synaptotagmin-like protein 4,37990,0.0988081641776217,0.0065641297489112,0.0859424698697557,0.111673858485488,8.52918079829101e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH2B3,SH2B adapter protein 3,39980,0.13164445430148,0.00875451342670634,0.114485607985135,0.148803300617824,9.51712687299428e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GTPBP2,GTP-binding protein 2,37572,0.107883484161926,0.00717194028936664,0.0938264811947677,0.121940487129085,1.02406917747936e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,39961,0.0823624346289776,0.0054901521225934,0.0716017364686946,0.0931231327892607,1.61444172047766e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,39836,0.161948709456052,0.0107997492423292,0.140781200941087,0.183116217971017,1.78310424557112e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,37562,0.0857017284411609,0.00571263914200535,0.0745049557228304,0.0968985011594914,1.86359647272217e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPART,Spartin,37671,0.103816401061787,0.00692041726630758,0.090252383219824,0.11738041890375,1.86717693292737e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOK1,Docking protein 1,37942,0.18325685896888,0.0122187279697482,0.159308152148173,0.207205565789586,1.92772461009553e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX15,Sorting nexin-15,37671,0.0728668086935147,0.00486074101283003,0.0633397563083679,0.0823938610786616,2.18394117564031e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBNL,Drebrin-like protein,40422,0.123855722261479,0.008268472446601,0.107649516266141,0.140061928256817,2.20523686294057e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,0.114950955733657,0.00766846533213322,0.099920763682676,0.129981147784638,2.21450076402716e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD5,Programmed cell death protein 5,40471,0.0782878811696886,0.00522722168669663,0.0680425266637632,0.088533235675614,2.27690863055202e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMMD1,COMM domain-containing protein 1,37628,0.0826869119813574,0.00551814941395721,0.0718713391300013,0.0935024848327135,2.40648893873655e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.123301779464321,0.00824015607483616,0.107151073557642,0.139452485371,2.79648763987391e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",40536,0.065790123156233,0.00439695023665562,0.057172100692388,0.074408145620078,2.80537268573947e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,0.106121286556527,0.00710149335701631,0.0922023595767752,0.120040213536279,4.31250755164059e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,0.101714225433773,0.00682812456714446,0.0883311012821697,0.115097349585376,7.5635865802945e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNST,Consortin,40359,0.143912774057326,0.00966237406960561,0.124974520880899,0.162851027233753,7.79521836707148e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,0.102908332373475,0.00690761686585327,0.089369403316403,0.116447261430548,8.44379332719918e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAMBP,STAM-binding protein,40192,0.0862955458664081,0.00580394232989738,0.0749198188998093,0.097671272833007,1.14794599084689e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TWF2,Twinfilin-2,37998,0.110477786048253,0.00742901359251248,0.0959169194069284,0.125038652689577,1.24957736411789e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,0.146991626320066,0.00990313214059194,0.127581487324506,0.166401765315626,1.65224113071036e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRAF2,TNF receptor-associated factor 2,40341,0.0946783289751557,0.0063845191793199,0.0821646713836887,0.107191986566623,2.02514621270371e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,40500,-0.155803796615591,0.010510093951731,-0.176403580760984,-0.135204012470198,2.16817948768714e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,0.109628847019331,0.00739381933143917,0.0951369611297104,0.124120732908952,2.4000085644495e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STC1,Stanniocalcin-1,40471,0.0549903737414562,0.00371125785999448,0.047716308335867,0.0622644391470453,2.40711478145215e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,40536,0.0287404799661499,0.00194010799467655,0.0249378682965839,0.032543091635716,2.51988940528143e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,0.0960577789328761,0.00648321696800038,0.0833506736755954,0.108764884190157,2.80799886300604e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,37671,-0.0405142232563178,0.00273511982494443,-0.0458750581132088,-0.0351533883994267,3.01359971950975e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,0.112207476836095,0.00758391761624778,0.097342998308249,0.12707195536394,3.3894800855546e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS1BP3,HCLS1-binding protein 3,37628,0.118366125147562,0.00801789018375549,0.102651060387401,0.134081189907723,6.2612945385836e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGL1,Fibrinogen-like protein 1,37987,-0.0831949128791552,0.00563726747085433,-0.0942439571220297,-0.0721458686362807,6.5522927963533e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C9,Complement component C9,37987,-0.0644555544131094,0.00436892225242616,-0.0730186420278646,-0.0558924667983541,7.03041170321517e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRAP,BRCA1-associated protein,37778,0.144715128869974,0.00981095921382389,0.125485648810879,0.163944608929069,7.4275024903057e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,40396,0.0683739372158299,0.00463965984854357,0.0592802039126845,0.0774676705189753,7.83302446860801e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASHC3,WASH complex subunit 3,37942,0.099053662842883,0.00672289328707716,0.0858767920002118,0.112230533685554,9.35605595605675e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIFBP,KIF-binding protein,40305,0.108730643357802,0.00739193600039534,0.0942424487970267,0.123218837918576,1.17465703193539e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAT2,Signal transducer and activator of transcription 2,37598,0.101451503285145,0.00689761405899954,0.0879321797295064,0.114970826840785,1.38846174235297e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGFR,Opioid growth factor receptor,40305,0.0435329258565165,0.00296472580271807,0.037722063283189,0.0493437884298439,1.7087985684948e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,0.194258400556679,0.0132216604378708,0.168343946098453,0.220172855014906,1.71179189779929e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,39980,0.0841827796606021,0.00575338438150168,0.0729061462728588,0.0954594130483454,3.67924463682344e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,0.0637242071158847,0.00435578860535787,0.0551868614493832,0.0722615527823861,4.30844890986425e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,37987,0.094652662022042,0.00647526853327023,0.0819611356968324,0.107344188347252,5.03883015528841e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,40228,0.104123335817256,0.007132784153581,0.090143078876237,0.118103592758274,5.95369660840895e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,37598,0.117831732528676,0.00806760627170639,0.102019224236132,0.133644240821221,6.14453860176697e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.0537908768598697,0.00368944911130735,0.0465595566017072,0.0610221971180321,8.75808776871609e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,0.107490217373668,0.00738496970520459,0.0930156767514667,0.121964757995869,1.1140858000823e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,40391,0.0301797327819565,0.00207590649465976,0.0261109560524234,0.0342485095114897,1.40103125643708e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAP,Prolyl endopeptidase FAP,40536,0.0351509771621943,0.00242623693601454,0.0303955527676058,0.0399064015567828,2.86920222199044e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,0.0800028437929812,0.00552692936547658,0.0691700622366471,0.0908356253493153,3.53087421411158e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAT,Linker for activation of T-cells family member 1,40516,0.0980409418675452,0.00677416639620261,0.0847635757309881,0.111318308004102,3.56652002726229e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,0.0993785949072104,0.00686623358469196,0.0859207770812141,0.112836412733207,3.6115370983876e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC3B,Tetranectin,37681,0.0273656316310566,0.00189111978740752,0.0236590368477378,0.0310722264143753,4.25291601288312e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,40042,0.0969114622459523,0.00670532891554291,0.0837690175714882,0.110053906920416,4.84064177408447e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAX,Protein max,39961,0.135481308833397,0.00938093432935348,0.117094677547864,0.153867940118929,5.66322290870894e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBM17,Splicing factor 45,37959,0.0988299972612265,0.00684387717272118,0.0854159980026929,0.11224399651976,6.41822414657035e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYN,Tyrosine-protein kinase Lyn,40305,0.108603222364534,0.00753135345253018,0.0938417695975749,0.123364675131493,7.64832874035121e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,QDPR,Dihydropteridine reductase,40290,0.0566234966403545,0.00392673571385593,0.0489270946411969,0.0643198986395121,7.6702185693937e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP2,Microtubule-associated protein 2,37942,0.0592752309515051,0.00411289162009987,0.0512139633761093,0.0673364985269008,9.66215265300285e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,37562,0.0875330182553138,0.00608463346460302,0.0756071366646918,0.0994588998459357,1.43460763681004e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BGLAP,Osteocalcin,37998,0.117784262314736,0.00819000601143393,0.101731850532326,0.133836674097147,1.48924651036107e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,40341,0.0486613536297444,0.00338582314480206,0.0420251402659324,0.0552975669935564,1.51673807568649e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP7,Matrilysin,40015,0.062258840998823,0.00433259757435336,0.0537669497530904,0.0707507322445556,1.58759752928091e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,37901,0.0604101196357033,0.00420394404322713,0.0521703893109782,0.0686498499604285,1.76623128477397e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,0.0801235508286239,0.00557731172360592,0.0691920198503563,0.0910550818068915,1.90478883731594e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,-0.0482801076972478,0.00336671283995492,-0.0548788648635594,-0.0416813505309361,2.3746574684245e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASC3,Protein CASC3,37572,0.0528425629033465,0.00368326113614389,0.0456233710765045,0.0600617547301885,2.50400165838508e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,37628,0.0795024349482868,0.00554300202616152,0.0686381509770102,0.0903667189195634,2.63493786683575e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,40313,0.0707823006341257,0.00494112745319777,0.0610976908258581,0.0804669104423934,2.96265894159704e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,40422,0.169130864935507,0.0118262623619221,0.14595139070614,0.192310339164875,4.13743771479893e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM5,Tripartite motif-containing protein 5,40341,0.109100285223361,0.00763788276791385,0.0941300349982496,0.124070535448472,5.2973188586795e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.0289129855918524,0.00202665203236978,0.0249407476084076,0.0328852235752971,6.79869064938287e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C3,Complement C3,37360,0.0602861469762406,0.00422272013437994,0.0520096155128559,0.0685626784396253,6.84036511588222e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,0.0798018543984723,0.00559216413691982,0.0688412126901095,0.0907624961068352,7.22631156260984e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,0.0393818302335013,0.00276126240922684,0.0339697559114167,0.0447939045555859,7.22837670900366e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,A1BG,Alpha-1B-glycoprotein,38013,0.0224148956769297,0.00157264732918453,0.019332506911728,0.0254972844421314,9.19274906195392e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPI,Mannose-6-phosphate isomerase,40305,0.109723424491143,0.00770784376222208,0.0946160507171881,0.124830798265099,1.05821852086958e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC27,Cell division cycle protein 27 homolog,39980,0.0776983931522517,0.00546102972096766,0.0669947748991551,0.0884020114053483,1.19238700808302e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICA1,Islet cell autoantigen 1,40044,0.101192722265115,0.00711365590776693,0.0872499566858921,0.115135487844338,1.23460261537745e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,0.0447651413065742,0.00314526891157716,0.038600414239883,0.0509298683732655,1.27127543652395e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGA,Protein O-GlcNAcase,37901,0.0896393719836664,0.0062998078043329,0.0772917486871739,0.101986995280159,1.29869529943007e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",40314,0.139634955481268,0.00981978653109009,0.120388173880332,0.158881737082205,1.31731371731311e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FIS1,Mitochondrial fission 1 protein,40354,0.0982719004512023,0.00692472726483253,0.0846994350121306,0.111844365890274,1.96014997113777e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,40359,0.100868757496905,0.00710936226407521,0.0869344074593174,0.114803107534492,2.05265003892531e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAP25,Synaptosomal-associated protein 25,37541,0.059663610818202,0.00420236979882797,0.0514269660124992,0.0679002556239048,2.05914766490854e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,39980,0.11797510523258,0.00832234173460466,0.101663315432755,0.134286895032406,2.48358959547291e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,0.0698637634036777,0.00492892369450928,0.0602030729624395,0.0795244538449158,2.54534135934581e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA1,Ephrin type-A receptor 1,40400,0.0433582580572238,0.00306064484864549,0.0373593941538786,0.049357121960569,2.78409184608085e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BPIFB2,BPI fold-containing family B member 2,37951,0.0862516218697575,0.00609625821253862,0.0743029557731818,0.0982002879663332,4.019444014592e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRA1,GDNF family receptor alpha-1,40453,0.0353196373153266,0.00249834836331427,0.0304228745232307,0.0402164001074226,4.18614285594003e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STXBP1,Syntaxin-binding protein 1,37959,0.0981634435793768,0.00693998313517521,0.0845610766344334,0.11176581052432,4.22942168561265e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3GLB2,Endophilin-B2,37942,0.0849124094884348,0.00600869110422721,0.0731353749241494,0.0966894440527201,5.08014867372392e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,0.0403369998266618,0.00285800253964955,0.0347353148489486,0.0459386848043749,6.52486926762255e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST13,Hsc70-interacting protein,37671,0.0721984333064968,0.00511525165425894,0.0621725400641493,0.0822243265488444,6.5637664541809e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,0.0623783239095526,0.00442612166245471,0.0537031254511414,0.0710535223679638,8.79442950165321e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOLM2,Protein GOLM2,40471,0.0283414114630048,0.00201306248939082,0.0243958089837988,0.0322870139422108,9.48296177773587e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,40341,0.0415332924548843,0.00295587756504447,0.0357397724273971,0.0473268124823714,1.40237818867865e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,0.121787630730905,0.00867331783897195,0.10478792776652,0.13878733369529,1.78209024811634e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HJV,Hemojuvelin,37959,0.058064713426138,0.00413526578489474,0.0499595924877443,0.0661698343645317,1.78775990230926e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,0.100850687551869,0.00718543565944564,0.0867672336593551,0.114934141444382,1.94112584324208e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,40411,0.0418522153900015,0.00298475639266858,0.0360020928603711,0.0477023379196319,2.09804021479023e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RWDD1,RWD domain-containing protein 1,40471,0.0809340605740099,0.00577861795060083,0.0696079693908322,0.0922601517571875,2.62277153130204e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EREG,Proepiregulin,40192,0.100716891861581,0.00720943338202538,0.0865864024328108,0.11484738129035,4.34725101104154e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMVK,Phosphomevalonate kinase,39951,0.139034778663179,0.00995237165288725,0.119528130223519,0.158541427102838,4.39653598799443e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,40305,0.0704074815094167,0.00504089875987418,0.0605273199400633,0.0802876430787701,4.50667673580516e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATOX1,Copper transport protein ATOX1,40411,0.0897309700712387,0.0064368980353336,0.0771146499219849,0.102347290220493,6.53919213026654e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,37959,0.0854558471398841,0.00612903719639478,0.0734429342349503,0.0974687600448179,7.00945231880819e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,37541,0.124735412334209,0.00894796182828628,0.107197407150768,0.14227341751765,7.43779949933737e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA2,Integrin alpha-2,37671,0.0423438498519775,0.00304098359360356,0.0363835220085145,0.0483041776954405,9.17249517015779e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,37608,0.070738203320979,0.00508063058833532,0.0607801673678418,0.0806962392741162,9.3671276421941e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLG4,Disks large homolog 4,37942,0.0875838595104509,0.00629138778589729,0.0752527394500922,0.0999149795708096,9.44682998454355e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,0.0482046477790875,0.00346485688822012,0.0414135282781761,0.054995767279999,9.6217602319845e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,0.111729406337118,0.0080348066272134,0.0959811853477793,0.127477627326456,1.05656192727414e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDC,Nuclear migration protein nudC,40516,0.0788757858428554,0.00567500284675179,0.0677527802632219,0.0899987914224889,1.15269456179634e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL7,C-C motif chemokine 7,40341,0.0758668925486114,0.00545974325935551,0.0651657957602746,0.0865679893369482,1.21111051632882e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,40502,0.0472455414251256,0.00340037190048523,0.0405808125001746,0.0539102703500767,1.22856697755912e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNCG,Gamma-synuclein,40228,0.0835084084707454,0.0060133273243623,0.0717222869149953,0.0952945300264955,1.36685315289017e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNLR1,Interferon lambda receptor 1,40341,0.0466420817686505,0.0033590957076662,0.0400582541816248,0.0532259093556763,1.39754596262798e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MGLL,Monoglyceride lipase,40396,0.107348343978924,0.00773685899124283,0.0921841003560885,0.12251258760176,1.60937048952559e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,0.0545840674449095,0.00393717506441151,0.046867204318663,0.0623009305711561,1.88304790802867e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53,Cellular tumor antigen p53,39980,0.053598263419029,0.00386730477483346,0.0460183460603554,0.0611781807777026,2.0258830911073e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,37900,0.0684196165040611,0.00493453349053993,0.0587479308626028,0.0780913021455193,2.03995877998487e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AFP,Alpha-fetoprotein,40182,0.086590096076598,0.00625013714745461,0.0743398272675869,0.098840364885609,2.16034688211594e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBXN1,UBX domain-containing protein 1,37671,0.0859675843542011,0.00620489295069853,0.073805994170832,0.0981291745375703,2.38965424623307e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,37901,0.0732135654528153,0.0052852116829353,0.0628545505542621,0.0835725803513685,2.43645077054543e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAX1BP1,Tax1-binding protein 1,37942,0.079724828545118,0.0057554986308841,0.0684440512285852,0.0910056058616509,2.45124082300206e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.0335794203029531,0.00242430998424971,0.0288277727338237,0.0383310678720825,2.47010121332265e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,0.106070521511354,0.00768582749426662,0.0910062996225918,0.121134743400117,4.52621943547869e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EHD3,EH domain-containing protein 3,37628,0.145159798004001,0.0105134223411107,0.124553490215424,0.165766105792578,4.60542324515845e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,0.096675131489078,0.00700612905691835,0.082943118537518,0.110407144440638,4.61875654231645e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,0.0725980806922375,0.00526012270267301,0.0622882401949984,0.0829079211894766,4.95412761325736e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,0.124497555657793,0.00903054500994547,0.106797687438299,0.142197423877286,5.45019470532487e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE4,Ribonuclease 4,37575,0.0338593997693505,0.00245455406691055,0.0290484737982058,0.0386703257404951,5.48430765311218e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,0.0716823914270517,0.00519988922901387,0.0614906085381845,0.0818741743159188,5.59103032429437e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MME,Neprilysin,40305,0.100673120540874,0.00730353768261672,0.0863581866829451,0.114988054398803,5.61748873463938e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,0.0550446990005423,0.00399409653772965,0.0472162697865922,0.0628731282144924,5.89393208186356e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOL1,Apolipoprotein L1,37987,0.0806042564371443,0.00584801149914856,0.0691421538988131,0.0920663589754754,6.2711139306407e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",40042,0.115047360115854,0.00835495357026821,0.0986716511181287,0.13142306911358,6.8876496944252e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOP2B,DNA topoisomerase 2-beta,37598,0.097771434389157,0.00710363710099353,0.0838483056712097,0.111694563107104,8.35823733093017e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,0.121946664247236,0.00887044135833744,0.104560599184895,0.139332729309577,9.37896206154983e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DGKA,Diacylglycerol kinase alpha,37598,0.0671033926761031,0.00488258901232341,0.0575335182119492,0.076673267140257,1.10028238951775e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,0.0343174503178701,0.00250105883902641,0.0294153749933784,0.0392195256423619,1.32571730232155e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP5,Platelet glycoprotein V,37671,0.0442713273785232,0.00322484816398923,0.0379506249771043,0.0505920297799421,1.34846909602671e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRAP2,GRB2-related adapter protein 2,40359,0.156114298290016,0.0113796237006859,0.133810235836672,0.17841836074336,1.37001293893117e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESM1,Endothelial cell-specific molecule 1,40357,-0.0415606424215583,0.00303960686784067,-0.047518271882526,-0.0356030129605906,2.55258135230332e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,37598,0.0598101616625154,0.00437310725039417,0.0512388714517428,0.068381451873288,2.71944849122998e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YJU2,Splicing factor YJU2,37900,0.0393077732306648,0.00287471452779772,0.0336733327561813,0.0449422137051483,2.79765727892797e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB27B,Ras-related protein Rab-27B,37990,0.100538522019601,0.00736342210471109,0.0861062146943676,0.114970829344835,3.64532726089683e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,0.054175580811422,0.00397200506413567,0.0463904508857161,0.0619607107371279,4.03855032969881e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GMPR,GMP reductase 1,40516,0.0624378352199266,0.00458142048317393,0.0534582510729057,0.0714174193669476,4.64583390492105e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS8,Galectin-8,40471,0.0738047382022804,0.00542099363515393,0.0631795906773787,0.0844298857271821,5.61413324882347e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUGT1,Protein SGT1 homolog,39980,0.0994008085696252,0.00730883211458794,0.0850754976250328,0.113726119514218,6.94797999527201e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.131981750015114,0.0096989553007524,0.112971797625639,0.150991702404588,7.04383799651677e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,0.12762126367287,0.00938673486919605,0.109223263329246,0.146019264016494,7.26057141829007e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTNB,Dystrobrevin beta,37878,0.0509723123495249,0.00374983318951775,0.0436226392980701,0.0583219854009797,8.30473783648359e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ISM1,Isthmin-1,40341,0.0475252230157092,0.00350193682954233,0.0406614268298062,0.0543890192016121,1.01465290845156e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED8,Protein TMED8,37901,0.125131579242744,0.00921932624852779,0.10706169979563,0.143201458689859,1.0930549421597e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CETN3,Centrin-3,37901,0.0935537460599193,0.00689323149924035,0.0800430123214083,0.10706447979843,1.10666840733215e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,0.136772867099386,0.0100943319715746,0.116987976435099,0.156557757763672,1.37617419048049e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARSB,Arylsulfatase B,40305,0.0668329704603593,0.00493356005052271,0.0571631927613348,0.0765027481593838,1.41372360262073e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTDH,Protein LYRIC,37598,0.111433990166951,0.0082245536845678,0.0953138649451981,0.127554115388704,1.52728996942038e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,0.0939478925508745,0.00695093549859301,0.0803240589736322,0.107571726128117,2.13556926665856e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACYBP,Calcyclin-binding protein,37642,0.124413092586933,0.0092080668875123,0.106365281487409,0.142460903686457,2.52489063286372e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPP,Lipoma-preferred partner,37562,0.0816432938153029,0.00604315248760152,0.0697987149396039,0.0934878726910019,2.57788238419851e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD69,Early activation antigen CD69,40288,0.106436254103482,0.00788928757407859,0.0909732504582876,0.121899257748676,2.9764000797203e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRY2,Protein sprouty homolog 2,40044,0.111463601116995,0.00826790349599508,0.0952585102648449,0.127668691969146,3.41988779351355e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,0.0685217508885143,0.00508479532998919,0.0585555520417354,0.0784879497352931,3.65375660660568e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH2,Cadherin-2,40359,0.0426234441344875,0.00316346367246191,0.0364230553364622,0.0488238329325129,3.75818125192808e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,37671,0.0813931230857235,0.00604166424196443,0.0695514611714732,0.0932347849999738,4.26856844142906e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL7,Interleukin-7,40341,0.0778065253171701,0.00578590930895575,0.0664661430716168,0.0891469075627233,5.33049298388209e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD244,Natural killer cell receptor 2B4,40516,0.0321387644492481,0.00239126152551273,0.0274518918592431,0.036825637039253,5.85982651493802e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,37598,0.0695464803421467,0.00517372496985706,0.0594059794012269,0.0796869812830666,6.36903887621387e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTX3,Pentraxin-related protein PTX3,40341,-0.059304295376046,0.0044154962287059,-0.0679586679843095,-0.0506499227677824,6.65778576370053e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,0.0868063628972061,0.00647158153504163,0.0741220630885245,0.0994906627058877,8.40656452271533e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBCB,Tubulin-folding cofactor B,40228,0.121807782597631,0.00908788863562886,0.103995520871799,0.139620044323464,9.66090004945829e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,0.102869273880156,0.0076719584962954,0.0878322352274171,0.117906312532895,9.82386153539416e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL24,C-C motif chemokine 24,40396,0.0996155658050724,0.00743990906602552,0.0850333440356624,0.114197787574482,1.15724353867804e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GMPR2,GMP reductase 2,37671,0.0813645540937833,0.00609199129929064,0.0694242511471737,0.093304857040393,1.99779504293465e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1R,Complement C1r subcomponent,38013,0.0238791776523494,0.00178996854595006,0.0203708393022873,0.0273875160024115,2.41422764949262e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,40471,0.0801964206739045,0.00601633631624625,0.0684044014940619,0.0919884398537472,2.54769195476483e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKD2,Polycystin-2,37562,0.0714848888858251,0.00536526296632551,0.0609689734718271,0.0820008042998231,3.08009032293906e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFRP1,Secreted frizzled-related protein 1,40178,0.0521716145803396,0.00391928402027274,0.0444898179006051,0.0598534112600742,3.27460986469204e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS9,Galectin-9,40350,0.0384101669766394,0.00288624217857101,0.0327531323066402,0.0440672016466386,3.41135505247002e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,0.11512020782688,0.00865243024212642,0.0981614445523125,0.132078971101448,3.55345703552654e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,37671,0.141580499573733,0.0106427885235633,0.120720634067549,0.162440365079917,4.02884742418317e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,0.112262067099639,0.00844680180978156,0.0957063355524668,0.128817798646811,4.3035377723391e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,0.0752702295251454,0.00566382634200157,0.0641691298948224,0.0863713291554685,4.33153277096147e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FETUB,Fetuin-B,40372,0.0402109057930286,0.00303226525745756,0.0342676658884117,0.0461541456976454,6.3440422229757e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUB1,NEDD8 ultimate buster 1,40341,0.0993206884675712,0.00749768267086324,0.0846252304326792,0.114016146502463,7.65328833129311e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,0.0871391168025718,0.00657861182808977,0.0742450376195159,0.100033195985628,8.53517679626591e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NSFL1C,NSFL1 cofactor p47,40471,0.0792187322105235,0.00598507231076685,0.0674879904814205,0.0909494739396265,8.78861726645513e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MESD,LRP chaperone MESD,40332,0.143688060610036,0.0108622582170056,0.122398034504705,0.164978086715367,9.78712908414635e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,0.112297546258826,0.00849052896924911,0.0956561094790975,0.128938983038554,1.00537880545626e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,40536,0.0800203249182707,0.00605862466526085,0.0681454205743594,0.091895229262182,1.27412245540583e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,37880,0.10384933591533,0.00786528656247467,0.0884333742528797,0.11926529757778,1.47705771212446e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,0.0896958099696759,0.00680123213324939,0.0763653949885071,0.103026224950845,1.65847683966702e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,0.0563656163566446,0.00427745148441075,0.0479818114471996,0.0647494212660897,2.07269475260634e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GASK1A,Golgi-associated kinase 1A,37562,0.0513906750447698,0.00390457521756745,0.0437377076183376,0.059043642471202,2.58889627735097e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,37628,0.0867519482322467,0.00659509897287868,0.0738255542454045,0.099678342219089,2.85292532541491e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,0.0992476725904662,0.007548586734245,0.084452442591346,0.114042902589586,3.08593182135957e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB6A,Ras-related protein Rab-6A,40341,0.0563297629194551,0.00429299593116386,0.0479154908943739,0.0647440349445362,3.97093465545682e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,0.102447010352938,0.00783069842822581,0.0870988414336157,0.117795179272261,6.55551026525937e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BIN2,Bridging integrator 2,40332,0.106544032215848,0.00814601759439143,0.0905778377308407,0.122510226700855,6.87052472795723e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDUA,Alpha-L-iduronidase,40489,0.0530986852110363,0.00406003017532889,0.0451410260673917,0.0610563443546809,6.91863334054515e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP7,Caspase-7,37942,0.0982255987810807,0.00752098168456385,0.0834844746793355,0.112966722882826,9.54553872047991e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,0.101681369559425,0.00778782210358486,0.0864172382363991,0.116945500882452,1.00383526154623e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPB1,Heat shock protein beta-1,40116,0.0794770506946514,0.0060910643203109,0.067538564626842,0.0914155367624608,1.03638702457507e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAG6,Large proline-rich protein BAG6,40042,0.0420540978707052,0.00322685620782894,0.0357294597033604,0.0483787360380499,1.27182675745191e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,0.0916949217360018,0.00703661269007287,0.077903160863459,0.105486682608545,1.29772130525504e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEXN,Nexilin,37987,0.0800243216824527,0.00614040247388743,0.0679891328336333,0.0920595105312721,1.36588055937182e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLMH,Bleomycin hydrolase,40536,0.0377525292110356,0.00290033294502632,0.032067876638784,0.0434371817832872,1.54116168169909e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRAS,Ras-related protein R-Ras,37572,0.152771621936727,0.0117358375827778,0.129769380274482,0.175773863598971,1.6840142631423e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB9,Serpin B9,40228,0.0392540223770263,0.00301812388574304,0.03333849956097,0.0451695451930827,1.78144879147185e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOLGA3,Golgin subfamily A member 3,37959,0.0914576524944597,0.00703699780093824,0.0776651368046207,0.105250168184299,2.17040789787768e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,0.0817974992722126,0.00629377534518239,0.0694616995956551,0.09413329894877,2.20251643502192e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,0.119585800598736,0.00920213858819371,0.101549608965877,0.137621992231596,2.23503161036108e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,40332,0.060834862568128,0.0046852573072079,0.0516517582460005,0.0700179668902555,2.35423312782242e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,0.0593921113796433,0.00457692440703503,0.0504213395418547,0.068362883217432,2.82521183844303e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LBR,Delta(14)-sterol reductase LBR,40471,0.0763270060795359,0.00588718140992737,0.0647881305160783,0.0878658816429935,3.01160125675377e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LACTB2,Endoribonuclease LACTB2,40359,0.0767664651534207,0.00592752733907861,0.0651485115688266,0.0883844187380148,3.62383007080572e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CERT,Ceramide transfer protein,39961,0.0716111428460516,0.00553295886821259,0.0607665434643549,0.0824557422277482,4.07309035475472e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,0.12083773195797,0.00933208350067482,0.102546848296648,0.139128615619293,4.07760526522404e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTF1,Cardiotrophin-1,40042,0.0983138786949266,0.00759705396096004,0.0834236529314449,0.113204104458408,4.14792639373302e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.0347076511313501,0.00268279633889942,0.0294493703071072,0.0399659319555929,4.3461947536533e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,0.0321891584433235,0.00248928424186103,0.0273101613292759,0.0370681555573711,4.6807340088782e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,37671,0.101439349928824,0.00784764772792523,0.0860579603820904,0.116820739475557,5.44830422596379e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGF,Pro-epidermal growth factor,40324,0.119064965400543,0.00922302022873808,0.100987845752217,0.13714208504887,6.17229109767495e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBC1D5,TBC1 domain family member 5,40341,0.0906897712460905,0.00704019618291535,0.0768909867275764,0.104488555764605,8.81887768565987e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COCH,Cochlin,37990,0.0538926571082778,0.00419016969004272,0.0456799245157941,0.0621053897007615,1.22806698008391e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FSHB,Follitropin subunit beta,37628,0.0807805173662311,0.00628332798069097,0.0684651945240768,0.0930958402083854,1.33344142955917e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,37572,0.0831605524287913,0.00647376643804682,0.0704719702102196,0.0958491346473631,1.52908724988253e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",40411,0.0707772974040967,0.005514965752064,0.0599679645300513,0.0815866302781421,1.62794564777546e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,0.136797077925408,0.0106619151721688,0.115899724187958,0.157694431662859,1.69619583607488e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSO,Cathepsin O,40516,0.0346135396315785,0.00270181594704795,0.0293179803753645,0.0399090988877925,2.1627989962866e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA4,Protein disulfide-isomerase A4,37998,0.0696069172188693,0.00543241040552999,0.0589593928240305,0.0802544416137081,2.27728088494025e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0432593097267534,0.00337928874657888,0.0366359037834588,0.049882715670048,2.4896710657604e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIAE,Sialate O-acetylesterase,40374,0.0538425662660886,0.00420684532729044,0.0455971494245993,0.0620879831075779,2.54321834288264e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THTPA,Thiamine-triphosphatase,37884,0.101823182894748,0.00795759901606799,0.0862262888232548,0.117420076966241,2.85913552135489e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,0.0525608154416599,0.00411080218985799,0.0445036431495383,0.0606179877337816,2.99597950320863e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,39980,0.0570625240687628,0.00447061675291804,0.0483001152330434,0.0658249329044821,4.00733584430264e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F12,Coagulation factor XII,38013,0.0479492900715849,0.0037558754142032,0.0405877742597466,0.0553108058834231,4.1260326341861e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TALDO1,Transaldolase,37966,0.0511295450351735,0.0040100182104084,0.043269909342773,0.058989180727574,5.06439884183152e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGH,Gamma-glutamyl hydrolase,40077,0.0392285401281981,0.00307816500568476,0.0331953367170559,0.0452617435393402,5.13754507905736e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFHR4,Complement factor H-related protein 4,37973,0.0842007593299885,0.00660675877792552,0.0712515121252545,0.0971500065347225,5.45015320007937e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB6,Serpin B6,40433,0.0683004243639859,0.00536503126359542,0.0577849630873389,0.078815885640633,6.03760103120536e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MIA,Melanoma-derived growth regulatory protein,40411,0.0422945313722464,0.0033245245056894,0.0357784633410952,0.0488105994033977,6.7442417631578e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,0.0698443769284109,0.00549408838194202,0.0590759636998045,0.0806127901570173,7.60624999664739e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PF4,Platelet factor 4,37934,0.111158677812799,0.00874707875787539,0.0940144034473629,0.128302952178234,8.66641194511371e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NIT1,Deaminated glutathione amidase,37628,0.0566458427046833,0.0044575482422144,0.0479090481499431,0.0653826372594235,8.7910045271139e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YWHAQ,14-3-3 protein theta,37671,0.0842698812779256,0.00663230042028804,0.071270572454161,0.0972691901016901,8.98630851781667e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RP2,Protein XRP2,40305,0.0471530385307595,0.0037150456478578,0.0398715490609583,0.0544345280005608,9.82692707332992e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDRKH,Tudor and KH domain-containing protein,39961,0.0970289996813584,0.00764915815570865,0.0820366496961695,0.112021349666547,1.09058047125191e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,40350,0.0562590723323461,0.00443599871090896,0.0475645148589645,0.0649536298057276,1.11462916144093e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBLN4,Cerebellin-4,40489,0.0358683290289607,0.00283116459234368,0.0303192464279671,0.0414174116299543,1.31355396788573e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,0.139371594172002,0.0110121699011564,0.117787741165735,0.160955447178268,1.55271447064861e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN2L,Ataxin-2-like protein,37959,0.0548225313987198,0.00433674186255472,0.0463225173481125,0.063322545449327,2.00642206115899e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,0.085657815236036,0.00677877631312466,0.0723714136623116,0.0989442168097603,2.01646313574954e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,0.0560548690421905,0.00443563157985838,0.047361031145668,0.0647487069387129,2.14022183221336e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLB1,Beta-galactosidase,40228,0.0463437017644799,0.0036696047684135,0.0391512764183895,0.0535361271105704,2.18978372037553e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTD,Deoxycytidylate deaminase,37671,0.107220447924591,0.00849217122164301,0.0905757923301709,0.123865103519012,2.4662264783863e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.100698811738638,0.00798449352556116,0.085049204428538,0.116348419048738,2.71516981372263e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STK24,Serine/threonine-protein kinase 24,39961,0.0700321312087012,0.00555629490585138,0.0591417931932324,0.0809224692241699,3.01756185594583e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,0.0618932305641531,0.00491360366912134,0.0522625673726752,0.0715238937556309,3.32094101841294e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,0.10502147858115,0.00834019441061981,0.0886746975363353,0.121368259625965,3.71982257363133e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2L1,Bcl-2-like protein 1,37942,0.112867226333057,0.00896613334327919,0.09529360498023,0.130440847685884,3.91503570842915e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,37900,0.0573803783309336,0.00455824643995613,0.0484462153086196,0.0663145413532477,3.9165222822713e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROBO2,Roundabout homolog 2,40471,0.0263192928354371,0.00209316534503971,0.0222166887591593,0.0304218969117149,4.34988657089136e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,37942,0.0518544278909858,0.0041243948207202,0.0437706140423742,0.0599382417395973,4.75631324141333e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,0.053893374156529,0.00428722535699077,0.0454904124568271,0.0622963358562309,4.87930274223854e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,0.111789212463165,0.00889778670450353,0.0943495505223384,0.129228874403992,5.31326926473781e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH9,Protocadherin-9,37901,0.0381896044799775,0.0030409744389711,0.0322292945795942,0.0441499143803609,5.69292090770761e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL11,Eotaxin,40516,0.0424422877997363,0.00338146198456921,0.0358146223099806,0.0490699532894919,5.75577332011001e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.0276857932393146,0.00220590012924352,0.0233622289859973,0.032009357492632,5.83202287647424e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,40411,0.0270074635030258,0.00215220625755353,0.0227891392382209,0.0312257877678307,5.97059184512747e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSNL1,Visinin-like protein 1,37942,0.0422658384208772,0.00336744535291754,0.0356656455291588,0.0488660313125956,6.20720356520363e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,0.0838036366960995,0.0066796451870802,0.0707115321294223,0.0968957412627767,6.61149545592752e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CIAPIN1,Anamorsin,40411,0.0718685526130395,0.00573351190615364,0.0606308692769784,0.0831062359491006,7.10432674559933e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,37901,0.0987958936066041,0.00788181009431527,0.0833475458217461,0.114244241391462,7.64959413557427e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGA,Glycoprotein hormones alpha chain,40332,0.100906182671439,0.00805604698026358,0.0851163305901223,0.116696034752756,7.99457148685252e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACAN,Aggrecan core protein,40224,0.0319544895123796,0.00255183795981854,0.0269528871111352,0.0369560919136239,8.36047898799257e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,0.0778473527890498,0.0062313065287642,0.065633991992672,0.0900607135854276,1.19468960769419e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD226,CD226 antigen,37598,0.0471433251280492,0.00377184658729753,0.039750505816946,0.0545361444391523,1.20908734137511e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP170,Centrosomal protein of 170 kDa,37628,0.0867494273088615,0.00694778336178595,0.073131771919761,0.100367082697962,1.41644001468341e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,0.040873366121823,0.0032764128184262,0.0344515969977076,0.0472951352459384,1.61881248924556e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MICALL2,MICAL-like protein 2,37572,0.0768782988430173,0.00616359839419337,0.0647976459903983,0.0889589516956363,1.66682806638885e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMN,Protein amnionless,40044,0.0533646534863707,0.0042811602018205,0.0449735794908026,0.0617557274819389,1.71054934254879e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP2,Caspase-2,40341,0.0755849525420427,0.0060742404561183,0.0636794412480508,0.0874904638360345,2.21695338236844e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,0.087045829327795,0.00699896744718999,0.0733278531313026,0.100763805524287,2.4264917509613e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD207,C-type lectin domain family 4 member K,40029,0.0428502550235636,0.00345636476102537,0.0360757800919538,0.0496247299551733,3.94888986622758e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,0.12033965520862,0.00970579448830946,0.101316298011533,0.139363012405706,4.1286425451434e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL16,C-X-C motif chemokine 16,40517,0.0264243220248635,0.00213442550188413,0.0222408480411707,0.0306077960085564,4.84126782573209e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,39897,0.0637279031266762,0.00514878939486678,0.0536362759127373,0.0738195303406151,5.08570193688699e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX8,Syntaxin-8,40341,0.0542746988200203,0.00439080606728745,0.045668718928137,0.0628806787119037,6.15002901601172e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMTN,Smoothelin,37905,0.107063996839812,0.00865865127908015,0.0900930403328144,0.124034953346809,6.25803286694408e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,0.0758401633037146,0.00613955843541531,0.0638066287703006,0.0878736978371286,7.35736021972846e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F2R,Proteinase-activated receptor 1,40396,0.063688303213094,0.00515979301753036,0.0535751088987345,0.0738014975274535,7.64732683779027e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,40307,0.0725746009539509,0.0058827012348565,0.0610445065336321,0.0841046953742696,8.27415947919268e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYO9B,Unconventional myosin-IXb,40044,0.0735401568552858,0.00596154026822472,0.0618555379295654,0.0852247757810063,8.44772994899579e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX4,Syntaxin-4,40305,0.0660890634621293,0.00537193665787842,0.0555600676126876,0.076618059311571,1.26097763363382e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK13,Kallikrein-13,40032,0.0479791160076271,0.00390065111887294,0.0403338398146361,0.055624392200618,1.3063677284327e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,0.0681814344823455,0.0055553705577495,0.0572929081891565,0.0790699607755346,1.92609420193126e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,37959,0.138501184936675,0.0112868616317665,0.116378936138413,0.160623433734938,1.97701763466004e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,0.104113411206318,0.00848530838756515,0.0874822067666908,0.120744615645946,2.00904662622183e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,37959,0.0675253112040984,0.00550385772389712,0.0567377500652601,0.0783128723429368,2.03298220717527e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,0.0976559018646891,0.00796291195538281,0.0820485944321388,0.113263209297239,2.15576797786522e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,40341,0.0603613240738176,0.00492591611969511,0.0507065284792152,0.07001611966842,2.29056397709847e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,40359,0.0747514105264598,0.00610062831510637,0.0627941790288513,0.0867086420240683,2.31099175352133e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,0.0989669251819307,0.0080737063241315,0.083142460786633,0.114791389577228,2.31711441169446e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,40422,0.0421556949656919,0.00344119834247643,0.0354109462144381,0.0489004437169457,2.38727016913066e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP3,Caspase-3,40536,0.0968469577428601,0.00790649985653629,0.0813502180240489,0.112343697461671,2.41837980729104e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPARC,SPARC,40411,0.077791783732268,0.00636191583591848,0.0653224286938678,0.0902611387706683,3.14499530777111e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,0.0674037345411388,0.00551018890703606,0.0566037642833481,0.0782037047989295,3.19859970905291e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESYT2,Extended synaptotagmin-2,37942,0.0895555313507242,0.00733212147907173,0.0751845732517436,0.103926489449705,3.95615814257753e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL18,C-C motif chemokine 18,40172,0.0770420695452534,0.00631504714327221,0.0646645771444399,0.0894195619460669,4.44489843563057e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NHLRC3,NHL repeat-containing protein 3,37370,0.0350197382390532,0.00287159915760059,0.029391403890156,0.0406480725879503,5.07053111635961e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP6,Platelet glycoprotein VI,40311,0.0962841075473585,0.00790501133079669,0.080790285338997,0.11177792975572,5.62523915673092e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP3R1,Calcineurin subunit B type 1,40228,0.0452446447768971,0.00371802035487775,0.0379573248813367,0.0525319646724575,6.45019627695041e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,40044,0.0657933590228575,0.00540843784154152,0.0551928208534361,0.0763938971922789,6.80441003769863e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPI,Glucose-6-phosphate isomerase,37987,0.0511757893531393,0.00421281997077208,0.042918662210426,0.0594329164958526,8.8509345446888e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GMFG,Glia maturation factor gamma,37990,0.0783384243067915,0.00644919298147689,0.0656980060630968,0.0909788425504862,8.91684384709048e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,0.0883936709757329,0.00728087764793757,0.0741231507857752,0.102664191165691,9.0887324887646e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,40400,0.0777128362497861,0.00640293215151937,0.0651630892328082,0.0902625832667641,9.46491777001065e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,40328,0.0396327931231965,0.00326580722349082,0.0332318109651545,0.0460337752812385,9.64035293148676e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,40287,0.0968979844938903,0.0079919282327389,0.081233805157722,0.112562163830058,1.10490275030462e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,0.119790464659322,0.00988596978112816,0.100413963888311,0.139166965430333,1.20346351812493e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,0.0833518942917598,0.006880655373218,0.0698658097602525,0.0968379788232671,1.25204037564032e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PENK,Proenkephalin-A,37671,0.0336266963966818,0.00277510397992061,0.0281874925960374,0.0390659001973262,1.28949026499554e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,37901,0.106590035708025,0.00879828065242248,0.0893454056292774,0.123834665786773,1.31821679361544e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,37628,0.10146436986213,0.00838467935601111,0.0850303983243479,0.117898341399911,1.56803909454152e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POMC,Pro-opiomelanocortin,37628,0.0741716832273782,0.00613576033668318,0.0621455929674792,0.0861977734872772,1.82798429639965e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPPB,Natriuretic peptides B,40042,-0.139498055884965,0.0115548293291964,-0.16214552137019,-0.11685059039974,2.07485468981692e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN9,Septin-9,40305,0.0305818987952959,0.00253338788898718,0.025616458532881,0.0355473390577107,2.09226371753631e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH7,Protocadherin-7,37901,0.0378879474158035,0.00313831426606743,0.0317368514543113,0.0440390433772957,2.19048889420529e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,40470,0.0662981159938185,0.00549512053495788,0.055527679745301,0.0770685522423359,2.25847063281879e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,40422,0.0942821061776128,0.00782002924637822,0.0789548488547115,0.109609363500514,2.50166552138308e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,0.0662943768595231,0.00549616761976409,0.0555218883247855,0.0770668653942607,2.51058444888423e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,39961,0.0289623838418219,0.00240647711689576,0.0242456886927062,0.0336790789909376,3.26369051112525e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,0.073377352011054,0.00610232197160803,0.0614168009467023,0.0853379030754058,3.70852293065764e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDHB,Succinate dehydrogenase,37901,0.076937593028872,0.00640161506920303,0.0643904274932341,0.08948475856451,4.19925064296252e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1R2,Interleukin-1 receptor type 2,40330,0.0210584347917486,0.00175415511687401,0.0176202907626756,0.0244965788208217,4.65656481753253e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLUL1,Clusterin-like protein 1,40338,-0.0490772379278732,0.00408894234008127,-0.0570915649144325,-0.041062910941314,4.794958841193e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,37598,0.0985961256843353,0.00821118803411141,0.0825021971374769,0.114690054231194,4.8288982628168e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FADD,FAS-associated death domain protein,40359,0.0822766222189784,0.00686062069646802,0.068829805653901,0.0957234387840557,5.39188004861756e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP2B1,AP-2 complex subunit beta,37572,0.0528244802525374,0.00440727895618245,0.0441862134984198,0.061462747006655,6.27048144469471e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,37901,0.0692289261151869,0.00578049558082048,0.0578991547767788,0.0805586974535951,6.95116110604551e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,0.071540808380341,0.0059768464403592,0.059826189357237,0.0832554274034451,7.56449404390596e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASPN,Asporin,37990,0.0293790698675847,0.00245601769327903,0.0245652751887578,0.0341928645464116,8.21512192811788e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPY,Pancreatic prohormone,40337,0.10830167979844,0.00906917849878993,0.090526089940812,0.126077269656069,9.90195309955971e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA13,Carbonic anhydrase 13,40173,0.111158117758798,0.00930919812793296,0.0929120894280493,0.129404146089546,1.00606932994175e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,0.083271217628157,0.00697188492097794,0.0696063231830402,0.0969361120732738,1.031135156383e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,37990,0.0504585528745775,0.00422687627384683,0.0421738753778377,0.0587432303713173,1.10009622086891e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAO1,Hydroxyacid oxidase 1,40489,0.139796931551515,0.0117177761367175,0.116830090323548,0.162763772779481,1.1307901804321e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANG,Angiogenin,40309,0.0369537183704736,0.00309820780639142,0.0308812310699464,0.0430262056710008,1.17443985073943e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMEM106A,Transmembrane protein 106A,37900,0.0751006578170399,0.00630241955167772,0.0627479154957515,0.0874534001383282,1.42203014960198e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.0412653431156887,0.00346904356974115,0.034466017718996,0.0480646685123813,1.73023885277843e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRGN,Neurogranin,37987,0.0969918141983407,0.00815146229221228,0.0810149481056047,0.112968680291077,1.74521094114345e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,40516,0.0725813141895406,0.00610271977713399,0.060619983426358,0.0845426449527232,1.75587719690289e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,39980,0.0563905932676606,0.00474228263054069,0.0470957193118009,0.0656854672235204,1.82292189115443e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",39961,0.0522948764411614,0.00439891158516983,0.0436730097342286,0.0609167431480943,1.88710756064037e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,37598,0.0988057080004417,0.00832077294916977,0.0824969930200689,0.115114422980814,2.3477267358019e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,0.0611070918764479,0.00514946124776506,0.0510141478308284,0.0712000359220675,2.40851688452473e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX6,Peroxiredoxin-6,40489,-0.0636295818761702,0.00537844518889734,-0.074171334446409,-0.0530878293059314,3.69526064463834e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MVK,Mevalonate kinase,40044,0.0814759192207145,0.00688886368547904,0.0679737463971755,0.0949780920442534,3.87514366195037e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMT,Catechol O-methyltransferase,39877,0.0903554635143584,0.00764246288497399,0.0753762362598094,0.105334690768907,4.09428400331955e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,0.0332993710054439,0.0028159684989133,0.0277800727475738,0.038818669263314,4.17531190467591e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPCAM,Epithelial cell adhesion molecule,40358,-0.105923018687496,0.00897070271090278,-0.123505596000865,-0.0883404413741265,4.84910575606946e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,0.0847479790725607,0.00717813903960232,0.0706788265549402,0.0988171315901813,5.2481122552321e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPT,Dermatopontin,40536,0.028035271261692,0.00238066415516826,0.0233691695175622,0.0327013730058218,6.99612746018003e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFA,Vascular endothelial growth factor A,40456,0.0621688507360705,0.00528058407811673,0.0518189059429617,0.0725187955291793,7.26996105958637e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,37959,0.0416134898305989,0.00353441071462349,0.0346860448299368,0.0485409348312609,7.62153324193935e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYBB1,Beta-crystallin B1,37990,0.0685024623090737,0.00583043694321094,0.0570748059003803,0.0799301187177672,1.01734243355008e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMPACT,Protein IMPACT,37942,0.060106249781231,0.00511641659562148,0.0500780732538129,0.0701344263086491,1.0353254024391e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,0.0500198983522267,0.00425886383105366,0.0416725252433615,0.0583672714610919,1.07926613801247e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGLN1,Egl nine homolog 1,40341,0.0559771643718997,0.00477081528610011,0.0466263664111434,0.0653279623326559,1.16300739444173e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UROD,Uroporphyrinogen decarboxylase,37671,0.0742399078166135,0.00633110499365661,0.0618309420290465,0.0866488736041804,1.34121191365978e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MIF,Macrophage migration inhibitory factor,40307,0.0725117541212792,0.00619486155731867,0.0603698254689346,0.0846536827736239,1.61691723436574e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAP3,Cytosol aminopeptidase,40044,0.0517071083319046,0.00441907805645405,0.0430457153412547,0.0603685013225546,1.70804494119279e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,0.102925693451576,0.00880859886791317,0.0856608396704659,0.120190547232685,2.15952928445464e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBN1,Drebrin,37598,0.0544407400981383,0.00466198666516234,0.0453032462344201,0.0635782339618564,2.36988811162987e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,37942,0.0557974080332498,0.00477961923100158,0.0464293543404867,0.0651654617260129,2.44786653329662e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,37879,0.0739855201783014,0.00634050415263788,0.0615581320391312,0.0864129083174716,2.60828322602824e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,37978,0.0507268844868286,0.00435072814378429,0.0421994573250114,0.0592543116486458,2.89929967109413e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB2B,Ras-related protein Rab-2B,37900,0.0644078312188961,0.00552487926967925,0.0535790678503248,0.0752365945874674,2.96029896374476e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.0474328053799976,0.00407134415684989,0.0394529708325719,0.0554126399274234,3.24817216573698e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL26,C-C motif chemokine 26,40341,0.0929110302976004,0.00799286958223747,0.0772450059164149,0.108577054678786,4.14702804776522e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL8,C-C motif chemokine 8,40470,0.0630601155587171,0.00542666634056722,0.0524238495312053,0.0736963815862288,4.32524407619667e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,40305,0.0561634428020246,0.00484348121613623,0.0466702196183976,0.0656566659856516,5.77920780830085e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",40305,0.0803225134756031,0.00692712097146847,0.0667453563715249,0.0938996705796813,5.79994790560363e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPBP,Platelet basic protein,37934,0.087564240441747,0.00755348149539916,0.0727594167107647,0.102369064172729,6.29965075038782e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNM3,Dynamin-3,37959,0.057115563274855,0.00493228433683215,0.047448285974664,0.0667828405750461,7.2847381077449e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAEP,Glycodelin,40228,-0.137073521642402,0.0118487204822833,-0.160297013787677,-0.113850029497127,7.91300023402315e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOXJ3,Forkhead box protein J3,37598,0.0455017309009937,0.00393523651242398,0.0377886673366427,0.0532147944653447,8.97596256472603e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINE2,Glia-derived nexin,37990,0.0667769259340088,0.00577681610436021,0.0554543663694628,0.0780994854985548,9.21918037835941e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,0.0920160756321093,0.00796475107014756,0.07640516353462,0.107626987729598,9.55405068530071e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FRMD4B,FERM domain-containing protein 4B,37562,0.073408874205089,0.00635564482278476,0.0609518103524308,0.0858659380577471,1.03712894198197e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REEP4,Receptor expression-enhancing protein 4,37959,0.0644723708292494,0.00558932506067521,0.053517293710326,0.0754274479481728,1.22425077566102e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,40203,0.0411786000879329,0.0035716248393381,0.0341782154028302,0.0481789847730356,1.24521497416522e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB33A,Ras-related protein Rab-33A,37562,0.0693476645302266,0.00601587435823826,0.0575565507880796,0.0811387782723736,1.3473334044431e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSD,Cathepsin D,39243,0.0414163456600052,0.00359446814068775,0.0343711881042572,0.0484615032157532,1.37658643108091e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST3,Cystatin-C,40372,0.0290429065699612,0.00252252595161814,0.0240987557047897,0.0339870574351328,1.49174071525068e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,37572,0.0840673583928191,0.00730308124417446,0.0697533191542372,0.0983813976314011,1.62305006450455e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,0.123406130378633,0.0107299275766515,0.102375472328397,0.14443678842887,1.71941300398151e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MARCO,Macrophage receptor MARCO,40359,0.0274516488675743,0.00238926298697025,0.0227686934131126,0.032134604322036,1.96218235041138e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFB,Complement factor B,37770,0.0339008286346894,0.00295129091140613,0.0281162984483334,0.0396853588210455,2.13752378331053e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARA5,Scavenger receptor class A member 5,40471,0.0302626578611926,0.0026357827739637,0.0250965236242237,0.0354287920981614,2.1496898930961e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBI,Acyl-CoA-binding protein,40270,0.0812894334145356,0.0070913436300392,0.0673903998996588,0.0951884669294125,2.65990037331147e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,37562,0.0719314533418159,0.00627571208381567,0.0596310576575372,0.0842318490260947,2.85718270773942e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTN4R,Reticulon-4 receptor,40489,0.0348593749442239,0.00304441181932588,0.0288923277783452,0.0408264221101026,3.07206208239222e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,0.0978120085070745,0.00854285183927179,0.0810680189021018,0.114555998112047,3.11090247596669e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LSP1,Lymphocyte-specific protein 1,40341,0.0410355193053681,0.00359291647580422,0.0339934030127918,0.0480776355979444,4.29254958445148e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.0333498566223971,0.00292018125642614,0.0276263013598019,0.0390734118849923,4.31889342980271e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,40341,0.063675004088635,0.005575527916037,0.0527469693732025,0.0746030388040675,4.33114876165112e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CETN2,Centrin-2,39961,0.0690443647034144,0.00604924853599019,0.0571878375728736,0.0809008918339551,4.70790450490962e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,37628,0.0574460974366772,0.00503249864068494,0.0475824001009347,0.0673097947724197,4.8688117743104e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,40411,0.085855161253018,0.00752607049183297,0.0711040630890253,0.100606259417011,5.00289528264257e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RFC4,Replication factor C subunit 4,37900,0.0210666601948927,0.00184842011311265,0.0174437567731919,0.0246895636165935,5.93076847149459e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PARK7,Parkinson disease protein 7,40332,0.0548173011991345,0.004812419461184,0.0453849590552138,0.0642496433430551,6.07328857965966e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCRG1,Scrapie-responsive protein 1,37990,0.0281314185091863,0.00247130219220549,0.0232876662124636,0.0329751708059091,6.92991039620188e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,37746,0.0569562293921862,0.00500922513372847,0.0471381481300784,0.066774310654294,8.07516003550253e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNM1,Dynamin-1,37901,0.11606503684545,0.0102127825621409,0.0960479830236544,0.136082090667247,8.57213279687498e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FST,Follistatin,40396,0.0529142288810518,0.00467154567381027,0.0437579993603837,0.0620704584017199,1.2529412908367e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCRN1,Secernin-1,40341,0.0572549354453789,0.00505993839334628,0.0473374561944202,0.0671724146963377,1.42964308994143e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,40471,0.0454767628435039,0.004021312155196,0.0375949910193198,0.0533585346676881,1.53382958068571e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALM,Paralemmin-1,37824,0.0298388590521649,0.00263877887080543,0.0246668524653862,0.0350108656389435,1.63394277304077e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN3,Ataxin-3,37942,0.0634002582292949,0.00560807699270594,0.0524084273235913,0.0743920891349985,1.67922391822354e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.0243516938760419,0.00215549583566875,0.0201269220381312,0.0285764657139526,1.75029005505502e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,37687,0.0653649503617812,0.00578488608370957,0.0540265736377104,0.0767033270858519,1.80543429646835e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,40536,0.0727998710034894,0.00645961783447287,0.0601390200479226,0.0854607219590562,2.37798332085163e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,40042,0.111970421510839,0.00994534860920517,0.0924775382367966,0.131463304784881,2.72612575679929e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,0.0477597192494171,0.00424302396701736,0.039443392274063,0.0560760462247711,2.78501726124384e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS3,Galectin-3,40374,0.0298159267031896,0.00266116914527201,0.0246000351784564,0.0350318182279227,5.00047635079179e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARFIP1,Arfaptin-1,37959,0.0692878935653132,0.00618219695020397,0.0571707875429135,0.081404999587713,5.02248045630438e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DXO,Decapping and exoribonuclease protein,37942,0.046142834362244,0.0041228346687597,0.038062078411475,0.054223590313013,5.98419207046623e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,39980,0.0597562609616921,0.00534084971628506,0.0492881955177734,0.0702243264056108,5.98822094694192e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,0.0476721024208785,0.00426043292842218,0.039321653881171,0.056022550960586,6.15281225364115e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,37990,0.0712132568850281,0.00637684153268489,0.0587146474809658,0.0837118662890905,7.86183880627622e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTC,Probetacellulin,39980,0.0756600149118711,0.00678140156379425,0.0623684678468344,0.0889515619769078,8.51782858600228e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LIPF,Gastric triacylglycerol lipase,37628,0.0599602511451931,0.00538030198355426,0.0494148592574268,0.0705056430329595,1.02472530804947e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALM2,Paralemmin-2,37942,0.0370301496635341,0.0033261500591568,0.0305108955475868,0.0435494037794814,1.15492284888538e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VCAM1,Vascular cell adhesion protein 1,40372,-0.0270152290905302,0.00243211151789787,-0.03178216766561,-0.0222482905154504,1.465041819373e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,40044,0.0659946666394084,0.00595999656769721,0.0543130733667219,0.077676259912095,2.16584262787115e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FRZB,Secreted frizzled-related protein 3,40176,0.0265476992918311,0.00240088290117776,0.0218419688055227,0.0312534297781395,2.56490886017615e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSC22D1,TSC22 domain family protein 1,37959,0.0669038760677517,0.00605551083436575,0.0550350748323948,0.0787726773031086,2.94766699283571e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,0.0398320856276294,0.00360665747626906,0.032763036974142,0.0469011342811167,3.09181007366708e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,0.0383643196420044,0.00347441988027821,0.0315544566766591,0.0451741826073497,3.17044340036839e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,0.0580442890737987,0.00525976993210018,0.0477351400068824,0.0683534381407151,3.26151315048609e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMSB10,Thymosin beta-10,40332,0.0753181335176994,0.00682592311492677,0.061939324212443,0.0886969428229559,3.31183973163978e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABHD14B,Protein ABHD14B,40171,0.0581309039186593,0.00526913672599099,0.047803395935717,0.0684584119016017,3.38613770867649e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP10,Caspase-10,39961,0.0713002361978549,0.00646362792710826,0.0586315254607227,0.0839689469349871,3.44785051071625e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,0.0406398364852223,0.00368329059426303,0.0334205869204668,0.0478590860499779,3.50178519194184e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAV,Integrin alpha-V,40489,0.0162508725836293,0.00147378179930627,0.013362260256989,0.0191394849102696,3.58872377177365e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,40341,0.0536175895865718,0.00486999264330414,0.0440724040056956,0.0631627751674479,4.3310003736775e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGS10,Regulator of G-protein signaling 10,37959,0.0593865488539443,0.00539316125157881,0.0488159528008498,0.0699571449070387,4.43027292869449e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C8B,Complement component C8 beta chain,38013,0.0302411512728091,0.00275275581364473,0.0248457498780654,0.0356365526675528,5.86855609959935e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,37598,0.0866764534161086,0.00789706255996126,0.0711982107985846,0.102154696033633,6.60417608141493e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD84,SLAM family member 5,40341,0.0303920088264081,0.00277191985601299,0.0249590459086226,0.0358249717441935,7.14534052953546e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6AP2,Renin receptor,39980,0.0411330670997987,0.00375265015199498,0.0337778728018885,0.0484882613977088,7.43788002386468e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,37671,0.0537945020145563,0.00490803790763734,0.0441747477155871,0.0634142563135255,7.79717946492351e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,40422,-0.0202884845768873,0.00185347470328062,-0.0239212949953173,-0.0166556741584573,8.69929292874743e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,0.0569638337022551,0.00520498283168283,0.0467620673521568,0.0671656000523535,8.95844508242614e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,0.0535727283265657,0.00490663408486661,0.0439557255202271,0.0631897311329042,1.18061270160844e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BDNF,Brain-derived neurotrophic factor,37998,0.0812878411401815,0.00744420451992742,0.0666972002811238,0.0958784819992392,1.21103165863708e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBCA,Tubulin-specific chaperone A,37671,0.0856453028682167,0.00784584617075403,0.0702674443735388,0.101023161362895,1.26789686505841e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TST,Thiosulfate sulfurtransferase,39923,0.0742913801651126,0.00683569431455507,0.0608934193085847,0.0876893410216406,2.05357224379147e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA6,Integrin alpha-6,40341,0.0519853181095326,0.00478361779312309,0.0426094272350114,0.0613612089840539,2.05895838093523e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA3,Annexin A3,40442,0.0683963217860472,0.00629423453160187,0.0560596221041075,0.0807330214679868,2.07543147801075e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,0.0565506196270758,0.00520657386861958,0.0463457348445814,0.0667555044095701,2.20981863714655e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,0.0853398458503854,0.00786046339045562,0.0699333376050924,0.100746354095678,2.40235716636011e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HGF,Hepatocyte growth factor,40516,0.0332737228720556,0.00308031246074211,0.0272363104490011,0.0393111352951101,4.17072576055852e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARF1,Scavenger receptor class F member 1,40536,0.0411019973099512,0.00380767301177168,0.0336389582068787,0.0485650364130237,4.52385348086721e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,0.0653140371705184,0.00605451532119552,0.0534471871409751,0.0771808872000616,5.1117784799185e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHAD,Chondroadherin,37671,0.0522480780266885,0.00484731238240904,0.0427473457571668,0.0617488102962103,5.61353752174856e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADD1,Alpha-adducin,37671,0.0680235932615936,0.00632127070207901,0.0556339026855187,0.0804132838376685,6.79274048111445e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PARD3,Partitioning defective 3 homolog,37714,0.071900749374686,0.00668663365752835,0.0587949474059304,0.0850065513434415,7.40936183171671e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,0.0944485352526672,0.00878524798077637,0.0772294492103455,0.111667621294989,7.5907776507274e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,0.0849030177253775,0.00790765759902431,0.0694040088312899,0.100402026619465,8.4826116082145e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",37942,0.101918440862093,0.00949822565870458,0.0833019185710325,0.120534963153154,9.4093666264446e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,0.115508121426043,0.0107706242634974,0.0943976978695883,0.136618544982498,9.65134955635607e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TADA3,Transcriptional adapter 3,37900,0.0374764420071478,0.00350452231230249,0.0306075782750349,0.0443453057392606,1.39256208578317e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0367153565516592,0.00343882741023719,0.0299752548275943,0.0434554582757241,1.60890329799551e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSME1,Proteasome activator complex subunit 1,40216,0.0362307517130953,0.00339472206248655,0.0295770964706217,0.042884406955569,1.68295104359435e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,37901,0.0799964217920516,0.00749482827659718,0.0653065583699212,0.0946862852141821,1.727775482907e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIF1,Allograft inflammatory factor 1,39980,0.0506652944026373,0.00474857453424303,0.041358088315521,0.0599725004897536,1.74495816631046e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HGFAC,Hepatocyte growth factor activator,37849,0.0278474282953578,0.00261086414543856,0.0227301345702982,0.0329647220204174,1.87487110365121e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,37419,0.0514602726664463,0.00483099468238202,0.0419915230889775,0.0609290222439151,2.19123813494722e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,0.0771451765659057,0.00724352472944118,0.062947868096201,0.0913424850356104,2.22757694693529e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSR,"Glutathione reductase, mitochondrial",37944,0.0211940100777178,0.00199569942199833,0.0172824392106011,0.0251055809448345,3.05884222748727e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,37987,0.0247416877843791,0.00233014939045401,0.0201745949790892,0.029308780589669,3.11460023714046e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JAM3,Junctional adhesion molecule C,37671,0.0483734580690793,0.00456072964454815,0.039434427965765,0.0573124881723937,3.54085212132207e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,0.0875593509490311,0.00825834692475617,0.071372990976509,0.103745710921553,3.56113260365284e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REN,Renin,40359,-0.0680033959520413,0.00641980823454006,-0.0805862200917398,-0.0554205718123428,3.93474593299963e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL1,Growth-regulated alpha protein,40329,0.0926388863196748,0.0087485161560009,0.0754917946539131,0.109785977985437,4.09157977341691e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMPA1,Inositol monophosphatase 1,40228,0.0581024400363761,0.0054900080726844,0.0473420242139147,0.0688628558588376,4.35622711132012e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,37990,0.0284727179002194,0.00269127499792329,0.0231978189042898,0.033747616896149,4.68117066577971e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.0863614173859844,0.00817668316701916,0.0703351183786268,0.102387716393342,5.64943586833981e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RILP,Rab-interacting lysosomal protein,40434,0.0571874619383627,0.00541928270784491,0.0465656678309866,0.0678092560457387,6.01486150002924e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,0.0548793162262992,0.00520090438966245,0.0446855436225608,0.0650730888300376,6.28732659358418e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TTF2,Transcription termination factor 2,37572,0.0462935982775696,0.00438999136764831,0.0376892151969789,0.0548979813581603,6.78156785924731e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKN3,Serine/threonine-protein kinase N3,37714,0.0732762658059274,0.00695212072966415,0.0596501091757857,0.0869024224360691,7.14032152913226e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QA,Complement C1q subcomponent subunit A,40442,-0.0215121843299972,0.00204634253466607,-0.0255230156979427,-0.0175013529620517,9.18098060626178e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.0337580617134773,0.00321477757562115,0.0274570976652599,0.0400590257616948,1.07488180802521e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CORO1A,Coronin-1A,39990,0.0850714989583947,0.0081054161912987,0.0691848832234493,0.10095811469334,1.10257847206846e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,37572,0.040843157258223,0.0038916733329344,0.0332154775256716,0.0484708369907744,1.1508131939526e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,0.0337602541617108,0.00321900565517715,0.0274510030775636,0.040069505245858,1.24138270140733e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTRB1,Chymotrypsinogen B,40332,0.0501639089340037,0.00479023522214961,0.0407750478985904,0.0595527699694169,1.40559994142242e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,0.0636161718491211,0.00607314877828965,0.0517128002436734,0.0755195434545688,1.41734300926113e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFHR5,Complement factor H-related protein 5,37785,0.0394497056108523,0.00376668830082942,0.0320669965412267,0.046832414680478,1.43964922224982e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,37714,0.0633176429202467,0.00605342610567021,0.0514529277531331,0.0751823580873603,1.66050410619704e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,39980,0.0722246991414695,0.00691325715578115,0.0586747151161384,0.0857746831668005,1.83151465724195e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,40396,-0.079661738725943,0.00762707067493407,-0.0946107972488138,-0.0647126802030722,1.87394911160549e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NID1,Nidogen-1,40355,0.0371667799258212,0.00355899383976916,0.0301911519998737,0.0441424078517688,1.90545273049853e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREML2,Trem-like transcript 2 protein,40332,0.0314963129441603,0.00301708559987351,0.0255828251684082,0.0374098007199124,1.98206499610359e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELE,E-selectin,40536,0.0468549506404846,0.00449437559797706,0.0380459744684496,0.0556639268125196,2.29083383283284e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,0.053301677382735,0.00511118062132228,0.0432837633649433,0.0633195914005266,2.30905228070052e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,0.0388248777385076,0.00372883511814105,0.0315163609069512,0.0461333945700641,2.73579604293542e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",37928,0.038144711328942,0.00366698019035933,0.0309574301558377,0.0453319925020463,3.01859856241602e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1RL,Complement C1r subcomponent-like protein,37993,0.0181769381329545,0.00174772096568465,0.0147514050402126,0.0216024712256964,3.07399497846693e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPT1,Angiopoietin-1,40263,0.0793044591696194,0.00763239456279789,0.0643449658265356,0.0942639525127033,3.3016050885161e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLNK,B-cell linker protein,37598,0.0359232598647592,0.00345841043051296,0.0291447754209538,0.0427017443085646,3.54772233453755e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK7,Kallikrein-7,37352,0.0362527483630944,0.00349433400329332,0.0294038537166395,0.0431016430095493,4.05663521477139e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGA,Fibrinogen alpha chain,37698,0.028770118206553,0.00277328496257818,0.0233344796798997,0.0342057567332062,4.06222862678006e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDS,Iduronate 2-sulfatase,40516,0.00807376553419829,0.000778793742877281,0.00654732979815882,0.00960020127023776,4.20345317702663e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,40305,0.0322387746983886,0.00310982721529091,0.0261435133564185,0.0383340360403588,4.22556272781412e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,37562,0.0635613752299726,0.00613477982962644,0.0515372067639048,0.0755855436960405,4.66910525871651e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.0514817907891649,0.0049719340743535,0.0417368000034321,0.0612267815748977,4.78755447455085e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,0.059710320403095,0.00576748969423581,0.0484060406023928,0.0710146002037972,4.89789359923154e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACRBP,Acrosin-binding protein,37900,0.0353164352509972,0.00341104017124728,0.0286307965153526,0.0420020739866419,5.00604803214253e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,40273,0.031335252826487,0.00303103829472737,0.0253944177688213,0.0372760878841526,5.68867294303792e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDZD2,PDZ domain-containing protein 2,37562,0.0573307076854921,0.00554860338386939,0.046455445053108,0.0682059703178761,6.26364556426282e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,0.0612362877152722,0.00593361184493151,0.0496064084992064,0.072866166931338,6.83083785460171e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,0.0454630455729728,0.00440681962728731,0.0368256791034897,0.054100412042456,7.38079170115803e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,39980,0.0421981929415954,0.00409237546061513,0.0341771370387897,0.050219248844401,7.52555232486951e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALB2,Calretinin,39961,0.0292710173240679,0.00283951857387915,0.0237055609192648,0.034836473728871,7.76218764016153e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEMIP2,Cell surface hyaluronidase,37598,0.0314196627508007,0.00304782225251535,0.0254459311358706,0.0373933943657307,7.98582299121683e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LARP1,La-related protein 1,37900,0.0589319048490976,0.00571807396861077,0.0477244798706205,0.0701393298275747,8.16649337486547e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,0.0489817243873889,0.0047533775637257,0.0396651043624866,0.0582983444122913,8.34185382496289e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB10,Ras-related protein Rab-10,37990,0.0496771776171898,0.00483398731868198,0.0402025624725731,0.0591517927618065,1.10645428867012e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PXN,Paxillin,39961,0.0478537834451338,0.00466224062363332,0.0387157918228125,0.0569917750674551,1.22598924072609e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD40LG,CD40 ligand,40516,0.0706727432152355,0.0068888369855317,0.0571706227235934,0.0841748637068776,1.28391341230847e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA4,Annexin A4,40279,0.0661306647434339,0.00645541433286332,0.0534780526510218,0.078783276835846,1.49888701397805e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,37901,0.0243686405295608,0.00238132637182089,0.0197012408407919,0.0290360402183298,1.73069162720497e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL3,C-C motif chemokine 3,40341,0.0566578433238061,0.00553939666948777,0.0458006258516101,0.0675150607960022,1.7662121722818e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,40490,0.0294802944324712,0.00288336091991739,0.0238289070294331,0.0351316818355093,1.83493383688032e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,0.0322908719501613,0.00316466109092137,0.0260881362119554,0.0384936076883672,2.34414403902618e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSAP,Prosaposin,37901,0.0260562310031744,0.00256188084116891,0.0210349445544833,0.0310775174518655,3.27723229069383e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,0.0620804483564995,0.00610393313267726,0.0501167394164521,0.074044157296547,3.30025352157513e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.0495784079605936,0.00488144841694607,0.0400107690633793,0.0591460468578079,3.6888938505649e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",37628,0.0792730493545037,0.00780902287731836,0.0639673645149597,0.0945787341940477,4.00414283776716e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,0.0813054667539562,0.00801441816119274,0.0655972071580184,0.0970137263498939,4.27783139213831e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,37901,0.070327197662247,0.00693325318225348,0.0567380214250301,0.0839163738994638,4.32576088567392e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDCP1,CUB domain-containing protein 1,40228,0.0443226936347944,0.0043756266396127,0.0357464654211535,0.0528989218484353,4.84400598703471e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,-0.0278936153497088,0.00275392220455085,-0.0332913028706285,-0.0224959278287891,4.87369061181714e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGF,Placenta growth factor,40516,0.0238858556244752,0.00236343031309512,0.0192535322108088,0.0285181790381416,6.10024345476454e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS2,Trypsin-2,40403,0.0454101387407736,0.00451446342429361,0.0365617904291581,0.0542584870523891,9.88702961020152e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,37990,0.024555750746059,0.00244202475683014,0.0197693822226719,0.0293421192694461,1.05236252146787e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HPSE,Heparanase,37848,0.0840800397331221,0.00836326190261142,0.0676880464040037,0.10047203306224,1.07584500474918e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.02204438318695,0.00219463290140275,0.0177429027002006,0.0263458636736993,1.1410836745259e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD164,Sialomucin core protein 24,40332,0.0239871612963115,0.00238897008137992,0.0193047799368068,0.0286695426558161,1.18651921139012e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,0.0520535134260767,0.00518506423542735,0.0418907875246391,0.0622162393275143,1.20793566700127e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GZMA,Granzyme A,40516,0.0317898614407972,0.00316834036997324,0.0255799143156497,0.0379998085659447,1.27333873850906e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAL,Integrin alpha-L,37598,0.0394231202389117,0.00393552585327452,0.0317094895664937,0.0471367509113298,1.55480381565813e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,40044,0.0615479380178598,0.00614654236248371,0.0495007149873917,0.0735951610483278,1.56732705604146e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,40403,0.0411765076842473,0.00411335513796348,0.0331143316138389,0.0492386837546558,1.60906923967704e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL4,C-C motif chemokine 4,40376,0.0609310891312807,0.00608789265465395,0.048998819528159,0.0728633587344025,1.64010074405412e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,0.0380865787724375,0.00380497704983274,0.0306288237547653,0.0455443337901097,1.67463456720996e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,0.0523604914064606,0.00524208800750222,0.0420859989117563,0.062634983901165,2.00559149108996e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.0448403502394575,0.00448876882574351,0.0360423633410003,0.0536383371379148,2.04273900485914e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,0.0740263685245475,0.00741681787258912,0.0594894054942728,0.0885633315548222,2.16585901989667e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,37942,0.0338218244205064,0.00338948246449416,0.0271784387900978,0.0404652100509149,2.28203282979978e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEP1B,Meprin A subunit beta,40359,0.106207843476038,0.0106576039608753,0.085318939712722,0.127096747239353,2.52704955335093e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSL,Cathepsin L1,40359,0.0217128367429912,0.00218169804537038,0.0174367085740652,0.0259889649119171,2.88308494302343e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",37959,0.0552646842111346,0.0055561187101351,0.0443746915392698,0.0661546768829994,3.13527369147074e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C7,Complement component C7,37678,-0.0282878003564256,0.00284396727124002,-0.0338619762080561,-0.0227136245047952,3.14863323929432e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLU,Clusterin,38013,0.0296803006410284,0.00298497027165771,0.0238297589085793,0.0355308423734775,3.24058704831249e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENO2,Gamma-enolase,40471,0.0586408553767205,0.00591993823958612,0.0470377764271317,0.0702439343263093,4.5828412725104e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,-0.0402544900036937,0.00407324050724325,-0.0482380413978904,-0.0322709386094969,5.75808914752091e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOXO3,Forkhead box protein O3,39980,0.086113521844732,0.008731552978809,0.0689996780062664,0.103227365683198,7.07702052975633e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP3,Stromelysin-1,40332,-0.0429150991539244,0.00435301519131142,-0.0514470089288948,-0.0343831893789541,7.31099678959651e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,37959,0.0439285897130772,0.00445774759508812,0.0351914044267045,0.0526657749994499,7.83044741348741e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,40291,0.0382278218029582,0.00388432653729803,0.030614541789854,0.0458411018160623,8.66558933142818e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX9,Sorting nexin-9,40359,0.0608161876757555,0.00618103868345117,0.0487013518561912,0.0729310234953199,8.86816976745923e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACE2,Angiotensin-converting enzyme 2,40042,0.0432720505573113,0.00440228742213308,0.0346435672099305,0.0519005339046922,9.78968676941527e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,39980,0.0421495925391632,0.00429156307283907,0.0337381289163987,0.0505610561619278,1.05942226187723e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,0.0387484333319688,0.0039501510373279,0.0310061372988061,0.0464907293651314,1.19338935569551e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,40305,0.0522069629974153,0.00534476136239061,0.0417312307271297,0.0626826952677009,1.78968230613675e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FXN,"Frataxin, mitochondrial",40489,0.0649806003255029,0.00665858609061689,0.0519297715878937,0.078031429063112,1.9507122813763e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,37900,0.0432031412591012,0.0044284160477605,0.0345234458054906,0.0518828367127118,2.06553486307419e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APP,Amyloid-beta precursor protein,40309,0.0587723172961251,0.00602777619323552,0.0469578759573835,0.0705867586348668,2.12708664615275e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.0226302134637079,0.00232147357228188,0.0180801252620354,0.0271803016653804,2.16897535815896e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUS,RNA-binding protein FUS,39960,0.0346028944967382,0.00355104967524953,0.0276428371332491,0.0415629518602273,2.25944888368214e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL1,Fc receptor-like protein 1,40359,0.0394624943562605,0.00405440047983374,0.0315158694157864,0.0474091192967346,2.51082797368565e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,0.0399590826504483,0.00410457570717284,0.0319141142643895,0.048004051036507,2.52729556881502e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,0.0487584615817889,0.00501468500378914,0.0389296789743622,0.0585872441892156,2.77962570039144e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,40332,0.0462071210531062,0.00475357749932469,0.0368901091544298,0.0555241329517826,2.84475543901092e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MATN2,Matrilin-2,40379,0.0259154593054195,0.00267075257329845,0.0206807842617546,0.0311501343490845,3.35859000189528e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,0.0533757480178287,0.00550831812879201,0.0425794444853963,0.064172051550261,3.82824449277684e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,0.0567561002063147,0.00585710870528386,0.0452761671439583,0.068236033268671,3.92338903665103e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPM1F,Protein phosphatase 1F,37990,0.0456381406514702,0.00471496308542675,0.0363968130040338,0.0548794682989067,4.34841068561659e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,0.0459741155131815,0.00475695258494146,0.0366504884466963,0.0552977425796668,4.91685999869405e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HRG,Histidine-rich glycoprotein,37934,0.0274667152988675,0.00284252680061137,0.0218953627696692,0.0330380678280658,5.11428158634606e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SULT2A1,Bile salt sulfotransferase,40341,0.0462691769771752,0.00479583557789337,0.0368693392445042,0.0556690147098462,5.77031761717914e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCS,Copper chaperone for superoxide dismutase,40228,0.0419838855811219,0.00435377250219735,0.0334504914768151,0.0505172796854287,6.04382633649349e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,0.0569512331050035,0.00590734424002509,0.0453728383945543,0.0685296278154527,6.19695615952507e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.0198543241749022,0.00206075920724948,0.0158152361286932,0.0238934122211111,6.55348426197e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,40359,0.0268211718550582,0.00279086664596219,0.0213510732289723,0.0322912704811441,8.28809153353663e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,0.0362373281716663,0.00377443472693311,0.0288394361068774,0.0436352202364552,9.11833848582063e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.0241355341963113,0.00251652292039161,0.0192031492723438,0.0290679191202789,9.99842334953667e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELOA,Elongin-A,40305,0.0440283360999922,0.00459568372440215,0.0350207960001639,0.0530358761998204,1.10700904770322e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,0.0387843856701983,0.00405848533305128,0.0308297544174178,0.0467390169229788,1.39521852158199e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF2,Fibroblast growth factor 2,40341,0.0568909015043011,0.00596385580155293,0.0452017441332573,0.0685800588753448,1.64223759093526e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C5,Complement C5,38013,0.0131329075051951,0.00137950909273069,0.0104290696834429,0.0158367453269472,2.02051953156174e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AREG,Amphiregulin,40305,-0.0424404161455998,0.00446552357854206,-0.0511928423595423,-0.0336879899316574,2.30211043814595e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREML1,Trem-like transcript 1 protein,37987,0.0452033262111057,0.00475737276671512,0.0358788755883441,0.0545277768338673,2.40580713587796e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,0.0490249526794405,0.00519318845273243,0.0388463033120849,0.0592036020467961,4.32232176346407e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,40305,0.0186592365242441,0.00198070032446899,0.0147770638882849,0.0225414091602033,5.09373491038486e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSS,Cathepsin S,37057,0.0210166937735849,0.00223155759277744,0.0166428408917411,0.0253905466554287,5.39151454894397e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C19orf12,Protein C19orf12,39961,0.0527386024330021,0.00560342259652239,0.0417558941438182,0.0637213107221859,5.54486761696398e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DMD,Dystrophin,37628,0.0441288340103146,0.00468876353551673,0.0349388574807018,0.0533188105399274,5.68517927064226e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,0.0243174329021176,0.00258436873701458,0.019252070177569,0.0293827956266662,5.80430954838621e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,0.0238043465145192,0.00253085011912404,0.0188438802810361,0.0287648127480024,6.01808189642976e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATG4A,Cysteine protease ATG4A,39980,0.0503536255558888,0.00536218825407838,0.0398437365778952,0.0608635145338824,6.78395132587698e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,37572,0.0584285152668963,0.00622170787453648,0.0462339678328048,0.0706230627009878,6.90641080915814e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,37900,0.0368141455435151,0.00392423968098835,0.0291226357687779,0.0445056553182523,7.55125996081149e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL11,C-X-C motif chemokine 11,40471,0.0670456735120712,0.00715670995319431,0.0530185220038103,0.081072825020332,8.33737330998972e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWC2,Brorin,40167,0.0328421263883719,0.00350581540426795,0.0259707281960067,0.0397135245807371,8.38279094053479e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,0.0250284932050821,0.00267622690802042,0.0197830884653621,0.0302738979448021,9.70566159462518e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,0.0624928325523337,0.00668313158743419,0.0493938946409627,0.0755917704637047,9.84167398496941e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSHB,Thyrotropin subunit beta,40359,0.070623314265595,0.00755384749440985,0.0558177731765517,0.0854288553546383,9.96985652923498e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRG2,Bone marrow proteoglycan,37998,-0.0440101846719676,0.00470785734610844,-0.0532375850703401,-0.034782784273595,1.02873016741662e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP6,Gastrotropin,40017,0.0470362196055432,0.00503692854478689,0.0371638396577609,0.0569085995533255,1.10895200060684e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,0.0271942619248457,0.00291253921799159,0.0214856850575821,0.0329028387921092,1.12019647885033e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNRD2,Protein ZNRD2,37901,0.0572870872762533,0.00613412168417488,0.0452642087752706,0.0693099657772361,1.1222112706997e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRK5,G protein-coupled receptor kinase 5,40042,0.04428756602011,0.00474375381803897,0.0349898085367536,0.0535853235034664,1.13292882929355e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF6,SLAM family member 6,39980,0.0319305619279085,0.00342484551902017,0.025217864710629,0.0386432591451881,1.2776666448744e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSTN,Growth/differentiation factor 8,40042,0.0429815185091458,0.0046101911517319,0.0339455438517512,0.0520174931665403,1.27774693168014e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,0.0241543843674782,0.00259403911120935,0.0190700677095078,0.0292387010254485,1.4568426892962e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GET3,ATPase GET3,37990,0.0471257140895107,0.00506441904797229,0.037199452755485,0.0570519754235364,1.53916740036253e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HPCAL1,Hippocalcin-like protein 1,40516,0.0614248337725853,0.00660428056539112,0.0484804438644187,0.0743692236807519,1.57020332105344e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPA1,Carboxypeptidase A1,40536,0.0478405270669196,0.00514924193558083,0.0377480128731812,0.0579330412606581,1.72338352829335e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,0.0518682581773154,0.00559605909873774,0.0408999823437894,0.0628365340108414,2.16456396242955e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,37998,0.0216653146754106,0.00233769038871387,0.0170834415135314,0.0262471878372897,2.18243449366926e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMOTL2,Angiomotin-like protein 2,37855,0.040123108265525,0.00434053051159596,0.0316156684627969,0.0486305480682531,2.73243105670013e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18,Interleukin-18,40292,0.0393959562327332,0.0042643031096015,0.0310379221379143,0.0477539903275522,2.80951707335713e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,39961,0.0553375510368251,0.00599734547300326,0.0435827539097387,0.0670923481639114,3.13510486259244e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACYP1,Acylphosphatase-1,37622,0.0549854154065055,0.00596511303890964,0.0432937938502426,0.0666770369627684,3.48603752642767e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUC13,Mucin-13,39961,0.0415833077670356,0.00452700326879941,0.0327103813601888,0.0504562341738825,4.59991026711962e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,37959,0.0291578139781516,0.00317547882542872,0.0229338754803113,0.0353817524759919,4.83092045581633e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.0455958959209219,0.00497055317493414,-0.0553381801437928,-0.0358536116980509,5.14429450678949e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD5,T-cell surface glycoprotein CD5,40470,0.0275505455735889,0.00300873802468197,0.0216534190452122,0.0334476721019656,5.97666316000691e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAMDC4,Apical endosomal glycoprotein,37900,0.0450398225243659,0.00492110826773206,0.0353944503196111,0.0546851947291207,6.3618128844552e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,0.0610187691867385,0.0066737032076581,0.0479383108997286,0.0740992274737483,6.91804992601253e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPT2,Angiopoietin-2,40489,-0.0318930622062818,0.00349054545222054,-0.0387345312926341,-0.0250515931199296,7.17460306828714e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPHS1,Nephrin,37598,0.0286507900628268,0.00313520770485937,0.0225057829613024,0.0347957971643511,7.2558227198292e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD72,B-cell differentiation antigen CD72,37671,0.0348835893822354,0.00382066174541257,0.0273950923612267,0.042372086403244,7.81422946438986e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMM2,Phosphomannomutase 2,37562,0.0498457328742648,0.00546801717983117,0.0391284192017957,0.0605630465467339,8.92567291081833e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,0.0632603834415782,0.00694159191013496,0.0496548632977137,0.0768659035854427,9.11276847186278e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNMT,Histamine N-methyltransferase,40147,0.0379889826476438,0.00418266718937275,0.0297909549564732,0.0461870103388144,1.18544690730041e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRL,Prolactin,40471,-0.0627730403218476,0.00691230907259467,-0.0763211661041331,-0.049224914539562,1.19515847470419e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,40359,0.0288223920247108,0.00317970566618292,0.0225901689189923,0.0350546151304294,1.39515131907845e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,37671,0.0307484705265989,0.00339244436897673,0.0240992795634045,0.0373976614897933,1.43488219036449e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CR1,Complement receptor type 1,37959,0.029551072000045,0.00327015177073002,0.0231415745294141,0.0359605694706758,1.83300290369907e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM1,Intercellular adhesion molecule 1,40291,0.0232029314896005,0.00256980261751872,0.0181661183592638,0.0282397446199372,1.92705931510485e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY75,Lymphocyte antigen 75,40341,0.0316496668740119,0.00350777742745368,0.0247744231162027,0.0385249106318212,2.04101540747667e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRK1,Protein BRICK1,39961,0.0359723318384379,0.00398791935162068,0.0281560099092614,0.0437886537676145,2.09116695045672e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIF22,Kinesin-like protein KIF22,37562,0.0996664167621204,0.0110577466780008,0.0779932332732389,0.121339600251002,2.27413115537872e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDT,D-dopachrome decarboxylase,37998,0.0332177619556956,0.00368848853730858,0.0259883244225708,0.0404471994888205,2.42352528440446e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECE1,Endothelin-converting enzyme 1,39961,0.0286501562087035,0.00318362080632959,0.0224102594282975,0.0348900529891095,2.53202165896771e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.0267958562835386,0.00297818413181782,0.0209586153851757,0.0326330971819015,2.61554285301298e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNAS,Neuroendocrine secretory protein 55,37959,0.0731945646173104,0.00813592807826921,0.0572481455839028,0.0891409836507181,2.63813557239484e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSNAX,Translin-associated protein X,37562,0.0320982859779664,0.00356844212392797,0.0251041394150676,0.0390924325408652,2.68223781390011e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTN6,Dynactin subunit 6,39961,0.0573645459684347,0.00638429144369663,0.0448513347387893,0.0698777571980801,2.8734587169235e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB1,Integrin beta-1,40333,0.0177193999955117,0.00197318967591119,0.0138519482307258,0.0215868517602977,3.00389910096063e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL2,C-C motif chemokine 2,40203,0.0428074266923591,0.00477042230895118,0.0334573989668148,0.0521574544179034,3.19045905908969e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD274,Programmed cell death 1 ligand 1,40228,0.0280523921422364,0.00313424167916406,0.0219092784510748,0.0341955058333979,3.9333380906111e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRDT,Bromodomain testis-specific protein,37562,0.0301148018189718,0.00336775885167517,0.0235139944696884,0.0367156091682551,4.32490080488169e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FMNL1,Formin-like protein 1,39961,0.0482865941801762,0.00540484472368418,0.0376930985217552,0.0588800898385972,4.56536619296004e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP5,Microfibrillar-associated protein 5,40536,0.0329721091684427,0.00369230671614775,0.0257351880047931,0.0402090303320923,4.71490975073098e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,40359,0.0282474381618968,0.0031653563852128,0.0220433396468797,0.0344515366769139,4.98238837250892e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS3BP,Galectin-3-binding protein,38013,0.0237995254848724,0.00267161297587842,0.0185631640521507,0.0290358869175941,5.83441445086404e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THBD,Thrombomodulin,40359,0.0222653190294932,0.00250003633282915,0.0173652478171481,0.0271653902418383,5.85317851980577e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.0408982502615889,0.00459484771714444,-0.049904151787192,-0.0318923487359858,6.1255941195096e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,0.0538774694676679,0.00607231784494245,0.0419757264915807,0.0657792124437551,8.05970712740942e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.0123972036693034,0.00139820902118218,0.00965671398778633,0.0151376933508205,8.32760522390216e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMA4,Laminin subunit alpha-4,40422,0.0261880865572736,0.00295370465035653,0.0203988254425749,0.0319773476719724,8.35615227994004e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,40453,0.0528607579417905,0.00596328322310492,0.0411727228245049,0.0645487930590762,8.49084250947057e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRD1,Natural killer cells antigen CD94,40516,0.0364187059740045,0.00410884020963484,0.0283653791631202,0.0444720327848888,8.55387237662205e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OPLAH,5-oxoprolinase,37628,0.0543498489755906,0.00613944421401467,0.0423165383161218,0.0663831596350593,9.63377707239495e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,0.042432474986323,0.00479556307774856,0.0330331713539358,0.0518317786187102,1.0011779746555e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STXBP3,Syntaxin-binding protein 3,39980,0.0352357255356715,0.00398346659281529,0.0274281310137535,0.0430433200575895,1.00782558310846e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPXM1,Probable carboxypeptidase X1,40411,0.0547420806720335,0.00619297012590206,0.0426038592252655,0.0668803021188016,1.06125454467163e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,39980,0.0321138244128401,0.00363757746615079,0.0249841725791845,0.0392434762464956,1.1739435373164e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,-0.0276027708196162,0.00313087857687148,-0.0337392928302843,-0.0214662488089481,1.30319940085792e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHB4,Ephrin type-B receptor 4,40536,-0.0195609838944805,0.00221888702841474,-0.0239100024701734,-0.0152119653187876,1.3095116390999e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.0379864961699469,0.0043156737309563,0.0295277756572725,0.0464452166826212,1.48374279216122e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,0.0427478121097512,0.00486183943268399,0.0332186068216906,0.0522770173978118,1.64290640442397e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STK4,Serine/threonine-protein kinase 4,40359,0.0680193018708014,0.00774157949295155,0.0528458060646164,0.0831927976769865,1.70205904911408e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VGF,Neurosecretory protein VGF,37959,0.0241546283595182,0.00275033079654706,0.0187639799982859,0.0295452767207504,1.79010627331664e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS27,Serine protease 27,40314,0.0320050740232892,0.00364599155844516,0.0248589305687366,0.0391512174778417,1.82867520292194e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALCAM,CD166 antigen,40536,0.0152957119750433,0.00174718950064586,0.0118712205537775,0.0187202033963092,2.25141621801614e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,0.0321100997257878,0.00366893068519378,0.0249189955828079,0.0393012038687676,2.35137849275807e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAP18,Chromatin complexes subunit BAP18,37942,0.0508914713774513,0.005842300547632,0.0394405623040926,0.06234238045081,3.36334397233064e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RASSF2,Ras association domain-containing protein 2,39980,0.0430583243996177,0.00495515799824007,0.0333462147230672,0.0527704340761683,3.99541637829697e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,37671,0.0284942049794451,0.00329390055076054,0.0220381598999545,0.0349502500589358,5.70916131135408e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SWAP70,Switch-associated protein 70,37901,0.0274234283014542,0.00317283105673613,0.0212046794302514,0.033642177172657,6.07765590283636e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,0.0541380985173474,0.00627839793199663,0.041832438570634,0.0664437584640608,7.13627723325721e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLR2,Folate receptor beta,40471,-0.0228873374115029,0.00265479207614554,-0.0280907298807482,-0.0176839449422577,7.24057936718281e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEP1A,Meprin A subunit alpha,37901,0.0532212398457472,0.00617200639679637,0.0411241073080263,0.065318372383468,7.24502593128789e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UNC79,Protein unc-79 homolog,37482,0.0440889142978141,0.00511357354202994,0.0340663101554354,0.0541115184401928,7.33712942837915e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBKS,Ribokinase,39991,0.0385466391373935,0.00448174097270339,0.0297624268308949,0.0473308514438922,8.66141528309976e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAA10,N-alpha-acetyltransferase 10,37562,0.0399160888028961,0.00464381797330342,0.0308142055752214,0.0490179720305708,9.21931204147137e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENAH,Protein enabled homolog,40044,0.0366474957738307,0.00426605693032209,0.0282860241903994,0.0450089673572619,9.47014935477785e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,37901,0.0877325052225141,0.0102197877211881,0.0677017212889855,0.107763289156043,1.01097393628906e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD83,CD83 antigen,40341,0.0259360892869365,0.00303105095697094,0.0199952294112735,0.0318769491625996,1.26515464151981e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,0.0795441545533642,0.00930122879285416,0.06131374611937,0.0977745629873583,1.3392741030668e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR3,Toll-like receptor 3,40516,0.0468253552804952,0.00548830816271131,0.036068271281581,0.0575824392794093,1.56735215573798e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD276,CD276 antigen,40357,-0.0276524229758175,0.00324213364019151,-0.0340070049105929,-0.0212978410410422,1.60632044183408e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.0276494164766556,0.00324663938299342,0.0212860032859885,0.0340128296673227,1.79285710540239e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASS1,Argininosuccinate synthase,37562,0.0618703867408498,0.00726439207827285,0.047632178267435,0.0761085952142646,1.81546675572371e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,40042,0.028971976601229,0.00340934608783328,0.0222896582690758,0.0356542949333822,2.10479644160203e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.0721260013083817,0.00850240744120156,0.0554612827236266,0.0887907198931368,2.38707029620476e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SF3B4,Splicing factor 3B subunit 4,40305,0.0560024947207625,0.0066167812985113,0.0430336033756804,0.0689713860658447,2.81403985363322e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPB1,Carboxypeptidase B,40536,0.0429259221812419,0.00507243779142127,0.0329839441100562,0.0528679002524276,2.83781535484108e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,0.0447251408487039,0.00528844450238727,0.0343597896240249,0.055090492073383,2.97736995677481e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,37628,0.0427111197765046,0.00505559283809561,0.0328021578138372,0.052620081739172,3.26357216443255e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,37714,0.02646253219017,0.00313640781548632,0.0203151728718168,0.0326098915085232,3.58409494191112e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PODXL,Podocalyxin,40305,0.0115711306532435,0.00137180172293707,0.00888239927628684,0.0142598620302001,3.59477982944172e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,0.0663627073056064,0.00787132208393484,0.0509349160210941,0.0817904985901187,3.78013389371441e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,-0.0295875469356953,0.00351598999082859,-0.0364788873177193,-0.0226962065536713,4.25553649560408e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP8,Caspase-8,40434,0.0469127075816624,0.00557536528833667,0.0359849916165225,0.0578404235468023,4.28386262550475e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASAH1,Acid ceramidase,37882,0.0350415046807437,0.00416393606567337,0.0268801899920239,0.0432028193694635,4.30578663069137e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17D,Interleukin-17D,40044,0.0259765203759647,0.0030913405263751,0.0199174929442695,0.0320355478076599,4.72399215146759e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.0330856676636771,0.00394844238955619,0.025346720580147,0.0408246147472073,5.7697231690432e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB6,Integrin beta-6,40044,0.0228052817308782,0.00272249477668635,0.0174691919685729,0.0281413714931834,5.90654187916135e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,0.0465016226288738,0.00555237711055743,0.0356189634921812,0.0573842817655664,5.98533092081295e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,37628,0.0430153155195187,0.00514093028964549,0.0329390921518136,0.0530915388872239,6.48902379964739e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,40314,-0.0212923982917902,0.00254684899243918,-0.026284222316971,-0.0163005742666094,6.770377777181e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,0.0262208760406442,0.00313671171674691,0.0200729210758203,0.0323688310054682,6.82718394003635e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMB1,Laminin subunit beta-1,37628,0.0222566208003564,0.00266259658494644,0.0170379314938614,0.0274753101068514,6.95565897595744e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX16,Syntaxin-16,39980,0.0444327252822777,0.00532760201731579,0.0339906253283387,0.0548748252362166,8.04016295077758e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYTL1,Cytokine-like protein 1,37998,0.0172740432535771,0.00207532429098094,0.0132064076432544,0.0213416788638997,9.34915839429019e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BOLA1,BolA-like protein 1,37541,0.0411371149683565,0.00494861112689153,0.0314378371596491,0.0508363927770639,1.02578980960853e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.0682576485176952,0.00823914565873089,0.0521089230265826,0.0844063740088077,1.29931146711913e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PVALB,Parvalbumin alpha,40417,0.0843189615477381,0.0101820634997735,0.0643621170881821,0.104275806007294,1.31591810124047e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGMN,Legumain,40422,0.0264566223068877,0.00319726543799659,0.0201899820484144,0.032723262565361,1.3877579102544e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANSC1,MANSC domain-containing protein 1,40411,-0.0204198597314708,0.00247243281911005,-0.0252658280569265,-0.0155738914060151,1.58287087447513e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,40489,0.0275001044043674,0.00333470794728699,0.0209640768276849,0.0340361319810499,1.75436165294351e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,37990,0.0240729370262314,0.00292043598722579,0.0183488824912689,0.029796991561194,1.83408596841651e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WDR46,WD repeat-containing protein 46,37900,0.0264139263896519,0.00321073178000429,0.0201208921008435,0.0327069606784603,2.09901099057758e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,0.0533359962995702,0.00649315992156929,0.0406094028532944,0.066062589745846,2.30236875575348e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSTN3,Calsyntenin-3,37942,0.0226586641782981,0.00275861417926618,0.0172517803869364,0.0280655479696598,2.33699155087694e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSG4,Desmoglein-4,40250,0.0376958487737742,0.00459398949664164,0.0286916293603566,0.0467000681871918,2.47242596509611e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPMT,Thiopurine S-methyltransferase,39980,0.0547151855698612,0.00667291510830845,0.0416362719575766,0.0677940991821457,2.59914370892586e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPQ,Carboxypeptidase Q,37986,0.0269642357088377,0.00329660299895103,0.0205028938308937,0.0334255775867817,3.10523026018872e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.0421423846484177,0.00515337528715143,0.032041769085601,0.0522430002112345,3.11228005332413e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTN,Pleiotrophin,40042,0.0369776997431633,0.00452891040113449,0.0281010353569397,0.0458543641293869,3.46381077134537e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.0405264469407473,0.00496508433675807,0.0307948816407015,0.0502580122407932,3.57792064387751e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ING1,Inhibitor of growth protein 1,39925,0.0328318983555406,0.00402864161626018,0.0249357607876707,0.0407280359234106,3.92793154098576e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OCLN,Occludin,37959,0.0320187133588555,0.00393185592234649,0.0243122757510564,0.0397251509666546,4.17792695833038e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF7,SLAM family member 7,40341,-0.0423765111561349,0.00520589363671149,-0.0525800626840894,-0.0321729596281804,4.23983337720936e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAM,Signal transducing adapter molecule 1,37900,0.0275850285273834,0.00338888272865693,0.0209428183792158,0.034227238675551,4.30323086117182e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,39980,0.033621033666535,0.00413625383105217,0.0255139761576728,0.0417280911753972,4.67643515732077e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD46,Membrane cofactor protein,40250,0.0210043099370296,0.00258427844950437,0.015939124176001,0.0260694956980582,4.69571283913452e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGXT,Serine--pyruvate aminotransferase,40359,0.0562163843351346,0.00692250380256268,0.0426482768821117,0.0697844917881575,4.96740824753123e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX6,Syntaxin-6,39980,0.0503759674491924,0.00621040476717458,0.0382035741055302,0.0625483607928545,5.36909212884168e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL5,Fc receptor-like protein 5,40332,-0.0408909175257502,0.00504723257272476,-0.0507834933682907,-0.0309983416832097,5.813124650637e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,37671,0.0278123839147605,0.00343352635041282,0.0210826722679513,0.0345420955615696,5.96346804101882e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A13,Protein S100-A13,37598,0.0254540979822157,0.00315089941438612,0.0192783351300189,0.0316298608344125,7.13379118074492e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3BP1,SH3 domain-binding protein 1,37901,0.0340324806219619,0.0042172983267523,0.0257665759015274,0.0422983853423964,7.63928473554918e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX7,Syntaxin-7,37598,0.036607146992945,0.00454874717238112,0.027691602535078,0.045522691450812,9.15373234746566e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,0.0553540904244905,0.00688227192032086,0.0418648374606616,0.0688433433883194,9.49390334481245e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCN1,Ficolin-1,37967,0.0409478110522241,0.00509241735299093,0.0309666730403619,0.0509289490640863,9.65262023586958e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA4,Carbonic anhydrase 4,40536,-0.0169020639083249,0.00210505170791104,-0.0210279652558305,-0.0127761625608192,1.04773648958696e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,-0.0845652038921461,0.0105464519792122,-0.105236249771402,-0.0638941580128903,1.1463638792667e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERI1,3'-5' exoribonuclease 1,37714,0.0243012637656315,0.00303412823964264,0.0183543724159319,0.0302481551153311,1.24929571465278e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,40332,0.0215853266837846,0.0026977602065147,0.0162977166790158,0.0268729366885534,1.31661497304227e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMMT,MICOS complex subunit MIC60,37900,0.0320215467540294,0.00401032971542822,0.0241613005117901,0.0398817929962687,1.52160444263448e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOF,Apolipoprotein F,37987,0.0174011414371182,0.0021797252789846,0.0131288798903083,0.021673402983928,1.54042672437596e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],39978,0.0351867586530498,0.00441985587066565,0.0265238411465451,0.0438496761595544,1.82298163770172e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARB2,Lysosome membrane protein 2,40011,0.022109357879965,0.00278598609580917,0.016648825132179,0.027569890627751,2.23101987088369e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFAP,Glial fibrillary acidic protein,39959,0.0335445025724007,0.0042278204925717,0.0252579744069602,0.0418310307378413,2.26193657251036e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,0.0352828597646834,0.00445847729575489,0.0265442442650039,0.044021475264363,2.70281634660965e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPAG1,Sperm-associated antigen 1,37959,0.0410631863546373,0.00519519107269598,0.0308806118521532,0.0512457608571215,2.90750256270342e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,0.0317840738175602,0.00402367272446814,0.0238976752776027,0.0396704723575178,3.02692669322799e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,0.0340702069422461,0.00431854341354127,0.0256058618517053,0.042534552032787,3.27227215390184e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LBP,Lipopolysaccharide-binding protein,40403,-0.0412854644988368,0.00524829034070592,-0.0515721135666204,-0.0309988154310532,3.88068811187129e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTGES2,Prostaglandin E synthase 2,37484,0.0388715517406649,0.00494046352596014,0.029188243229783,0.0485548602515468,3.8867874790651e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTX1,Neuronal pentraxin-1,40332,0.027833893066463,0.00355819252124525,0.0208598357248223,0.0348079504081036,5.503380118889e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,0.0412436511410744,0.00527262960895083,0.0309092971075308,0.0515780051746181,5.57385104609581e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLF4,Krueppel-like factor 4,37541,0.0275985268911445,0.00353088248535086,0.0206779972198568,0.0345190565624322,5.85288303326644e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSC2,Desmocollin-2,40177,-0.0237542050421366,0.00303990570972193,-0.0297124202331916,-0.0177959898510816,5.88297629681034e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAGED1,Melanoma-associated antigen D1,39980,0.0342372182622096,0.00438442131809434,0.0256437524787447,0.0428306840456745,6.13900649165912e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOB,Apolipoprotein B-100,37987,0.0157557886025962,0.00201783185423424,0.0118008381682971,0.0197107390368953,6.22217007444365e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,-0.0255642233340014,0.0032794856650977,-0.0319920152375928,-0.0191364314304099,6.91201215148752e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPB6,Heat shock protein beta-6,40489,0.0256273226428245,0.00328841032424867,0.0191820384072971,0.0320726068783519,6.93060236636027e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GDF15,Growth/differentiation factor 15,40536,-0.0302041791901268,0.00387700837805756,-0.0378031156111196,-0.0226052427691339,7.07498185804499e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,37714,0.049129201509124,0.00630947051842987,0.0367626392930015,0.0614957637252466,7.39387410576049e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP1,Guanylate-binding protein 1,37931,0.045149291592779,0.00580883936938647,0.0337639664287815,0.0565346167567764,8.24977879512989e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XG,Glycoprotein Xg,40458,0.0209750832379238,0.00269927069503774,0.0156845126756498,0.0262656538001977,8.28041858824688e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXN,Thioredoxin,37819,0.031251558151453,0.00402336782190414,0.0233657572205209,0.0391373590823852,8.58561879481329e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA3,Protein disulfide-isomerase A3,37671,0.0178902602216117,0.00230717133866407,0.0133682043978301,0.0224123160453932,9.53907885143701e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,0.0314379855957677,0.00405481491515284,0.0234905483620682,0.0393854228294673,9.61406194857518e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,0.033776312598788,0.00435805932933633,0.0252345163132888,0.0423181088842873,9.71447397599898e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSZ,Cathepsin Z,40345,0.0216894780558624,0.00279987048889609,0.016201731897626,0.0271772242140987,1.00059125097916e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,40042,-0.0238729881899002,0.0030817719990437,-0.0299132613080258,-0.0178327150717745,1.00240817464633e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,39925,0.046220767703299,0.00596734689264727,0.0345247677937104,0.0579167676128877,1.00995280334147e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FSTL1,Follistatin-related protein 1,37628,-0.015714506862375,0.0020312881423198,-0.0196958316213218,-0.0117331821034282,1.09836652754132e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1R1,Interleukin-1 receptor type 1,40303,-0.0155669528702266,0.00201376904394725,-0.0195139401963633,-0.01161996554409,1.13743818187832e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,37714,0.0528665784861758,0.00684726744028616,0.0394459343032149,0.0662872226691367,1.238336616075e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C7orf50,Uncharacterized protein C7orf50,37942,0.0152854183001373,0.00198111390291651,0.0114024350504209,0.0191684015498537,1.2887727669064e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMIGO2,Amphoterin-induced protein 2,40305,0.0156523070168478,0.00203538643149574,0.0116629496111162,0.0196416644225795,1.55633069699517e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCAN,Neurocan core protein,40471,0.025836595124032,0.00336155794275733,0.0192479415562277,0.0324252486918364,1.60701557287198e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.0228161147730756,0.0029733742757667,-0.0286439283535784,-0.0169883011925729,1.78895319188544e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSR,Insulin receptor,37598,0.0117064818637073,0.00152763661280244,0.00871231410261454,0.0147006496248001,1.94141595464639e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGMB,RGM domain family member B,40471,0.0179229130160529,0.00234060433630672,0.0133353285168918,0.0225104975152141,2.00551229500479e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCT,Secretin,37572,0.0318168623739901,0.00415806488429054,0.0236670552007807,0.0399666695471996,2.11918677704212e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THBS2,Thrombospondin-2,40332,-0.0247007520771894,0.00322917294619774,-0.031029931051737,-0.0183715731026418,2.13710440889859e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,40359,0.0185320120369325,0.00242285999456443,0.0137832064475862,0.0232808176262788,2.14409292540555e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,0.0377973275247117,0.00494126171904151,0.0281124545553903,0.047482200494033,2.15735064404062e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PER3,Period circadian protein homolog 3,37598,0.0815378298965878,0.0106729577034402,0.060618832797845,0.102456826995331,2.32828437886853e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDK,Midkine,40352,0.0348666673840013,0.00456959948472787,0.0259102523939347,0.043823082374068,2.47758868228778e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NID2,Nidogen-2,40332,0.0506840874565896,0.00665110906970773,0.0376479136799625,0.0637202612332168,2.67135630277632e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.0166639990923003,0.00218782076590085,0.0123758703911347,0.020952127793466,2.7477050338944e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XRCC4,DNA repair protein XRCC4,39961,0.025591957964292,0.00336413447730873,0.0189982543887668,0.0321856615398171,2.95927889662941e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.0236594763149221,0.00311448204346763,0.0175550915097256,0.0297638611201187,3.20956239703107e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,37572,0.0424004059273732,0.00558412493545,0.0314555210538912,0.0533452908008552,3.33617991927189e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APRT,Adenine phosphoribosyltransferase,40216,0.0331192698463857,0.00437538170201135,0.0245435217104435,0.041695017982328,3.95474386708877e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.0373375676517886,0.00493409086340171,0.0276667495595213,0.047008385744056,4.06547352308858e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,0.0255216955743289,0.00337670957146461,0.0189033448142583,0.0321400463343996,4.31079456437699e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPPK1,Epiplakin,37628,0.0500985196094898,0.00663890416484915,0.0370862674463855,0.0631107717725941,4.77505546050752e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DENR,Density-regulated protein,37598,0.0392405845248631,0.00520569319821094,0.0290374258563697,0.0494437431933566,5.08400249569769e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,0.0647636705159394,0.00859911688297548,0.0479094014253074,0.0816179396065713,5.29057691716521e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.0286312557672023,0.00380222110946433,0.0211789023926522,0.0360836091417524,5.39112258484367e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.0692272538263707,0.00920317846030551,0.0511890240441719,0.0872654836085695,5.7317167479924e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,0.0463537837411226,0.0061653424821563,0.0342697124760962,0.0584378550061489,5.89213665749737e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,0.0323568370072556,0.00430773053935733,0.0239136851501152,0.040799988864396,6.17167588819093e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK6,Kallikrein-6,40387,0.0206213698003762,0.00274724467011109,0.0152367702469585,0.026005969353794,6.4080972337931e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NGRN,Neugrin,37942,0.0149043700746998,0.00198809457621618,0.0110077047053161,0.0188010354440835,6.94628056885409e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMOX1,Heme oxygenase 1,40184,-0.0316678655607667,0.00423205432131141,-0.0399626920305371,-0.0233730390909964,7.6563759010158e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLIT2,Slit homolog 2 protein,39961,0.0353978599001449,0.00473760695356472,0.026112150271158,0.0446835695291317,8.33982625099548e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,0.0264344463427038,0.00354173601557198,0.0194926437521827,0.0333762489332249,8.94143541340426e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYGD,Gamma-crystallin D,37942,0.064311173597275,0.00866087848718443,0.0473358517623935,0.0812864954321564,1.19107766827123e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRN,Progranulin,40262,0.0162433092491272,0.00218819293145216,0.011954451103481,0.0205321673947734,1.20175824253932e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,0.0149908626176781,0.002020693969178,0.0110303024380892,0.018951422797267,1.25336562670538e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,40305,-0.0366206292526351,0.004938242945794,-0.0462995854263913,-0.0269416730788788,1.27078355744419e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP12,Macrophage metalloelastase,40346,0.0345778939959906,0.00466890782395067,0.0254268346610473,0.0437289533309339,1.36700062540945e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMPER,BMP-binding endothelial regulator protein,37671,0.0150242968413601,0.00202905179149859,0.0110473553300229,0.0190012383526973,1.39516403703258e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMP6,Bone morphogenetic protein 6,40024,0.028211195546136,0.00381936557380849,0.0207252390214714,0.0356971520708006,1.58550681303133e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,0.0425009968114389,0.00577004841888156,0.031191701910431,0.0538102917124467,1.84723839967857e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCA,Calcitonin,40192,0.0364437292255685,0.00496574094987479,0.0267108769638139,0.0461765814873231,2.25648658960123e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,0.0344713781199711,0.0046973300203841,0.0252646112800182,0.0436781449599239,2.26395048558049e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN4,CCN family member 4,40489,0.0270520332180188,0.00369034223603391,0.0198189624353924,0.0342851040006453,2.40237167745699e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNF,Tumor necrosis factor,40014,0.0263284001749408,0.00359213118945342,0.0192878230436121,0.0333689773062695,2.42426641391069e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL25,C-C motif chemokine 25,40516,0.0322206850493903,0.00440632013505687,0.0235842975846788,0.0408570725141018,2.74819917069641e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MILR1,Allergin-1,40044,-0.0328865102469862,0.00450867141637417,-0.0417235062230796,-0.0240495142708928,3.15220172882646e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PQBP1,Polyglutamine-binding protein 1,39980,0.0362986979603034,0.00497666885610365,0.0265444270023403,0.0460529689182666,3.15944122486849e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP9,Caspase-9,37598,0.0411918657385819,0.00564760936697414,0.0301225513793126,0.0522611800978513,3.18865451576984e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.0267103857434782,0.00366465929975035,0.0195276535159675,0.0338931179709889,3.31049629427492e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NXPH3,Neurexophilin-3,37598,0.0199761524560493,0.00274423353218815,0.0145974547329606,0.0253548501791381,3.54566149894312e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDGF,Hepatoma-derived growth factor,40471,0.0626216681399033,0.00861144591745626,0.045743234141689,0.0795001021381176,3.70817835048854e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NBN,Nibrin,40044,0.0333976053027374,0.00459413518338044,0.0243931003433117,0.0424021102621631,3.77612399746619e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,40489,0.0248417744098279,0.00341801671440512,0.0181424616495938,0.0315410871700619,3.81960786805225e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMS,Spermine synthase,37541,0.0418492881850673,0.00577455761334365,0.0305311552629138,0.0531674211072209,4.49371548281979e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,37562,0.0242457892883333,0.00335119043595704,0.0176774560338575,0.0308141225428091,4.91481117492863e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST5,Cystatin-D,40070,0.0359534578507395,0.00498200223001261,0.0261887334799148,0.0457181822215643,5.57273219174569e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHRDL1,Chordin-like protein 1,40396,0.0198508800616088,0.00275075445114613,0.0144594013373624,0.0252423587858553,5.57359381742373e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,0.0186287344760487,0.00258204221163219,0.0135679317412496,0.0236895372108478,5.70108077916212e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,40305,0.023368423118677,0.00323974760279559,0.0170185178171976,0.0297183284201563,5.7190895140548e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCAM,Cell surface glycoprotein MUC18,40403,-0.0220990811038254,0.00306484212942286,-0.0281061716774942,-0.0160919905301566,5.82427156566163e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS7_LGALS7B,Galectin-7,40270,0.0261552790674631,0.00362908564430836,0.0190422712046188,0.0332682869303075,5.97258666711428e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLTA,Clathrin light chain A,40042,0.030796569527682,0.00427738264620058,0.0224128995411289,0.0391802395142352,6.30247137801749e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,38013,-0.0166325715239376,0.00230986346968958,-0.0211599039245292,-0.012105239123346,6.30716995903095e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,0.0756371267041411,0.0105086384672236,0.0550401953083828,0.0962340580998994,6.45243145387528e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINI1,Neuroserpin,37642,0.0207491524845573,0.00288360218578738,0.0150972922004141,0.0264010127687006,6.55625122418198e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRTAC1,Cartilage acidic protein 1,40536,0.018992708904593,0.00264045350064417,0.0138174200433304,0.0241679977658555,6.61886698870961e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,37990,0.016300828532969,0.00227024388528209,0.0118511505178161,0.0207505065481219,7.32347100326426e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH17,Cadherin-17,40359,-0.0438418117239702,0.00610793818929451,-0.0558133705749874,-0.031870252872953,7.39494798190759e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA12,Carbonic anhydrase 12,40305,-0.0209204635990828,0.00291689074290946,-0.0266375694551854,-0.0152033577429803,7.70751897816839e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECM1,Extracellular matrix protein 1,37655,0.023957581919097,0.00334838998539014,0.0173947375477324,0.0305204262904617,8.81159558652163e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,37990,0.0384834491735101,0.00538207003642203,0.0279345919021229,0.0490323064448973,9.10254437024921e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.0220657658642655,0.00308703447945018,0.0160151782845431,0.0281163534439878,9.27661513324255e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,-0.0203133509839842,0.00284765915874629,-0.0258947629351269,-0.0147319390328415,1.02128499542942e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,0.0288240621056546,0.00404430809974933,0.0208972182301459,0.0367509059811633,1.07877578085726e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,0.0211681906971064,0.0029712435263693,0.0153445533854226,0.0269918280087902,1.09008844258015e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMP,Cartilage oligomeric matrix protein,40198,0.0217402530853163,0.00305409687642342,0.0157542232075264,0.0277262829631062,1.13909690037009e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,40311,0.0258825151981519,0.003654904336583,0.0187189026984492,0.0330461276978546,1.48498384282181e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,0.0311402052627274,0.00440163525850124,0.022513000156065,0.0397674103693899,1.56027892788728e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCRIB,Protein scribble homolog,37628,0.059439057637708,0.00840071127427628,0.0429736635401264,0.0759044517352895,1.56461661410134e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,40453,0.0267547003174837,0.00378310106744329,0.0193398222252949,0.0341695784096726,1.5885172608941e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.0388054265913076,0.00548620005897706,0.0280524744757126,0.0495583787069027,1.58971306541719e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,0.041385667014133,0.00585326553219533,0.0299132665710302,0.0528580674572359,1.62127537167215e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELOB,Elongin-B,37562,0.0256069595390815,0.00363532081291867,0.0184817307457609,0.0327321883324021,1.96213508464716e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,0.018726629140306,0.00265956129051888,0.013513889010889,0.0239393692697231,1.98386501558122e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,0.038081713829835,0.00541262473799261,0.0274729693433695,0.0486904583163005,2.06346447948165e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKK4,Dickkopf-related protein 4,40203,0.0288622572764033,0.00411693575762531,0.0207930631914577,0.0369314513613489,2.46905499809162e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00933266647279174,0.00133174810088695,0.00672244019505332,0.0119428927505302,2.53518195193913e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,0.031740783611568,0.00453390918897966,0.0228543216011679,0.0406272456219681,2.66920589619113e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,0.0500139966082596,0.00716603351092019,0.0359685709268561,0.0640594222896632,3.10524076227946e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,40422,0.026361999466799,0.0037803177603178,0.0189525766565761,0.0337714222770219,3.21298403933943e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",40359,0.0454995093015195,0.00652892780513723,0.0327028108034506,0.0582962077995885,3.31944694255585e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AK1,Adenylate kinase isoenzyme 1,40359,0.0401284432663581,0.00576401627724206,0.0288309713629637,0.0514259151697525,3.48865910680761e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,0.0241580617732326,0.00349175571791008,0.0173142205661288,0.0310019029803364,4.7670165600681e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,40341,-0.0214656790611577,0.00310349779155569,-0.0275485347326069,-0.0153828233897086,4.8022552374046e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LACRT,Extracellular glycoprotein lacritin,37863,0.0332592020433672,0.00480943897122471,0.0238327016597668,0.0426857024269676,4.87670117123515e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREH,Trehalase,37998,0.0464050084042435,0.00671912074102384,0.0332355317518368,0.0595744850566503,5.19237643114886e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,37562,0.0392359624300171,0.00568363559940614,0.0280960366551811,0.0503758882048531,5.31388836996905e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,0.0188654251340874,0.00273910015228902,0.0134967888356009,0.0242340614325738,5.89150823196613e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKD1,Polycystin-1,37990,0.016060536600966,0.00233746101649388,0.011479113008638,0.020641960193294,6.65719442703284e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PZP,Pregnancy zone protein,38013,0.0404070498392886,0.00588979243736327,0.0288630566620566,0.0519510430165206,7.15854357528152e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.0156157552361254,0.00228386231592638,0.0111393850969097,0.0200921253753411,8.35340565570258e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,40489,0.0333050447739634,0.00487101937205653,0.0237578468047326,0.0428522427431942,8.35606831820479e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSTB,Cystatin-B,40097,0.0258263386876195,0.00377734194193434,0.0184227484814281,0.0332299288938108,8.37596765350289e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.0299533772170603,0.00438515684645817,-0.0385482846361183,-0.0213584697980023,8.76128548318278e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.0186804835654847,0.00273870685009844,-0.0240483489916777,-0.0133126181392918,9.37902438038648e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,0.0243108842631428,0.00356753390594226,0.017318517807496,0.0313032507187896,9.86221637081004e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPL,Periplakin,37598,0.0203421361821816,0.00298543952577788,0.014490674711657,0.0261935976527063,9.92067462589963e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,0.0409741936606625,0.00602544312471581,0.0291643251362196,0.0527840621851055,1.08869395939054e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.0446412264463641,0.00656997429373171,0.03176407683065,0.0575183760620783,1.13196836875557e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTRC,Chymotrypsin-C,40360,0.0383680866765178,0.00565572167731245,0.0272828721889854,0.0494533011640502,1.21063741336893e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,37987,0.0369733868256816,0.00545129102185441,0.026288856422847,0.0476579172285163,1.23016978785768e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,0.0242986532526821,0.00358393712923561,0.0172741364793803,0.0313231700259839,1.25274804050508e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,40359,-0.0174080332427143,0.00256858383342529,-0.0224424575562279,-0.0123736089292007,1.26753428669613e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICOSLG,ICOS ligand,40305,0.0117024656234959,0.00172675304808047,0.00831802964925815,0.0150869015977336,1.26888733971052e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,40234,0.0180462936693266,0.0026661781844714,0.0128205844277627,0.0232720029108906,1.34615159996659e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDF1,Endothelial differentiation-related factor 1,37959,0.0424814265119367,0.0062835092973513,0.0301657482891282,0.0547971047347453,1.42888275990333e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12A_IL12B,Interleukin-12,40305,0.0477720600547234,0.00707541980415403,0.0339042372385815,0.0616398828708653,1.51056806877265e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,37562,0.0340134495928531,0.00503701676114858,0.0241408967410019,0.0438860024447044,1.51237238871781e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,0.0186208454494599,0.0027581012347918,0.013214967029268,0.0240267238696518,1.52468486511691e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GC,Vitamin D-binding protein,38013,0.0158395987561085,0.0023484324687338,0.0112366711173903,0.0204425263948268,1.59498683286229e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTN2,Dynactin subunit 2,40305,0.057183734111403,0.00848828932309995,0.0405466870381271,0.0738207811846789,1.6750851699439e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL20,C-C motif chemokine 20,40516,0.0538553506806889,0.00799980498244921,0.0381757329150885,0.0695349684462893,1.7291467816041e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,37628,0.0322823273886474,0.00479734551718439,0.022879530174966,0.0416851246023288,1.77644706315693e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOM3,Myomesin-3,37671,-0.0547737030454838,0.00814546099716823,-0.0707388065999335,-0.0388085994910341,1.8350668307063e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,0.0508220178279192,0.00756779980871383,0.0359891302028401,0.0656549054529983,1.93854966174953e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.0235516927487128,0.00350743778917504,0.0166771146819298,0.0304262708154959,1.94740913283448e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHCHD6,MICOS complex subunit MIC25,37900,0.017585892096659,0.00261970027270292,0.0124512795621613,0.0227205046311567,1.98391056199815e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX2,Sorting nexin-2,37900,0.047277058702192,0.00704597049841039,0.0334669565253076,0.0610871608790763,2.0269225259039e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C2orf69,UPF0565 protein C2orf69,37572,0.0366015310278123,0.0054575415160834,0.0259047496562888,0.0472983123993358,2.07378129074496e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CABP2,Calcium-binding protein 2,37572,0.0396450796526624,0.00592096640135729,0.0280399855060021,0.0512501737993227,2.23362701976977e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRH,Corticoliberin,39947,0.0525022513077757,0.00784517989469948,0.0371256987141647,0.0678788039013866,2.27235595323344e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QL2,Complement C1q-like protein 2,37598,0.0260334958656689,0.00389012856543392,0.0184088438774184,0.0336581478539194,2.28761866213628e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.0220260700919366,0.00329319041838196,0.0155714168719079,0.0284807233119652,2.33118981370977e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLRX,Glutaredoxin-1,40260,0.0341532198317264,0.00510712036830915,0.0241432639098405,0.0441631757536124,2.3482764553953e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COPB2,Coatomer subunit beta',37562,0.0261565727182732,0.0039143294081208,0.0184844870783565,0.03382865835819,2.4479159054352e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.020137784401574,0.00301693784785363,0.0142245862197809,0.0260509825833671,2.57020492776479e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPP1,Tripeptidyl-peptidase 1,40255,0.0268989685519561,0.00403062744700966,0.0189989387558172,0.034798998348095,2.57828597209536e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COLEC12,Collectin-12,40357,0.0153597744581453,0.00230381959597276,0.0108442880500387,0.0198752608662519,2.69510860459507e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,37901,0.0156276123935974,0.00235213258009672,0.0110174325366078,0.0202377922505869,3.16992435280528e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINI2,Serpin I2,37901,0.033558828508777,0.00505506866657184,0.0236508939222962,0.0434667630952578,3.28715352067522e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,40357,0.023840149315516,0.00359429333872232,0.0167953343716202,0.0308849642594117,3.40049028385693e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSNK1D,Casein kinase I isoform delta,37598,0.0381754607304526,0.00576376180032778,0.0268784876018101,0.049472433859095,3.64788437062215e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTA,Lymphotoxin-alpha,40341,0.0240443543592412,0.00363316945232914,0.016923342232676,0.0311653664858063,3.75711490236187e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,0.0248104616234934,0.00374916828771334,0.0174620917795753,0.0321588314674116,3.79221906366145e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLPS,Colipase,40311,0.0408956231111613,0.00618771124859207,0.0287677090639208,0.0530235371584017,3.98808179196243e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PEPD,Xaa-Pro dipeptidase,37987,0.0154257726489248,0.00233391588784588,0.0108512975087469,0.0200002477891027,4.00345435610198e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,40536,0.018563216867247,0.0028216588965498,0.0130327654300094,0.0240936683044846,4.88794924795912e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOA2,Apolipoprotein A-II,37987,-0.0282191971385157,0.00429824472584421,-0.0366437568011704,-0.0197946374758611,5.38276493995767e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAPK2,Death-associated protein kinase 2,37598,0.0309408842524009,0.00473727501440729,0.0216558252241626,0.0402259432806392,6.75699721248174e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOE,Apolipoprotein E,38013,0.0442083304472889,0.00677531159900227,0.0309287197132444,0.0574879411813333,7.04565812730752e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,0.0298057466013643,0.00458949428427501,0.0208103378041853,0.0388011553985433,8.58473433523515e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS4,Galectin-4,40357,-0.0307177798468336,0.00476153724895405,-0.0400503928547836,-0.0213851668388837,1.14148931049011e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLO1,Lactoylglutathione lyase,40042,0.0344124385766959,0.00534515540673504,0.0239359339794952,0.0448889431738966,1.24546664072532e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEPR,Leptin receptor,40359,-0.0177957495229911,0.00276545434674202,-0.0232160400426054,-0.0123754590033767,1.26988157617934e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARSA,Arylsulfatase A,40332,0.0258271063124922,0.00401862963740492,0.0179505922231785,0.0337036204018058,1.3399275645858e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHCY,Adenosylhomocysteinase,40359,0.0392528546334483,0.00611301874504589,0.0272713378931584,0.0512343713737383,1.390461998553e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSDE1,Cold shock domain-containing protein E1,37562,0.0679493567211933,0.0106029867747253,0.0471675026427317,0.0887312107996549,1.519758480544e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,-0.0175453079185921,0.00273813260825785,-0.0229120478307775,-0.0121785680064067,1.52751044380601e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYM,Ketimine reductase mu-crystallin,37541,0.0446213070529881,0.00696570001331467,0.0309685350268914,0.0582740790790849,1.54639151046907e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH5,Cadherin-5,40536,-0.0175192672252209,0.00273928217574977,-0.0228882602896904,-0.0121502741607513,1.64364331459457e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,37990,-0.0188672453569173,0.00295401813447676,-0.0246571209004917,-0.0130773698133429,1.74726688111454e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.0153047648733103,0.00239898158905591,0.0106027609587608,0.0200067687878599,1.82347238272596e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,37942,0.0173587830493372,0.00272262976269527,0.0120224287144545,0.02269513738422,1.88010381359108e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL19,C-C motif chemokine 19,40471,0.0753180233043174,0.0118156382467281,0.0521593723407303,0.0984766742679045,1.88659689942952e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS53,Serine protease 53,37942,0.0211286818262536,0.00331916668769111,0.014623115118379,0.0276342485341281,2.00747284698428e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DGKZ,Diacylglycerol kinase zeta,40044,0.0201079055370005,0.00316496289392098,0.0139045782649154,0.0263112328090856,2.16612917638857e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BPIFA2,BPI fold-containing family A member 2,37150,-0.0636404818639325,0.0100393515753164,-0.0833176109515525,-0.0439633527763124,2.38929625802377e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,39961,0.0418671490209598,0.0066155914221332,0.0289005898335787,0.0548337082083409,2.54259102900999e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,39980,0.0205348212865022,0.00324573017829899,0.0141731901370362,0.0268964524359682,2.57289615777722e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM3C,Protein FAM3C,40330,0.0169237786493916,0.00267622803667992,0.0116783716974989,0.0221691856012842,2.62126892179944e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EBI3_IL27,Interleukin-27,40453,-0.0177381378660193,0.00281471491757613,-0.0232549791044685,-0.0122212966275701,3.01652379039747e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRSF1,G-rich sequence factor 1,37402,0.0450362129101737,0.00714663957690101,0.0310287993394477,0.0590436264808996,3.0387619797082e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA9,Serpin A9,40228,0.0409654404629766,0.0065114789393887,0.0282029417417748,0.0537279391841785,3.23191055321482e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,0.0275517547922181,0.00438507217982143,0.0189570133197681,0.0361464962646681,3.40581200762049e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFHR2,Complement factor H-related protein 2,37911,0.0324704518051866,0.00516829792364109,0.02234058787485,0.0426003157355231,3.4316673767223e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,37790,0.0317361140703209,0.00506796504359469,0.0218029025848753,0.0416693255557665,3.91475100570687e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPM1A,Protein phosphatase 1A,39980,0.0174996497031084,0.00280348298727484,0.0120048230480497,0.0229944763581671,4.42919481858859e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,40471,0.0195575479577048,0.00313489157494652,0.0134131604708096,0.0257019354445999,4.52395307056924e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA14,Carbonic anhydrase 14,40489,0.0193976767141815,0.00311483470676377,0.0132926006889245,0.0255027527394384,4.85698472002322e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0391989054585092,0.00629608495387355,0.026858578948917,0.0515392319681013,4.90858023620414e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XCL1,Lymphotactin,40489,0.0316510978027294,0.00508546158799687,0.0216835930902555,0.0416186025152033,4.97188549218475e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MST1,Hepatocyte growth factor-like protein,37787,0.0345983118979796,0.00556415931415257,0.0236925596422406,0.0455040641537187,5.18338273262931e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROBO1,Roundabout homolog 1,40379,0.0134788366604468,0.00217103678582642,0.00922360456022706,0.0177340687606666,5.48255976610605e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,40305,0.0118432776064502,0.00191012710161072,0.0080994284872932,0.0155871267256072,5.77674918891758e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD14,Monocyte differentiation antigen CD14,40048,0.0232413016687039,0.00375056091096509,0.0158902022832123,0.0305924010541955,5.90878122717236e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANPEP,Aminopeptidase N,40370,0.0158049619380545,0.00255197422663702,0.0108030924538459,0.020806831422263,6.03912325521041e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,37714,0.0309991637621579,0.00500483357942992,0.0211896899464753,0.0408086375778406,6.04488032892734e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,39961,0.0294713939800573,0.00476146402834158,0.0201389244845078,0.0388038634756068,6.18476362224624e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCP1,Plastin-2,37998,0.0263357822708528,0.0042546546959282,0.0179966590668336,0.0346749054748721,6.19487501076439e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLB,Beta-klotho,39961,-0.0410859370068047,0.00664824416213435,-0.054116495564588,-0.0280553784490214,6.57172741636224e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MENT,Protein MENT,37671,-0.0121064089613787,0.0019588461853136,-0.0159457474845933,-0.00826707043816404,6.58279854675627e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,0.0301664938657728,0.00489024144657574,0.0205816206304843,0.0397513671010613,7.08087898753393e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NME3,Nucleoside diphosphate kinase 3,40379,0.0133180978352866,0.00216088109495115,0.00908277088918236,0.0175534247813909,7.29725988426216e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMOT,Angiomotin,37671,0.023186870382938,0.00376949832661038,0.0157986536627817,0.0305750871030944,7.91260331663995e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL3,Myosin light chain 3,37628,-0.0380028115560808,0.0061801105635814,-0.0501158282607003,-0.0258897948514612,8.01194617626939e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDM1,Nuclear protein MDM1,37572,0.0174151683711711,0.00283263856563058,0.0118631967825352,0.0229671399598071,8.07229954786382e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,37879,0.0230798129361919,0.00376482666215354,0.0157007526783709,0.0304588731940128,9.01263173049541e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL2A1,Collagen alpha-1(II) chain,37628,0.0455498152562786,0.00743276303904836,0.0309815996997438,0.0601180308128134,9.13857862048268e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.0430700164904407,0.00703925223438492,0.0292730821110463,0.0568669508698352,9.71067317211976e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX5,Sorting nexin-5,37628,0.0165551634240427,0.00270847128742013,0.0112465597006993,0.0218637671473862,1.00936528687141e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFIC,Nuclear factor 1 C-type,37959,0.0240919364205577,0.00394272212591386,0.0163642010537665,0.0318196717873488,1.02060906764862e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AFAP1,Actin filament-associated protein 1,37671,0.0467835220639478,0.00765665790596334,0.0317764725682597,0.061790571559636,1.02317633127902e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAN,Brevican core protein,40228,0.0185051262213142,0.00302965642835728,0.0125669996217339,0.0244432528208944,1.03257507355378e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0381921609546671,0.00625400267990006,-0.0504500062072712,-0.025934315702063,1.03996968813965e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.0487735363235995,0.0079973294145771,0.0330987706710284,0.0644483019761706,1.09382691770033e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,37539,0.0226748344080613,0.00372883507804737,0.0153663176550884,0.0299833511610341,1.22804726582421e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL2,Fc receptor-like protein 2,40442,0.0267011399696485,0.00439226477710906,0.0180923010065148,0.0353099789327823,1.23582749284063e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,0.0211839583345398,0.00349052461720242,0.0143425300848231,0.0280253865842565,1.32258939303946e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL3,Fc receptor-like protein 3,40044,0.0300005092996001,0.00494430353351459,0.0203096743739115,0.0396913442252887,1.32762981776247e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD93,Complement component C1q receptor,39725,-0.017261562917093,0.00284489516567469,-0.0228375574418154,-0.0116855683923706,1.32937602787329e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.0375244564216728,0.00619628553658305,0.02537973676997,0.0496691760733756,1.43381015727029e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,40396,-0.0248513447315808,0.00411428468907127,-0.0329153427221605,-0.0167873467410011,1.5728504320454e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL8,Interleukin-8,40209,0.0368335317191382,0.00612020048628014,0.0248379387660292,0.0488291246722473,1.80104400946716e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,0.0257533836888868,0.00428544354428554,0.0173539143420871,0.0341528530356864,1.90884037015931e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,39961,0.0349963055425172,0.00582787783476402,0.0235736649863798,0.0464189460986547,1.95623612572576e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,39980,0.0257628972638985,0.00429174624772477,0.0173510746183579,0.034174719909439,1.98146693765109e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD86,T-lymphocyte activation antigen CD86,37901,0.0158263322187359,0.00264310985340704,0.0106458369060581,0.0210068275314137,2.18160748963124e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,39934,0.0288314788824147,0.0048462761500491,0.0193327776283185,0.038330180136511,2.75259801457792e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMG3,Proteasome assembly chaperone 3,40341,0.0275087334080414,0.00462444081049092,0.0184448294194792,0.0365726373966036,2.76200393943504e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSG3,Desmoglein-3,40419,0.017955208585156,0.00302246548033875,0.0120311762436921,0.02387924092662,2.89909703758328e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB1A1,Uteroglobin,40384,0.0303613963959613,0.00511766911867273,0.0203307649233627,0.0403920278685598,3.04237319590345e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPC1,Glypican-1,40489,0.0157080440913294,0.00264988536278827,0.0105142687802644,0.0209018194023944,3.13278360896086e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,40330,0.0390290211948073,0.00658660409884188,0.0261192771610772,0.0519387652285374,3.17759922496885e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR15L,Protein GPR15L,37901,0.0320791527639877,0.00544979029984962,0.0213975637762825,0.042760741751693,4.04324709436914e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWF,von Willebrand factor,40536,-0.0378733742602396,0.00644997220741323,-0.0505153197867696,-0.0252314287337097,4.39405815198368e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,37628,0.0124548651831044,0.00212337698010956,0.00829304630208963,0.0166166840641191,4.58267675377453e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTPN,Myotrophin,40042,0.017455764914217,0.00299351705913605,0.0115884714783103,0.0233230583501236,5.61224175905767e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHGA,Chromogranin-A,37998,-0.0475915111263804,0.00816125321920738,-0.0635875674360269,-0.031595454816734,5.62183129533303e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300LF,CMRF35-like molecule 1,40489,0.031941986978608,0.00548111075188753,0.0211990099049085,0.0426849640523076,5.72920775124089e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,0.0421801228063084,0.00724272799426363,0.0279843759375517,0.0563758696750651,5.8665033862255e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCOF1,Treacle protein,37990,0.0159018288992974,0.00273147790415225,0.010548132207159,0.0212555255914358,5.95744170304423e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERMAP,Erythroid membrane-associated protein,37598,0.0236238743411991,0.00406125553025586,0.0156638135018976,0.0315839351805005,6.134798518848e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.0182739413018608,0.00314849357991471,0.0121028938852279,0.0244449887184936,6.59790396593812e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.0189003140337335,0.00326454636793739,0.0125018031525762,0.0252988249148908,7.19247418738041e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENSA,Alpha-endosulfine,37900,0.027574195233684,0.00477198759861457,0.0182210995403995,0.0369272909269686,7.71101127676894e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,40359,0.00907883005113179,0.00157701111457568,0.00598788826656347,0.0121697718357001,8.72079139309781e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTB,Lymphotoxin-beta,37900,0.0184030072657723,0.0032052680278007,0.0121206819312829,0.0246853326002617,9.5876172144491e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD27,CD27 antigen,40411,-0.0210854930179968,0.00367327214123678,-0.0282851064148209,-0.0138858796211727,9.62554351206375e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD1,Programmed cell death protein 1,40455,0.0226792559512033,0.00395103510867203,0.0149352271382061,0.0304232847642005,9.63462452565634e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,37653,0.0281927635757046,0.00492472440124418,0.018540303749266,0.0378452234021432,1.05847322525152e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYZL2,Lysozyme-like protein 2,37482,0.0185971997146925,0.00325099866065988,0.0122252423397991,0.0249691570895859,1.08573571582925e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,37900,0.0211837779146683,0.00370568168735768,0.0139206418074472,0.0284469140218894,1.11006518644165e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,0.0190880053224302,0.00333989428968137,0.0125418125146547,0.0256341981302056,1.11931631684299e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,-0.0134494062793621,0.00235708538203654,-0.0180692936281537,-0.00882951893057048,1.18188001417129e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.0155464133858149,0.00272517449258519,-0.0208877553912819,-0.010205071380348,1.18975340147219e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRA2,GDNF family receptor alpha-2,40305,0.010939723266981,0.00191888150567955,0.00717871551584904,0.0147007310181129,1.21160682922903e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNLY,Granulysin,40332,0.0260674946703326,0.00458274323269094,0.0170853179342584,0.0350496714064069,1.30658113627506e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.0144951608001858,0.00254843867466317,0.00950022099784598,0.0194901006025256,1.30903606995718e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,37815,0.0159169914649772,0.00280055410654832,0.0104279054161425,0.0214060775138119,1.34711572329659e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADA,Adenosine deaminase,40516,0.0174195876052096,0.0030684423782399,0.0114054405438594,0.0234337346665598,1.3943553575213e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,0.0379523321243918,0.00670228579233175,0.0248158519714215,0.051088812277362,1.52195150968995e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAPG,Macrophage-capping protein,40185,0.0296426061503507,0.00523715522063724,0.0193777819179017,0.0399074303827997,1.53960401118932e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,39980,0.029189312462923,0.00516481375704998,0.019066277499105,0.0393123474267409,1.61781179198319e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PYY,Peptide YY,37562,0.0486075235936516,0.00860006424142648,0.0317513976804557,0.0654636495068475,1.61901671296534e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,40042,0.029871276891677,0.00530596114936574,0.0194715930389201,0.0402709607444339,1.83573192534523e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD302,CD302 antigen,40305,0.0152772403390387,0.00271751327746962,0.00995091431519825,0.0206035663628792,1.92194100404369e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,37910,0.0208321776423569,0.00370866055907122,0.0135632029465773,0.0281011523381365,1.9795646278405e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA9,Carbonic anhydrase 9,40489,-0.0228001530855671,0.00406359515656959,-0.0307647995924435,-0.0148355065786907,2.04684233355807e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VIT,Vitrin,37990,0.018641596981355,0.00333242086406636,0.012110052087785,0.0251731418749251,2.26183904764593e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,37942,0.120552102786498,0.0215743677345726,0.0782663420267353,0.16283786354626,2.34489429646501e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN2,Contactin-2,40489,0.0225466606340455,0.00404835924246325,0.0146118765188176,0.0304814447492735,2.59823168157351e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,0.0237029340920388,0.00425625394419342,0.0153606763614197,0.0320451918226579,2.60520668585576e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,39980,0.0294987573102052,0.00530069068850697,0.0191094035607315,0.0398881110596788,2.66369314929202e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSE,Cathepsin E,37671,0.0259101846269271,0.00465956038792947,0.0167774462665853,0.0350429229872688,2.73983856053265e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,0.0201342847781935,0.00363638170211764,0.0130069766420429,0.027261592914344,3.13599176471195e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BGN,Biglycan,39956,-0.0606705481187113,0.0109723129724902,-0.0821762815447921,-0.0391648146926305,3.26478171819022e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRTG,Protogenin,40489,0.0125455656756772,0.00227269976700156,0.0080910741323541,0.0170000572190002,3.44031720566345e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRR3,Small proline-rich protein 3,37942,0.035492857181221,0.00643314913417576,0.0228838848782365,0.0481018294842055,3.5082495564728e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD101,Immunoglobulin superfamily member 2,37901,0.02120960944077,0.00384442363706014,0.0136745391121321,0.0287446797694078,3.51247100954262e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,40422,0.0141636558831579,0.00256775529985376,0.0091308554954445,0.0191964562708713,3.5225307289042e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,40167,0.013928624725365,0.0025381768039249,0.00895379818967217,0.0189034512610578,4.13619041868831e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,39961,0.0189609600172399,0.00346220223722606,0.0121750436322769,0.025746876402203,4.40418343107385e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA2,Annexin A2,37441,0.0353823112437594,0.00646461662994079,0.0227116626490755,0.0480529598384434,4.50112999474972e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,0.0226375369026129,0.00413986190936669,0.0145234075602541,0.0307516662449716,4.62989821971942e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.0209956700596326,0.00384225102056748,0.0134648580593204,0.0285264820599449,4.71387116817039e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPR,Nucleoprotein TPR,37562,0.0232505675887614,0.00425454495319803,0.0149116594804932,0.0315894756970295,4.71689381886269e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKK3,Dickkopf-related protein 3,40536,-0.0144724248719633,0.00265678910885041,-0.0196797315253101,-0.00926511821861649,5.18804818906548e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL3A1,Collagen alpha-1(III) chain,37998,-0.0113513629921362,0.00208975532890355,-0.0154472834367872,-0.00725544254748527,5.67165966655929e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POF1B,Protein POF1B,37598,-0.0228220734263356,0.00420597683568831,-0.0310657880242847,-0.0145783588283865,5.86175682288397e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,0.0140083997561452,0.00258271832196004,0.00894627184510347,0.0190705276671868,5.93425735193316e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,0.0181077668576204,0.00334023737314728,0.0115609016062517,0.0246546321089891,6.0269407846044e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLAU,Urokinase-type plasminogen activator,40332,0.014354552575203,0.00265148851928258,0.00915763507740912,0.0195514700729968,6.26070616403655e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM5,Intercellular adhesion molecule 5,40359,0.0215358945548946,0.00398197278739955,0.0137312278915915,0.0293405612181977,6.45272229473493e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,40359,0.0324119205123956,0.00599369110504664,0.0206642859465042,0.044159555078287,6.47704251392963e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APLP1,Amyloid-like protein 1,40359,-0.0253768337574853,0.00469356483551708,-0.0345762208350988,-0.0161774466798718,6.51118367081337e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,40332,-0.0153358897809244,0.00283986291644575,-0.0209020210971581,-0.00976975846469072,6.751562654218e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAL,Galanin peptides,40422,0.0303942661943991,0.00563333652580313,0.019352926603825,0.0414356057849732,6.93341399943042e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12B,Interleukin-12 subunit beta,40516,0.0263810031948308,0.00489660657993113,0.0167836542981658,0.0359783520914958,7.24067368104603e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VASN,Vasorin,40116,0.0133239804259474,0.00247918759875902,0.00846477273237976,0.0181831881195151,7.79664147498422e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFNA4,Ephrin-A4,40203,0.0142776959280386,0.00266062375052861,0.0090628733770025,0.0194925184790746,8.15067162142334e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.0142306088827504,0.00265537239793076,0.00902607898280611,0.0194351387826947,8.47590639670269e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.0151830737414846,0.00283655950922351,-0.0207427303795626,-0.00962341710340647,8.81298218478754e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP1,Interstitial collagenase,39757,0.0449036824487789,0.00839056674552122,0.0284581716275573,0.0613491932700005,8.83936926655582e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,0.0116803338022487,0.00218715501849935,0.00739350996598995,0.0159671576385074,9.40170670148324e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,0.0408297618296532,0.00766585078511644,0.025804694290825,0.0558548293684814,1.01952768208883e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TF,Serotransferrin,38013,0.0104905684752236,0.00197171529365003,0.00662600649966957,0.0143551304507777,1.0511165269499e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CIT,Citron Rho-interacting kinase,37572,0.0216497140106878,0.00408096452229796,0.0136510235469838,0.0296484044743918,1.14474545788701e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,0.0180772891920966,0.00341918219745297,0.0113756920850888,0.0247788862991044,1.25970256018076e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FEN1,Flap endonuclease 1,39980,0.0295392372145861,0.00559514581428706,0.0185727514185835,0.0405057230105888,1.31324242727181e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,39980,0.0171502676276046,0.00324979360652179,0.0107806721588219,0.0235198630963873,1.32834547198506e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,37959,0.0247722704858141,0.00469819669509375,0.0155638049634304,0.0339807360081978,1.36489795624615e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM3B,Protein FAM3B,40305,0.0171739717307986,0.0032610658628373,0.0107822826396375,0.0235656608219597,1.4096713940279e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSH,Pro-cathepsin H,40013,0.0342687603654147,0.00653787848402539,0.0214545185367249,0.0470830021941045,1.61294816985899e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,0.0205044287158696,0.00391266862292437,0.0128355982149378,0.0281732592168013,1.62599555271726e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL14,C-C motif chemokine 14,40309,0.0184238190614777,0.00351932118981954,0.0115259495294314,0.025321688593524,1.67045652590238e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS8,Prostasin,40293,0.0189187761817609,0.00364104087290469,0.0117823360708677,0.0260552162926541,2.06170372719377e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPM3,Tropomyosin alpha-3 chain,37562,-0.0200110584944902,0.00385291127915452,-0.0275627646016331,-0.0124593523873474,2.09187305986882e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POSTN,Periostin,37998,-0.0177609431865019,0.00342244086801346,-0.0244689272878083,-0.0110529590851956,2.13844021319691e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCB,Calcitonin gene-related peptide 2,37942,0.0187230495433713,0.00360866194991012,0.0116500721215474,0.0257960269651951,2.15226052450257e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEK,Angiopoietin-1 receptor,40411,0.0100707121732055,0.00194339424272931,0.00626165945745605,0.013879764888955,2.22167732393395e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN2,Ataxin-2,37541,0.0539775784712815,0.0104225291072103,0.0335494214211494,0.0744057355214137,2.2647030340676e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,0.0224607133283461,0.00433886114189874,0.0139565454902246,0.0309648811664676,2.29176631261178e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTX2,Neuronal pentraxin-2,37998,-0.0152792539742847,0.00295311653470903,-0.0210673623823144,-0.00949114556625503,2.32479436158384e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP2,Retinol-binding protein 2,40305,-0.03556335670199,0.00687797733218143,-0.0490441922730656,-0.0220825211309144,2.36165718522936e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,37567,0.0277674066579766,0.00538798629007492,0.0172069535294297,0.0383278597865234,2.59276217581085e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,40042,0.0260509073036629,0.00506062336550325,0.0161320855072765,0.0359697291000492,2.66811371952219e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF16,Fibroblast growth factor 16,37598,0.0229260769468167,0.00445415603889533,0.0141959311105818,0.0316562227830515,2.68331300957013e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,37598,0.0150305057834602,0.00292114005161105,0.00930507128230257,0.0207559402846179,2.70761736938469e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YAP1,Transcriptional coactivator YAP1,37942,0.012385794825329,0.00240747496913248,0.00766714388582931,0.0171044457648286,2.71672758366176e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,-0.0168269102534229,0.00327720181705111,-0.0232502258148431,-0.0104035946920027,2.86183346535014e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBS,Cystathionine beta-synthase,37628,0.0235316142441585,0.00458893891240895,0.0145372939758369,0.03252593451248,2.97149713092589e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTGR1,Prostaglandin reductase 1,37990,0.0367419600444503,0.00717837554398925,0.0226723439782314,0.0508115761106693,3.12323677550958e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYT1,Synaptotagmin-1,37942,0.0180971659144866,0.00353898325247558,0.0111607587396344,0.0250335730893387,3.20301515161311e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPL14,60S ribosomal protein L14,37628,0.0191061556149103,0.00373705659377646,0.0117815246911085,0.0264307865387122,3.22173190248632e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMOD1,Leiomodin-1,37959,-0.0167242028895198,0.00327711257771526,-0.0231473435418417,-0.0103010622371979,3.38251211608879e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,39980,0.0276844617537685,0.00543187633321485,0.0170379841406674,0.0383309393668696,3.49746151811033e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPME1,Protein phosphatase methylesterase 1,40305,0.0282067407007685,0.00553722315623651,0.0173537833145449,0.039059698086992,3.54568330590339e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,40341,-0.0166528964714543,0.00327815113381939,-0.0230780726937403,-0.0102277202491683,3.81779431773057e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,0.028916046741865,0.00569347545744992,0.0177568348452632,0.0400752586384669,3.84125985543034e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,37875,-0.0124113869030904,0.00244598439199136,-0.0172055163113934,-0.00761725749478731,3.94352764634063e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,0.0159442664443348,0.00314958681011083,0.00977107629651761,0.022117456592152,4.18729282675135e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,0.0250890116008951,0.00496311119295962,0.0153613136626943,0.034816709539096,4.34987028251446e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NXPH1,Neurexophilin-1,39961,0.0172259372021584,0.00341113544437012,0.0105401117311929,0.0239117626731238,4.47025870018564e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFF3,Trefoil factor 3,40309,-0.0241690302402118,0.00482061273000927,-0.03361743119103,-0.0147206292893936,5.39737048544975e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRELP,Prolargin,40357,0.0104954481144334,0.00209398527904758,0.00639123696750018,0.0145996592613667,5.43927528268704e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITM2A,Integral membrane protein 2A,40341,-0.0267664096369479,0.0053414089462353,-0.0372355711715691,-0.0162972481023268,5.46973543812499e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE3,Eosinophil cationic protein,40288,0.0489829692258758,0.00980599409100622,0.0297632208075037,0.068202717644248,5.93986728850548e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.0100766410214489,0.00201786148950079,0.00612163250202736,0.0140316495408704,5.98549515358149e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LUZP2,Leucine zipper protein 2,37900,0.0201591701922328,0.00404148922449357,0.0122378513122254,0.0280804890722402,6.17514821803134e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G15,Phospholipase A2 group XV,40411,0.0115699318375288,0.00232218709014348,0.00701844514084758,0.01612141853421,6.34763256244562e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THBS4,Thrombospondin-4,40355,0.0202670703864042,0.00407122248952849,0.0122874743069284,0.02824666646588,6.48737955925767e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGR,Tyrosine-protein kinase Fgr,39961,0.0248504589475935,0.00499600394039945,0.0150582912244106,0.0346426266707764,6.62640200379138e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,39925,0.0196930662763921,0.00396024783834278,0.0119309805132403,0.0274551520395439,6.67391377524863e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.0165714622593004,0.00333565465781059,0.0100335791299916,0.0231093453886092,6.85028673692124e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDHB15,Protocadherin beta-15,37900,-0.018072513808669,0.00364630305585292,-0.0252192677981407,-0.0109257598191973,7.26880878181303e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,0.0201990041804076,0.00407778354835662,0.0122065484256287,0.0281914599351866,7.36668489417588e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLGN,Calmegin,37572,0.0199237939262618,0.00402563599736096,0.0120335473714344,0.0278140404810893,7.54329886725942e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NADK,NAD kinase,40359,0.0238817769708781,0.00483043973864938,0.0144141150831253,0.0333494388586309,7.73086395447344e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17C,Interleukin-17C,40044,-0.0313617126454312,0.00634451307977092,-0.0437969582817822,-0.0189264670090802,7.76792796730249e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,0.0298459119849505,0.00603802466355593,0.0180113836443809,0.0416804403255202,7.78892931718192e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBA,Lysosomal acid glucosylceramidase,37572,0.0236528337312008,0.00478795930074587,0.0142684335017389,0.0330372339606627,7.90587413254843e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,37942,0.0160253377594844,0.00324597067412947,0.00966323523819062,0.0223874402807782,8.02844600019416e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,0.0384142003959939,0.00779142523706879,0.0231430069313391,0.0536853938606488,8.3072490670559e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.0168659092646246,0.00342116782078543,-0.023571398193364,-0.0101604203358852,8.32618491474182e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP9,Fatty acid-binding protein 9,40341,0.0248484292001676,0.00504768248967507,0.0149549715204044,0.0347418868799307,8.61967789054996e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,37671,0.0118766392025932,0.0024168916702324,0.00713953152893768,0.0166137468762487,9.02997650710733e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,37671,-0.0111026653432148,0.00226277238107122,-0.0155376992101144,-0.00666763147631524,9.37419653139467e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.0128206143346844,0.00261384512879541,0.0076974778822454,0.0179437507871234,9.43946120072797e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB8,Serpin B8,40516,0.0241118815248691,0.0049218211519036,0.014465112067138,0.0337586509826001,9.72756782499131e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN5,Contactin-5,40367,0.0163297375636383,0.00334625677752268,0.00977107427969385,0.0228884008475828,1.071122650226e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,39957,0.0124463998111886,0.00255204134440489,0.00744439877615502,0.0174484008462222,1.08759161781143e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,0.0242043161102257,0.0049635052915396,0.0144758457388081,0.0339327864816433,1.09055592454116e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LHB,Lutropin subunit beta,39980,0.0373559251114509,0.00767065605424274,0.0223214392451351,0.0523904109777666,1.12709673127579e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAX,Apoptosis regulator BAX,39934,0.0393047562758048,0.00807279323237119,0.0234820815403572,0.0551274310112523,1.13389933582595e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,0.0181489597317373,0.00373072735665169,0.0108367341127,0.0254611853507746,1.15710404662369e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,37628,0.0172045935801599,0.00353692640682892,0.0102722178227753,0.0241369693375446,1.16203176339716e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFDN2,Prefoldin subunit 2,39961,0.0247113798590097,0.00508054562926978,0.0147535104256409,0.0346692492923785,1.16211073156012e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA12,Serpin A12,39903,0.0501656613124373,0.0103224197785028,0.0299337185465719,0.0703976040783027,1.18613386659689e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,0.0456721943823369,0.00941100065982608,0.0272266330890778,0.064117755675596,1.22966761260156e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,0.0156209768403957,0.00321905649356288,0.0093116261130125,0.021930327567779,1.23216659939253e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,37942,0.0201567300803616,0.00416856091106401,0.0119863506946761,0.0283271094660471,1.3433264160745e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,40136,0.0128467876639215,0.0026676757957017,0.00761814310434618,0.0180754322234968,1.48036982363727e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAS2,Growth arrest-specific protein 2,37714,0.0232756983796622,0.00483912949034345,0.013791004578589,0.0327603921807353,1.52671015369636e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX1,Peroxiredoxin-1,39953,-0.0387165395383251,0.00806055095665146,-0.054515219413362,-0.0229178596632883,1.57600045830913e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPON1,Spondin-1,40379,0.0142556804777728,0.00296857258334172,0.00843727821442303,0.0200740827411226,1.58358422861598e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,37900,0.0144294436019236,0.00300476299538485,0.00854010813096929,0.0203187790728779,1.58630602150469e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,0.0303693090557661,0.00634620590516923,0.0179307454816344,0.0428078726298978,1.72479443866154e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,0.013112882177591,0.00274117372756177,0.00774018167156991,0.0184855826836121,1.7370308897578e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,0.0240481875817192,0.00503234414712085,0.0141847930533623,0.033911582110076,1.7799183749587e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAM,Basal cell adhesion molecule,40332,-0.0102147563569338,0.00213912519984685,-0.0144074417486336,-0.00602207096523399,1.81128334520369e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,0.0220525782007298,0.00462126688109096,0.0129948951137916,0.0311102612876681,1.84087098715681e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,37978,-0.0104867315095981,0.00219778005727949,-0.0147943804218659,-0.00617908259733028,1.84760114438819e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAYN,Layilin,40192,-0.0148157572574532,0.00310680609098101,-0.020905097195776,-0.00872641731913045,1.8698033270467e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.0114166610344225,0.00239518843088644,0.00672209170988507,0.0161112303589599,1.89405033174948e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPO,Erythropoietin,40341,-0.0336639562663999,0.00707130922599958,-0.047523722349359,-0.0198041901834407,1.94681071815913e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2,Apoptosis regulator Bcl-2,37901,0.0232748488820325,0.00488936632212438,0.0136916908906687,0.0328580068733963,1.95319293982744e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSBP1,Heat shock factor-binding protein 1,37628,0.0410762721853937,0.00863678893251184,0.0241481658776705,0.058004378493117,1.99592664407882e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,39961,0.036482734942457,0.00767356071219968,0.0214425559465457,0.0515229139383684,2.00882147527278e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DHPS,Deoxyhypusine synthase,37900,0.0176879339462231,0.00372343144417164,0.0103900083156467,0.0249858595767995,2.05073115772545e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,37562,0.0203557526319026,0.0043042605309601,0.0119194019912208,0.0287921032725844,2.2774362212734e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOM2,Myomesin-2,37562,-0.0201025225035217,0.00426472481400145,-0.0284613831389645,-0.0117436618680788,2.45792916166081e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,39980,0.0148892005598446,0.00316766620308328,0.00868057480180134,0.0210978263178878,2.619215846816e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,37562,0.0430350067303144,0.00918789477145021,0.025026732978272,0.0610432804823568,2.8431958527318e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCG2,Secretogranin-2,40392,0.0136347669567084,0.00291123689423595,0.00792874264400599,0.0193407912694109,2.84349175881598e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACRV1,Acrosomal protein SP-10,37598,0.0149324155746105,0.00319613966965591,0.00866798182208494,0.0211968493271361,3.01215060410575e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,37482,-0.0111216478750649,0.00239605826718909,-0.0158179220787555,-0.00642537367137426,3.49021150938375e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,0.0275671681657263,0.00594099188137947,0.0159228240782225,0.03921151225323,3.51421475827265e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.0249746865486978,0.00539618688113772,0.0143981602616678,0.0355512128357277,3.72398075247484e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.0145350460414477,0.00314289426051565,0.00837497329083707,0.0206951187920584,3.78002608624125e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH1,Protocadherin-1,40475,0.00909171519892223,0.00196671686361698,0.00523695014623295,0.0129464802516115,3.81571468452678e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHI3L1,Chitinase-3-like protein 1,40054,-0.0309967673724208,0.00671606033590641,-0.0441602456307974,-0.0178332891140443,3.95616763722972e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFRP4,Secreted frizzled-related protein 4,37671,0.017435396891054,0.00378238563046457,0.0100219210553434,0.0248488727267645,4.07163775431585e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA7,Thyroxine-binding globulin,38013,0.00779393618448783,0.00169141665146505,0.00447875954761633,0.0111091128213593,4.10395971223808e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,0.0238699418512608,0.00518128542832836,0.0137146224117372,0.0340252612907844,4.11845916865449e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LXN,Latexin,40183,-0.0276156170523758,0.00599768212549852,-0.039371074018353,-0.0158601600863987,4.16932073255018e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDA,Cytidine deaminase,37970,0.0190678327508797,0.00414391578306693,0.0109457578160685,0.0271899076856908,4.23467140952339e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,37900,0.0167905024006087,0.00365052743418908,0.00963546862959811,0.0239455361716193,4.2742607224868e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRD1,Bromodomain-containing protein 1,37714,-0.0128810840044884,0.00280696937522183,-0.0183827439799232,-0.0073794240290536,4.49535101313306e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,40272,0.00959620014730753,0.00209336857582207,0.00549319773869628,0.0136992025559188,4.59446905941256e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA7,Carbonic anhydrase 7,37714,-0.0145654942747656,0.0031828751476933,-0.0208039295642444,-0.0083270589852867,4.77779672100611e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS22,Brain-specific serine protease 4,37598,0.0146502605699424,0.00320214617708065,0.00837405406286434,0.0209264670770205,4.8025928368536e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,0.0112761993611223,0.00246746007058494,0.00643997762277583,0.0161124210994688,4.91487574300786e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSLN,Mesothelin,40271,0.022314993985109,0.00489570023794157,0.0127194215187435,0.0319105664514745,5.20099233658839e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEZ6L,Seizure 6-like protein,40411,0.0112811780758861,0.00247972862641843,0.00642090996810599,0.0161414461836662,5.42058127176329e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",40310,-0.0279175642179853,0.00614092037338445,-0.0399537681498188,-0.0158813602861518,5.50393394041467e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RSPO3,R-spondin-3,40489,0.0117021201193406,0.00258069673956508,0.00664395450979302,0.0167602857288881,5.81634328590826e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1B,Interleukin-1 beta,39946,0.023055359878913,0.00509217849974251,0.0130746900194176,0.0330360297384083,6.01012113569234e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL34,Interleukin-34,39934,0.0146956500312804,0.00324726493471084,0.00833101075924712,0.0210602893033136,6.06879378233308e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.0184945911702707,0.00409108514794585,-0.0265131180602446,-0.0104760642802968,6.20749345233048e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM171B,Protein FAM171B,37900,0.0112966932854169,0.00250669794649492,0.00638356531028683,0.0162098212605469,6.64293883844133e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTXR,Neuronal pentraxin receptor,40359,0.0138037997308231,0.00306541125998835,0.00779559366124597,0.0198120058004003,6.745092056936e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMP10,Bone morphogenetic protein 10,37671,0.0116456430346947,0.00259715439651994,0.00655522041751565,0.0167360656518738,7.38730809815032e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CILP,Cartilage intermediate layer protein 1,37998,0.0217638304141954,0.00486701918207161,0.0122244728173351,0.0313031880110558,7.82325302926309e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BST2,Bone marrow stromal antigen 2,40471,0.0215980167226894,0.00483285898815722,0.0121256131059013,0.0310704203394776,7.91271585091608e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,0.0181575283228386,0.00406561828199861,0.0101889164901213,0.0261261401555559,8.02023354827239e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC4A1,Band 3 anion transport protein,37998,-0.0186419761346889,0.00417888399068283,-0.0268325887564273,-0.0104513635129505,8.22375312050836e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN1,Tetraspanin-1,40042,0.012252754480864,0.00275885500908727,0.00684539866305296,0.0176601102986751,9.00545464936781e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,40422,0.0113182019916453,0.00254986549810862,0.0063204656153524,0.0163159383679382,9.10912781973233e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG4,Regenerating islet-derived protein 4,40379,0.0194315546456182,0.00438869138263143,0.0108297195356606,0.0280333897555758,9.59026937357097e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,40341,0.013606620027107,0.00307605413437916,0.00757755392372389,0.0196356861304902,9.78049273343634e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIF1C,Kinesin-like protein KIF1C,37562,0.0150795682266162,0.00341070933281906,0.00839457793429081,0.0217645585189415,9.89248995764366e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA6,Corticosteroid-binding globulin,38013,0.00714055733868442,0.00161655714214467,0.00397210534008086,0.010309009337288,1.00790815239996e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,37921,0.0154124285090763,0.00349095309504589,0.00857016044278635,0.0222546965753662,1.01813834553117e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0716412784751028,0.016228248877817,0.0398339106745815,0.103448646275624,1.01865126628127e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN5,CCN family member 5,40332,0.0156138964179753,0.00354304203774646,0.00866953402399223,0.0225582588119584,1.05539011520969e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,37598,-0.0483590509218181,0.0110038067742369,-0.0699265121993224,-0.0267915896443138,1.11766247050729e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MET,Hepatocyte growth factor receptor,40375,0.00794626666526074,0.0018132116056377,0.00439237191821085,0.0115001614123106,1.18115728324853e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DGCR6,Protein DGCR6,37541,0.0180261224891761,0.00411309672535122,0.00996445290748771,0.0260877920708645,1.18176246087706e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.0157082264968305,0.00358525668542742,0.00868112339339277,0.0227353296002683,1.18726153333374e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,40411,0.0167813633517352,0.00383700619652593,0.00926083120654432,0.024301895496926,1.23012969088099e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSV,Cathepsin L2,40444,0.016744753039199,0.00383461812457041,0.00922890151504103,0.024260604563357,1.26911363862651e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD59,CD59 glycoprotein,39665,0.00888831176789908,0.00203687777226547,0.00489603133425876,0.0128805922015394,1.28726951135957e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIP,Gastric inhibitory polypeptide,37628,0.0203554073742382,0.00467123735136123,0.0111997821655702,0.0295110325829062,1.32488835166935e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A11,Protein S100-A11,40207,0.0176827893085139,0.00405959116662031,0.00972599062193808,0.0256395879950897,1.33416138755186e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HLA_E,,40341,0.0113161968708314,0.00260266107679486,0.0062149811603135,0.0164174125813493,1.38281350972403e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPS10,40S ribosomal protein S10,37562,-0.0166828533928047,0.00383937412847347,-0.0242080266846127,-0.00915768010099672,1.40195221032448e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY96,Lymphocyte antigen 96,40228,-0.0136131568250447,0.00313838155814987,-0.0197643846790185,-0.007461928971071,1.449177432364e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,37598,0.0150905211321101,0.00349166990694714,0.00824684811449374,0.0219341941497265,1.5585432284297e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,0.0139221908592587,0.00322534815545601,0.00760050847456494,0.0202438732439525,1.59662001409923e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.0104785420291527,0.0024318933830355,0.00571203099840313,0.0152450530599023,1.65303721279764e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PVR,Poliovirus receptor,40471,0.0142731021557999,0.00331674008306749,0.00777229159298757,0.0207739127186121,1.69230805618557e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,0.0271410055200599,0.00632057025329454,0.0147526878236026,0.0395293232165172,1.76470902996973e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,37628,-0.0246620637822628,0.00574546750238081,-0.0359231800869292,-0.0134009474775964,1.77984706279433e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PON3,Serum paraoxonase/lactonase 3,40422,-0.0105994206237837,0.00247043726708895,-0.015441477667278,-0.00575736358028936,1.79316967692705e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLL4,Delta-like protein 4,37628,0.0326181558705265,0.00763065959207025,0.0176620630700688,0.0475742486709842,1.92811853570468e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.00756696948465854,0.00177077453037177,-0.0110376875641872,-0.00409625140512987,1.93955517106768e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GM2A,Ganglioside GM2 activator,37714,0.0147871760654061,0.00347794492842174,0.00797040400569948,0.0216039481251127,2.13606959805301e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EXTL1,Exostosin-like 1,37562,0.0183984256958899,0.00433408361917113,0.0099036218023145,0.0268932295894653,2.20043749847728e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,0.0173272458318755,0.00409824171736927,0.00929469206583174,0.0253597995979193,2.37366792950149e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK8,Kallikrein-8,39801,0.0135772825919012,0.00321182552164358,0.00728210456947978,0.0198724606143226,2.37902526087538e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,40208,-0.0153202585793417,0.0036379339322883,-0.0224506090866268,-0.00818990807205665,2.55369038046757e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BSG,Basigin,40502,0.00764634520161764,0.00182336081769286,0.00407255799893963,0.0112201324042956,2.76102217832943e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIMAP8,GTPase IMAP family member 8,37482,0.0196656488535924,0.0046925621653416,0.0104682270095228,0.0288630706976619,2.79790231583852e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,37969,0.0183660391443681,0.00438324027124442,0.00977488821272903,0.0269571900760072,2.80652441457782e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUC16,Mucin-16,40305,0.0709349007291941,0.0169405866224995,0.0377313509490951,0.104138450509293,2.83848022100009e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,39980,0.0156669737103477,0.00375342674421612,0.00831025729168414,0.0230236901290113,3.0086831436886e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,-0.0166391007277906,0.0039871780622306,-0.0244539697297626,-0.00882423172581866,3.01994828278207e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRUNE2,Protein prune homolog 2,37714,0.0111482737214405,0.00267507457951882,0.00590512754558365,0.0163914198972974,3.09962434642882e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,40332,-0.0129520590018617,0.00310814342258723,-0.0190440201101326,-0.00686009789359069,3.10082120025825e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THY1,Thy-1 membrane glycoprotein,40471,-0.0105209783518315,0.00252940374572385,-0.0154786096934502,-0.00556334701021272,3.20649459046165e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACTN2,Alpha-actinin-2,37562,-0.0206441446730465,0.00496307300115522,-0.0303717677553107,-0.0109165215907822,3.20908110286992e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,40291,0.0108586038047395,0.00261835017298743,0.00572663746568414,0.0159905701437949,3.38442854585392e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOM1,Myomesin-1,37541,0.0175869651098606,0.00424252174298547,0.00927162249360909,0.0259023077261121,3.41352071029026e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,37714,0.0161304222657186,0.00389315395382645,0.00849984051621872,0.0237610040152184,3.44499297088157e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.0116250003758717,0.00280665195519043,0.00612396254369844,0.0171260382080449,3.46469316049424e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RCOR1,REST corepressor 1,40042,0.0167648534729126,0.00404831969935629,0.0088301468621743,0.024699560083651,3.47330702934728e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,37714,-0.0108754817897436,0.00263103896443202,-0.0160323181600304,-0.00571864541945686,3.59428080684643e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP4,Guanylate-binding protein 4,39961,0.018396730103182,0.00446086044237783,0.00965344363612148,0.0271400165702426,3.74237230107482e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OBP2B,Odorant-binding protein 2b,40184,-0.0246538120855228,0.00598840631262712,-0.036391088458272,-0.0129165357127736,3.85922219686548e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFNA1,Ephrin-A1,40303,0.0101342095610128,0.00246536402113868,0.00530209607958097,0.0149663230424446,3.96560517960412e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,0.0122630484600949,0.00298632402472367,0.00640985337163652,0.0181162435485533,4.03874724526708e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",40359,-0.0286330876196353,0.00697810765470157,-0.0423101786228504,-0.0149559966164202,4.09374130570814e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNPY2,Protein canopy homolog 2,40042,0.0226689245075609,0.00552545795306806,0.0118390269195475,0.0334988220955743,4.10551050301365e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFHD1,EF-hand domain-containing protein D1,37959,0.0128788231207723,0.00313959039854708,0.00672522593961998,0.0190324203019245,4.11869323382849e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.0143744893687544,0.00350438622274603,-0.0212430863653367,-0.00750589237217223,4.12244244439641e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEO1,Neogenin,37959,0.00791394828364076,0.00192979759803155,0.00413154499149892,0.0116963515757826,4.13918673838336e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOD,Apolipoprotein D,37345,-0.0165287489093953,0.00403264381234959,-0.0244327307816005,-0.00862476703719011,4.17953804133744e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,39961,0.0527527663652299,0.0128830239406079,0.0275020394416385,0.0780034932888214,4.2476661490132e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF23,Fibroblast growth factor 23,40469,0.0227293602846231,0.00556737986326859,0.0118172957526166,0.0336414248166295,4.4751687948297e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WIF1,Wnt inhibitory factor 1,40489,0.0126078229571848,0.00309180189124179,0.00654789125035087,0.0186677546640187,4.56786481905874e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEPACAM2,HEPACAM family member 2,37942,-0.0149752572098211,0.00368171042023351,-0.0221914096334788,-0.00775910478616341,4.77959250402361e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,37998,-0.012127995181636,0.00298311792990046,-0.0179749063242409,-0.00628108403903112,4.81915023092609e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRTAP,Cartilage-associated protein,37572,0.0178452135936425,0.00439247038801773,0.00923597163312773,0.0264544555541572,4.87942616484041e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA5,Protein disulfide-isomerase A5,37482,0.0225685712015159,0.00556867454701069,0.011653969089375,0.0334831733136569,5.09080609087571e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,37835,0.0214655679096502,0.00530770949454598,0.0110624573003401,0.0318686785189604,5.27909881790457e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL32,Interleukin-32,40341,-0.015587488537208,0.00385650372231919,-0.0231462358329537,-0.00802874124146242,5.32763204319553e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAA4,Serum amyloid A-4 protein,38013,0.0118696375962786,0.00295467225634883,0.00607847997383489,0.0176607952187223,5.92005430219603e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCAM1,Neural cell adhesion molecule 1,40403,0.0100085699687619,0.00249443443147124,0.0051194784830783,0.0148976614544456,6.03889768536292e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,0.0150128685946879,0.00374543930579463,0.00767180755533041,0.0223539296340454,6.14334288610443e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OXT,Oxytocin-neurophysin 1,40471,0.0476965281061986,0.0119294939023205,0.0243147200576504,0.0710783361547467,6.41116182650126e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP7,Dipeptidyl peptidase 2,40251,0.0208664735527452,0.00523481730909234,0.0106062316269242,0.0311267154785662,6.7471818060221e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,40489,0.0220386382507412,0.00553496807037443,0.0111901008328073,0.032887175668675,6.87228862836941e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH17,Protocadherin-17,40359,-0.012520220463523,0.00314684681847545,-0.0186880402277349,-0.00635240069931108,6.96131694999945e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL28,C-C motif chemokine 28,40278,0.0214189181667885,0.00538601592170953,0.0108623269602378,0.0319755093733392,7.01698893411494e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,0.0176179673806956,0.00443488226202905,0.00892559814711866,0.0263103366142725,7.1475740038749e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,0.0156617249520429,0.00394681803087511,0.00792596161152766,0.0233974882925581,7.27447386148736e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,40305,0.00940141666310746,0.002378596091511,0.0047393683237459,0.014063465002469,7.76722773826462e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB37,Ras-related protein Rab-37,40044,0.029745165939245,0.00753394991931937,0.0149786240973791,0.044511707781111,7.91032978845882e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADM,Pro-adrenomedullin,40489,0.0095896476475673,0.00243123954217421,0.00482441814490584,0.0143548771502287,8.03588124227209e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUCA2A,Guanylin,40276,-0.0119244708416455,0.00302398324247197,-0.0178514779968906,-0.00599746368640045,8.07144589556694e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST1,Cystatin-SN,36179,0.0372155712913425,0.00945814921159778,0.0186775988366109,0.0557535437460742,8.37593385970507e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.0211658726521803,0.00538121270013486,-0.0317130495444446,-0.010618695759916,8.41536826829726e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,37572,-0.0134276319124451,0.00341464426765146,-0.020120334677042,-0.00673492914784826,8.45463385452529e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOSB,Protein fosB,39961,0.0138855007148575,0.00353907427716844,0.0069489151316073,0.0208220862981076,8.76539776333872e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,0.020647100446427,0.0052628262816236,0.0103319609344448,0.0309622399584093,8.77491665758109e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALB1,Calbindin,40305,0.015027707643208,0.00383435211844094,0.00751237749106374,0.0225430377953522,8.9205531510903e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPO,Myeloperoxidase,40332,0.0165148201337407,0.00422223643282168,0.00823923672541021,0.0247904035420712,9.21478021966423e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100P,Protein S100-P,40042,0.0189249666486435,0.00484333835571325,0.00943202347144554,0.0284179098258415,9.36801649975581e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,0.0217132260924218,0.00560629285012487,0.0107248921061771,0.0327015600786665,0.000108022737211186
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTF3,Neurotrophin-3,40341,0.0122122329841666,0.00315768303182767,0.00602317424178441,0.0184012917265489,0.000110410343175851
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.0206197558679537,0.00535317846601073,0.0101275260745727,0.0311119856613347,0.000117684015509787
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,0.0253036838854394,0.00656908413283686,0.0124282789850791,0.0381790887857996,0.000117729566681366
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.0153429881964415,0.00398682956248066,0.00752880225397943,0.0231571741389036,0.000119432577283015
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARF2,Scavenger receptor class F member 2,40471,-0.0103262781367267,0.002684223301591,-0.0155873558078451,-0.00506520046560836,0.000120023390125672
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.0243535338813608,0.00633413223761507,0.0119386346956352,0.0367684330670863,0.000121110610600883
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENO1,Alpha-enolase,40299,0.0274897191321756,0.00715294988653871,0.0134699373545597,0.0415095009097915,0.000121948946395975
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSN,Gelsolin,37928,0.00661295719620038,0.00172195462335126,0.00323792613443191,0.00998798825796886,0.000123407218644286
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300A,CMRF35-like molecule 8,37671,0.0102739505829988,0.00267616178258841,0.00502867348912555,0.0155192276768721,0.000124080976185677
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EP300,Histone acetyltransferase p300,37598,0.0103836659806734,0.00270492141554084,0.00508202000621332,0.0156853119551334,0.000124213860209782
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,0.0107924753838345,0.00281670773805762,0.00527172821724154,0.0163132225504274,0.000127802071912651
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,37628,0.0174300621148278,0.00455352650852424,0.00850515015812033,0.0263549740715354,0.000129883193279808
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN10,Ataxin-10,39961,0.0250323089958865,0.00655294522491541,0.0121885363550523,0.0378760816367207,0.000133967031258899
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLASP1,CLIP-associating protein 1,37482,0.0247479263980104,0.00648181908628613,0.0120435609888896,0.0374522918071312,0.000135132246155152
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INHBB,Inhibin beta B chain,37671,0.0178020144627764,0.00466330031325733,0.00866194584879208,0.0269420830767608,0.000135441725139641
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,0.0154603815006356,0.00405068161852855,0.00752104552831966,0.0233997174729516,0.000135739418254417
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFA,Protransforming growth factor alpha,40341,0.0165134073615393,0.00432734418938544,0.00803181275034389,0.0249950019727348,0.000136113142636684
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,0.0135893413878215,0.00356555069759291,0.00660086202053939,0.0205778207551036,0.000138860657821053
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN4B,Sodium channel subunit beta-4,37628,0.0144421537576236,0.0037924699224535,0.00700891270961478,0.0218753948056325,0.000140666434674249
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,40152,0.0399544826937823,0.0104950979382127,0.0193840907348855,0.0605248746526792,0.000141216730540132
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMP4,Bone morphogenetic protein 4,40203,-0.0156018235326946,0.0041072396172679,-0.0236520131825397,-0.0075516338828495,0.000146053439836975
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.0121653802720402,0.00320395756644508,-0.0184451371022726,-0.00588562344180788,0.000147006029627485
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEFL,Neurofilament light polypeptide,39903,0.0146182702570148,0.00386487924326726,0.00704310694021102,0.0221934335738187,0.000155949291306544
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.0138355784271509,0.00366245725814872,-0.0210139946531224,-0.00665716220117942,0.000158998438850106
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CR2,Complement receptor type 2,40403,0.0158282699735421,0.00419736058125535,0.00760144323428158,0.0240550967128026,0.000163177977295201
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLC,Galectin-10,40333,-0.0223385881704568,0.0059399129310164,-0.033980817515249,-0.0106963588256647,0.000170005678205675
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST6,Cystatin-M,39992,0.0161883941394045,0.0043123330475566,0.00773622136619354,0.0246405669126154,0.0001746856525074
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP2,Guanylate-binding protein 2,40044,0.0201696747913536,0.00537983402867462,0.00962520009515136,0.0307141494875559,0.000178093145154361
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.00940292632054232,0.00251237641232298,-0.0143271840886954,-0.00447866855238929,0.000182847807051761
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK14,Kallikrein-14,40489,0.0154948434270856,0.00415070121851446,0.00735946903879729,0.023630217815374,0.000189816460372318
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL4,Myosin light chain 4,37628,-0.017751434534267,0.00476142300956639,-0.0270838236330172,-0.0084190454355169,0.000193676368700877
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NINJ1,Ninjurin-1,39980,0.0189786472298532,0.00509337252852416,0.00899563707394584,0.0289616573857605,0.000195119403670556
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PREB,Prolactin regulatory element-binding protein,40044,0.00997943826693594,0.002680410087622,0.00472583449519682,0.0152330420386751,0.000197483111311767
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBM19,Probable RNA-binding protein 19,37562,-0.0161126167595151,0.00434866798964254,-0.0246360060192144,-0.0075892274998157,0.000212105481321514
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,40341,0.0157786488112124,0.00426121859289073,0.00742666036914651,0.0241306372532782,0.000213913146324895
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,0.0124583635169303,0.00336943347645101,0.00585427390308634,0.0190624531307743,0.00021848771453912
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPSAB1,Tryptase alpha/beta-1,40498,0.0175828663047213,0.00476070397363606,0.00825188651639461,0.026913846093048,0.000222068058358972
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNC,Tenascin,40403,-0.0157406432915663,0.00426722522291245,-0.0241044047284748,-0.00737688185465795,0.00022612465541901
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF3,Granulocyte colony-stimulating factor,40044,0.0162138084548492,0.00441476130407018,0.00756087629887161,0.0248667406108267,0.000240864555187868
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CX3CL1,Fractalkine,40228,-0.0112781701905869,0.00309116178326664,-0.0173368472857895,-0.00521949309538425,0.000264604107226562
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA2,Carbonic anhydrase 2,40291,0.0232703225219379,0.00638072660247725,0.0107640983810825,0.0357765466627933,0.000266200883891694
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHNAK2,Protein AHNAK2,37628,0.00943471580500528,0.00259021997419138,0.00435788465559018,0.0145115469544204,0.000271104103620217
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,-0.00878538570895528,0.00241395541601574,-0.0135167383243461,-0.00405403309356443,0.000274303147475827
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUP50,Nuclear pore complex protein Nup50,37562,-0.01174040859095,0.00322795651194665,-0.0180672033543654,-0.00541361382753457,0.000276779583056311
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.0208322365482458,0.00572940517037564,-0.032061870682182,-0.00960260241430953,0.000277908960085901
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,40489,0.0190231915041373,0.00523354367912497,0.00876544589305235,0.0292809371152222,0.000279002770478417
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECTIN1,Nectin-1,37598,0.0105251428255969,0.00289565037954575,0.00484966808168721,0.0162006175695066,0.000279245454721563
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMNB2,Lamin-B2,37942,0.00898101145235213,0.00247313612018306,0.00413366465679333,0.0138283582479109,0.000282903426340059
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGA4,Pepsin A-4,37987,0.0222407306572405,0.00615575201663572,0.0101754567046345,0.0343060046098465,0.000303771462731914
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,37482,0.00955726330099155,0.00265071208328904,0.00436186761774503,0.0147526589842381,0.000312660988333849
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRTN3,Myeloblastin,39897,-0.0152995306905166,0.00424763247842953,-0.0236248903482385,-0.00697417103279471,0.000316895930078168
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPA33,Cell surface A33 antigen,40305,-0.0443321109566424,0.0123187902352339,-0.0684769398177008,-0.020187282095584,0.00032073820230903
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,40422,0.00838611541367583,0.00233247710888008,0.00381446028027087,0.0129577705470808,0.000324908694469039
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN3,CCN family member 3,40522,0.0109581539636269,0.0030484748451568,0.00498314326711958,0.0169331646601342,0.000325819091937404
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,L1CAM,Neural cell adhesion molecule L1,40411,0.00919030026541397,0.00255705380125436,0.00417847481495544,0.0142021257158725,0.000326498627564965
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RLN1,Prorelaxin H1,37959,-0.0268117373081112,0.0074698436384217,-0.0414526308394177,-0.0121708437768047,0.000332702597724263
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,40228,0.00734351797081812,0.00204935530753384,0.00332678156805178,0.0113602543735845,0.000340262700093769
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROBO4,Roundabout homolog 4,37628,-0.00578468221646185,0.0016177422775196,-0.00895545708040026,-0.00261390735252343,0.000350442101371377
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,40063,0.0136916683922012,0.00382936837490813,0.00618610637738129,0.0211972304070211,0.000350698194225681
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,39961,0.0129857523556096,0.00363379691638275,0.00586351039949941,0.0201079943117198,0.000353169123708018
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,0.0135346371551781,0.00380059308305787,0.00608547471238466,0.0209837995979715,0.000370276344221297
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOBR,Apolipoprotein B receptor,37628,-0.0136446944826672,0.0038349381526643,-0.0211611732618892,-0.00612821570344517,0.000375008107867599
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,-0.0235824392371895,0.00664176871305334,-0.0366003059147741,-0.0105645725596049,0.000385420029050854
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD80,T-lymphocyte activation antigen CD80,37990,0.0109025993816712,0.00307812506537609,0.00486947425353405,0.0169357245098083,0.00039849938262013
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.0151394544426862,0.00427677893132825,0.00675696773728283,0.0235219411480896,0.000401594605175379
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.0230713580534476,0.00652050541743526,0.0102911674352745,0.0358515486716207,0.00040388625998212
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELL,L-selectin,38013,0.00741101741074,0.00209664964020241,0.00330158411594328,0.0115204507055367,0.000409605642935933
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELENOP,Selenoprotein P,38013,0.00721811665858267,0.00204504995740018,0.00320981874207831,0.011226414575087,0.000417637928557191
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPA2,Carboxypeptidase A2,40398,0.0204121811702754,0.00578611965006182,0.00907138665615424,0.0317529756843966,0.00042023197415571
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPA2,Replication protein A 32 kDa subunit,37598,0.0104267527497801,0.00295897940536635,0.00462715311526202,0.0162263523842981,0.000426904029771153
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSL4,Early placenta insulin-like peptide,37900,-0.0171959764463782,0.00490252419020335,-0.0268049238591768,-0.00758702903357967,0.000453684955145301
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,40042,0.0198168001150522,0.00566624369437988,0.00871096247406759,0.0309226377560367,0.000471224888108431
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,37562,0.0121472039104482,0.00348765017374702,0.00531140956990408,0.0189829982509924,0.000497595300083409
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFF1,Trefoil factor 1,40261,-0.0243940333663405,0.00702166773898573,-0.0381565021347525,-0.0106315645979284,0.000513927106641743
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.010180825262726,0.00293328539956763,-0.0159300646458785,-0.0044315858795734,0.00052033461305493
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB7,Integrin beta-7,40489,0.0142599166210243,0.0041123492349237,0.00619971212057388,0.0223201211214748,0.000526536317271372
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC51B,Organic solute transporter subunit beta,37562,-0.0249918764404913,0.00723112146349541,-0.0391648745089423,-0.0108188783720403,0.000549676302047218
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA1,Alpha-1-antitrypsin,37779,-0.00253999422241611,0.000735268723121732,-0.00398112091973471,-0.00109886752509751,0.000553006029377193
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFB,Vascular endothelial growth factor B,37598,0.00891316893685134,0.00258520662072307,0.00384616396023413,0.0139801739134686,0.000567028494965136
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,0.0134581314539499,0.00390407780696691,0.00580613895229479,0.0211101239556051,0.000568204646425604
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRNN,Cornulin,39857,0.0206967575504357,0.00600506051176086,0.00892683894738443,0.032466676153487,0.000569302779705174
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNGR2,Interferon gamma receptor 2,40228,0.0160703297960944,0.00466595993023664,0.0069250483328306,0.0252156112593582,0.00057431737823892
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",37572,0.0120839127537352,0.0035209437485101,0.00518286300665541,0.018984962500815,0.000600974287921114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSC1,Hamartin,37598,0.0237351160910988,0.00691888478595899,0.0101741019106191,0.0372961302715784,0.000604359523435144
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UNC5D,Netrin receptor UNC5D,37598,0.00830977841832678,0.00242614162754632,0.003554540828336,0.0130650160083176,0.000616450176591515
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTN,Neuroplastin,39980,0.0261454881648108,0.00764205490685112,0.0111670605473826,0.041123915782239,0.000624913003926397
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,0.0104059518196844,0.00305362201831003,0.00442085266379674,0.016391050975572,0.000656640773588448
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300E,CMRF35-like molecule 2,40436,0.0122594359404256,0.00360721148364245,0.00518930143248643,0.0193295704483648,0.000678992872061263
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.014534455516264,0.00428785369282295,0.00613026227833098,0.0229386487541969,0.00070173801114224
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,-0.008631317847074,0.00256197987814166,-0.0136527984082317,-0.00360983728591634,0.000756212119221292
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,37562,0.0138412058607393,0.00412548989112298,0.00575524567413827,0.0219271660473403,0.000795770903834745
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,0.008379879940341,0.0024983328588686,0.00348314753695855,0.0132766123437234,0.000797887380782324
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,0.0102211816004301,0.00305068910982533,0.00424183094517242,0.0162005322556877,0.000808671296111028
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,0.0175457553709263,0.00523912622990101,0.00727706796032029,0.0278144427815323,0.000813003352428716
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCN1,Transcobalamin-1,37766,0.010021279972178,0.00299231194794153,0.00415634855421259,0.0158862113901434,0.000813261821368439
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,37990,-0.0117505557261097,0.00350877174748986,-0.0186277483511898,-0.00487336310102959,0.000813519495792565
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JAM2,Junctional adhesion molecule B,40471,0.00788871866099936,0.00235762066563857,0.00326778215634776,0.012509655165651,0.000821597694238975
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A12,Protein S100-A12,40139,0.0230754310622531,0.00691242362729951,0.00952708075274609,0.0366237813717602,0.000845025917731665
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSAP,Gamma-secretase-activating protein,39980,0.0269099997969956,0.00808226144731407,0.01106876736026,0.0427512322337312,0.000872003355086768
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,37572,-0.011842671908248,0.00355942279626679,-0.0188191405889309,-0.00486620322756507,0.000879857403354146
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGT,Angiotensinogen,37987,0.00728955427884948,0.00219225192532298,0.00299274050521645,0.0115863680524825,0.000886076504683512
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.011799348751204,0.00354850254751929,0.00484428375806617,0.0187544137443418,0.000886094307149945
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG1A,Lithostathine-1-alpha,40274,-0.0146397173171144,0.00440576609144437,-0.0232750188563454,-0.00600441577788348,0.000893036178298169
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,37714,0.0206135845844419,0.00621004599819976,0.00844189442797037,0.0327852747409134,0.00090456473641154
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROCR,Endothelial protein C receptor,37562,-0.0111388817679918,0.00335601662628993,-0.0177166743555201,-0.00456108918046357,0.000905613073755597
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,0.00643402089600859,0.00194366829844057,0.00262443103106507,0.0102436107609521,0.000934591374472209
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGFLAM,Pikachurin,37901,0.00920303099101144,0.00278466143908093,0.00374509457041283,0.0146609674116101,0.000952583571086924
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGN,Secretagogin,40044,-0.0131049444668326,0.00396892040415801,-0.0208840284589823,-0.00532586047468294,0.000962511042243594
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NME1,Nucleoside diphosphate kinase A,37598,-0.00656831497498364,0.00199234879236306,-0.0104733186080152,-0.00266331134195204,0.000980629973506129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL11,Interleukin-11,40044,0.01904438271345,0.00577715629326196,0.00772115637865657,0.0303676090482434,0.000981171459560109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,40536,0.0101872487191799,0.00309621392302124,0.00411866943005825,0.0162558280083015,0.00100321660783233
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,0.00792150089521802,0.00241226569519143,0.00319346013264283,0.0126495416577932,0.00102662511598614
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UMOD,Uromodulin,40502,-0.0160354967151465,0.00489147600435973,-0.0256227896836916,-0.00644820374660144,0.0010467378389009
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL22,Interleukin-22,37900,-0.019330638245617,0.00590758991144529,-0.0309095144720498,-0.00775176201918424,0.0010699443635673
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.0179834668095854,0.00550284638768097,-0.02876904572944,-0.00719788788973066,0.00108526073014848
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,37998,0.0173991914967059,0.00532948722236428,0.00695339654087195,0.0278449864525399,0.00109850938435084
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,40380,-0.0139318271994735,0.00429133995835703,-0.0223428535178532,-0.00552080088109367,0.00117075710469933
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSTN2,Calsyntenin-2,40516,-0.0114455377028194,0.00352645579698046,-0.0183573910649011,-0.00453368434073771,0.00117434851929306
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,-0.0164895739214084,0.00509530654515806,-0.0264763747499182,-0.00650277309289862,0.00121421253516413
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,39980,0.0118821114433876,0.0036717889534522,0.00468540509462125,0.0190788177921539,0.00121447906909014
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR4,Toll-like receptor 4,37598,0.00831774245440606,0.00257934009339179,0.00326223587135815,0.013373249037454,0.0012638813446786
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,37541,-0.0158649624238262,0.00492043677451967,-0.0255090185018848,-0.00622090634576764,0.00126590933225812
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MELTF,Melanotransferrin,37990,0.00849550105474353,0.00264252332254283,0.00331615534255959,0.0136748467669275,0.00130786989087042
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZBP1,Z-DNA-binding protein 1,37598,0.0117200778944955,0.00364818693655968,0.0045696314988385,0.0188705242901525,0.00131867293635715
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFC1,Cryptic protein,39980,0.0133971538110737,0.00417143641740343,0.00522113843296293,0.0215731691891844,0.00132248355591585
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,40333,0.0280693184513838,0.00875548564381692,0.0109085665895026,0.0452300703132649,0.00134901502193626
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,0.0110183334136297,0.00343858676973186,0.0042787033449553,0.0177579634823042,0.0013565416842747
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYB5A,Cytochrome b5,37482,0.021344855494564,0.00666730520530806,0.00827693729216019,0.0344127736969678,0.00137079437055565
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,37482,-0.0126826023044691,0.00396195448155901,-0.0204480330883248,-0.00491717152061347,0.00137233674996365
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAPS,Calcyphosin,37942,0.0274285961559826,0.00858893108189007,0.0105942912354781,0.0442629010764872,0.00140891012940261
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.0113499370133639,0.00356584820928218,0.00436087452317083,0.018338999503557,0.00146109593536463
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,37714,0.020382283868558,0.00642026235816046,0.00779856964656349,0.0329659980905525,0.00150344317129031
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHB6,Ephrin type-B receptor 6,40192,0.00894795739675962,0.00282342152454418,0.00341405120865302,0.0144818635848662,0.00153157329218116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRD3,Bromodomain-containing protein 3,37562,0.0139035054026357,0.00439769709124145,0.0052840191038025,0.022522991701469,0.00157293460843662
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRC1,Macrophage mannose receptor 1,37987,0.00808569964359588,0.00255798863297449,0.00307204192296588,0.0130993573642259,0.00157596781610469
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLL1,Delta-like protein 1,40411,-0.00835989288230039,0.00264554012249991,-0.0135451515224002,-0.00317463424220057,0.001580666141033
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,37628,0.00864503052204576,0.00274032347377443,0.00327399651344787,0.0140160645306436,0.00160997847950974
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAT,Catalase,37786,0.0155108335201826,0.00492841338728456,0.00585114328110484,0.0251705237592603,0.00165190181079919
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,37900,0.0150610318338755,0.00479362812298437,0.00566552071282618,0.0244565429549249,0.00168227788450249
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB39B,Ras-related protein Rab-39B,37562,0.0253998600718078,0.00809085013145877,0.00954179381414863,0.041257926329467,0.00169709613544144
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,37598,-0.0177709773048949,0.00567260218950395,-0.0288892775963226,-0.00665267701346716,0.001735433779722
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,0.00718329631540053,0.00229631265136284,0.00268252351872937,0.0116840691120717,0.0017627629427706
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANSC4,MANSC domain-containing protein 4,37562,0.0186632531572264,0.00597030949356331,0.00696144654984235,0.0303650597646105,0.00177582071397703
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,37541,-0.0108417931726533,0.00348150925288365,-0.0176655513083053,-0.00401803503700136,0.00184900557366422
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,0.0104650907848746,0.00336302719101096,0.00387355749049309,0.0170566240792561,0.00186276529511854
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,40264,-0.00750120059053425,0.00241113329659469,-0.0122270218518598,-0.00277537932920865,0.00186743520310526
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP9,Matrix metalloproteinase-9,40312,-0.0171331880268728,0.00552217992054631,-0.0279566606711436,-0.00630971538260209,0.00192157174341414
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,38484,-0.00875576011642457,0.00283387129503913,-0.0143101478547013,-0.00320137237814788,0.00200762962173674
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARTN,Artemin,40044,0.0124338921618759,0.00402821519512939,0.00453859037942226,0.0203291939443295,0.00202746584548885
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,0.0100011731504624,0.00324273584925157,0.00364541088592937,0.0163569354149955,0.00204540175265909
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERC2,ERC protein 2,37572,0.0214602456758549,0.00698025234239539,0.00777895108475997,0.0351415402669499,0.00211343605242764
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRR4,Proline-rich protein 4,37577,-0.0191577986166142,0.00623716615491895,-0.0313826442802553,-0.00693295295297302,0.00213382660329582
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UROS,Uroporphyrinogen-III synthase,37572,0.0195334688039351,0.00636467067916037,0.00705871427278074,0.0320082233350894,0.00215181558311936
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LIFR,Leukemia inhibitory factor receptor,40341,-0.00678969884549607,0.00221289674068948,-0.0111269764572475,-0.0024524212337447,0.00215685882128319
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL15,Interleukin-15,40341,-0.00905185511734612,0.00296269584726787,-0.0148587389779912,-0.00324497125670109,0.00225225758162363
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.0136863858474775,0.0044821510886644,0.00490136971369531,0.0224714019812598,0.00226548825120128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,0.00833280398502659,0.0027310253729551,0.0029799942540346,0.0136856137160186,0.00228341366296385
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,37541,-0.00918835722758228,0.00301341617832272,-0.0150946529370948,-0.00328206151806975,0.0022994842686028
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.00632701318437643,0.00208049592509741,0.00224924117118551,0.0104047851975673,0.00236090073857491
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC13A1,Solute carrier family 13 member 1,37900,0.0170575072715086,0.00562355918890371,0.00603533126125729,0.0280796832817598,0.00242418429487281
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,0.00883423721120626,0.00291729916667471,0.00311633084452383,0.0145521435778887,0.00246394175711202
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,37900,0.0166031950067906,0.0054861602090884,0.00585032099697735,0.0273560690166039,0.00247970747081694
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSC,Dipeptidyl peptidase 1,40349,0.0116255912260676,0.00384336764558178,0.0040925906407273,0.0191585918114079,0.00249157878802906
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,37598,0.00859481858904757,0.00284458971056342,0.00301942275634327,0.0141702144217519,0.00252041399200556
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCF2,Neutrophil cytosol factor 2,40324,0.0224837563771229,0.00750834233522545,0.00776740540008104,0.0372001073541648,0.00275315811531987
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACE,Angiotensin-converting enzyme,37987,-0.00692181978356525,0.00231309677214597,-0.0114554894569713,-0.00238815011015916,0.00277249704802216
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,40372,0.00799559720427726,0.0026767643343489,0.00274913910895342,0.0132420552996011,0.00282123598552749
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK4,Kallikrein-4,40489,-0.0164162125002823,0.00549595546999183,-0.0271882852214663,-0.00564413977909831,0.00282190319973125
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.0060842020372945,0.00203854960253927,0.00208864481631752,0.0100797592582715,0.0028440036089861
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACTA2,"Actin, aortic smooth muscle",40042,-0.0117808244988801,0.0039490389482343,-0.0195209408374193,-0.00404070816034084,0.00285680937558889
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,0.0193332026617082,0.00649651971521271,0.00660002401989129,0.0320663813035251,0.00292626249511288
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKCQ,Protein kinase C theta type,40044,0.0119104296675529,0.00401403863777119,0.00404291393752139,0.0197779453975845,0.00300987815302547
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB2,Integrin beta-2,40221,0.00767640322334608,0.00259164246262675,0.00259678399659765,0.0127560224500945,0.00306119564021886
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,37990,-0.0066863943258397,0.00225937386720948,-0.0111147671055703,-0.00225802154610912,0.00308770964630128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,37714,0.0123920311524568,0.00420123013091103,0.00415762009587119,0.0206264422090424,0.00318720922908855
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELAVL4,ELAV-like protein 4,37541,0.0232519239580151,0.0078958112286416,0.00777613394987752,0.0387277139661526,0.00323687009689814
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,0.00973642360156066,0.00330737110385086,0.00325397623801297,0.0162188709651084,0.00324716721915448
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.0112681610794262,0.00382812140807651,0.00376504311959619,0.0187712790392561,0.00325052575329208
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGMA,Repulsive guidance molecule A,40471,-0.00821314530324866,0.00279449334254579,-0.0136903522546384,-0.00273593835185891,0.00329693660498893
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX5,Syntaxin-5,37598,0.0111363734576367,0.00379914017378398,0.00369005871702007,0.0185826881982533,0.00338141186054124
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",37942,0.0160884121592201,0.00549123052707389,0.00532560032615526,0.0268512239922849,0.00339707644411726
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.0109463265332202,0.00374067265965703,-0.018278044946148,-0.00361460812029242,0.00343609845384222
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMOD4,Tropomodulin-4,37482,-0.0111075886859732,0.00380479857526991,-0.0185649938935022,-0.00365018347844415,0.00351347856003747
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPA4,Carboxypeptidase A4,37410,0.0116034395853191,0.00397606498252488,0.00381035221957035,0.0193965269510679,0.00352525308013057
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX18,Sorting nexin-18,37901,0.0119805466291479,0.00411580777669545,0.00391356338682483,0.020047529871471,0.00361025207573784
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEF,Thyrotroph embryonic factor,37562,0.011380637215255,0.00391318069095156,0.00371080306098996,0.0190504713695201,0.0036402908231846
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,-0.012113110900653,0.00416719919935008,-0.0202808213313791,-0.00394540046992681,0.00365676194493815
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.0313966539185843,0.0108670459503069,0.0100972438559829,0.0526960639811858,0.00386802388145846
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,0.0148393203214705,0.00514794859238266,0.00474934108040046,0.0249292995625405,0.00394987044039639
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTTG1,Securin,37714,0.0107936849215788,0.00374562205282474,0.00345226569804229,0.0181351041451153,0.00396195656571216
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP3,"Fatty acid-binding protein, heart",37990,0.0123779645277326,0.00429969967720556,0.00395055316040968,0.0208053758950555,0.00399819788831658
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSTN1,Calsyntenin-1,39961,0.0136832196370733,0.00476030065317988,0.00435303035684077,0.0230134089173059,0.00405289251077508
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA4C,Semaphorin-4C,40305,0.00736037833221706,0.0025617582282396,0.00233933220486745,0.0123814244595667,0.0040690924091905
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMEM25,Transmembrane protein 25,37959,-0.0113890643187841,0.0039656758717376,-0.0191617890273898,-0.00361633961017839,0.00408633997235223
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIGR,Polymeric immunoglobulin receptor,40154,0.0090818639843785,0.00317711337238492,0.00285472177450406,0.0153090061942529,0.00426173169801638
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYO6,Unconventional myosin-VI,37959,0.00968718241047152,0.00339033696035556,0.00304212196817463,0.0163322428527684,0.00427925376875473
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD109,CD109 antigen,40332,-0.00861803129447703,0.00301917708636963,-0.0145356183837615,-0.00270044420519255,0.00431698710857768
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,40437,0.0208780041618951,0.00732789561196669,0.00651532876244044,0.0352406795613499,0.00438972800799163
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,0.0107497782990513,0.00379648662449001,0.00330866451505085,0.0181908920830517,0.00463873769806409
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEPH,Hephaestin,37990,0.0063970074820323,0.00226690348277951,0.00195387665578445,0.0108401383082801,0.00478074741951163
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSF,Cathepsin F,40411,0.0101932192296888,0.00361424271543968,0.003109303507427,0.0172771349519505,0.00480391640456567
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUC2,Mucin-2,37998,0.0230657779122595,0.00820633006755433,0.00698137097985297,0.0391501848446659,0.00495001963230252
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA3G,Semaphorin-3G,37671,0.0109935864002773,0.00391409636797067,0.00332195751905481,0.0186652152814999,0.00498124209230087
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NGF,Beta-nerve growth factor,40228,0.00309909022743097,0.0011034515461986,0.000936325196881717,0.00526185525798022,0.00498275184808371
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,39865,-0.00960105581506766,0.00341953005517324,-0.0163033347232072,-0.00289877690692812,0.00499575089580242
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,37671,0.0135859754065639,0.00484387733588144,0.00409197582823632,0.0230799749848915,0.00504255522310948
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MATN3,Matrilin-3,40203,-0.00792600788761203,0.00282789372214019,-0.0134686795830068,-0.00238333619221727,0.00507236747833116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ULBP2,UL16-binding protein 2,40228,0.00943154635935352,0.00337139788515425,0.00282360650445118,0.0160394862142559,0.00515592860776393
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,0.013680415696006,0.00490493641436625,0.00406674032384819,0.0232940910681639,0.00529269093152861
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,37598,0.0272271113838621,0.009769214657408,0.00807945065534239,0.0463747721123818,0.00532695726912821
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALPP,"Alkaline phosphatase, placental type",40305,0.0259323116089178,0.00931717916751251,0.00767064044059328,0.0441939827772423,0.0053876163033207
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,0.0074156047630696,0.00267635836484634,0.00216994236797078,0.0126612671581684,0.00559868226394789
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXNB2,Plexin-B2,40472,0.00583151488761912,0.00210533465546822,0.0017050589629014,0.00995797081233683,0.00561422771752585
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,-0.00800532767019997,0.00289292148895502,-0.0136754537885518,-0.00233520155184813,0.00566038014050627
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPO,Lactoperoxidase,39831,-0.0147914611484134,0.00536352017539029,-0.0253039606921784,-0.00427896160464845,0.00582623006072833
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,37572,0.0134122658661277,0.00488522398462203,0.00383722685626856,0.0229873048759869,0.00605054355531407
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRXN3,Neurexin-3,37572,0.00865907526724704,0.00316345002658068,0.0024587132151489,0.0148594373193452,0.00620433113990481
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTF4,Neurotrophin-4,39980,0.0100912744090179,0.00369188470872756,0.00285518037991193,0.0173273684381239,0.00627614925164535
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD2,Sushi domain-containing protein 2,40332,-0.00706069362027813,0.00258699762117859,-0.0121312089577882,-0.00199017828276808,0.00635387559355963
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDK2,Protein sidekick-2,37671,0.00941682010746677,0.00345476066662418,0.00264548920088338,0.0161881510140502,0.00642397035920236
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,0.0094225586773735,0.00345778028352828,0.00264530932165807,0.0161998080330889,0.00643784667117583
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.0120528301990936,0.00442520712027934,0.00337942424334607,0.0207262361548411,0.00646478440795337
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,-0.00642150039532105,0.00236028600073951,-0.0110476609567705,-0.0017953398338716,0.00652381930246098
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA11,Carbonic anhydrase-related protein 11,39980,0.00813478596625593,0.00299339381869403,0.00226773408161564,0.0140018378508962,0.0065834262560243
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH12,Protocadherin-12,37959,0.00629616486766873,0.0023177450231978,0.00175338462220104,0.0108389451131364,0.00660592863502538
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA11,Integrin alpha-11,40341,0.00834141925413773,0.00307771390657343,0.00230909999725381,0.0143737385110217,0.00673016973442957
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCND2,G1/S-specific cyclin-D2,37714,0.00896963720702604,0.00332463604446197,0.00245335055988057,0.0154859238541715,0.00698602621788869
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LIF,Leukemia inhibitory factor,39961,0.0128324322549877,0.00476547172595288,0.00349210767212005,0.0221727568378553,0.0070932226100659
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,0.00639754275783129,0.00238436033255443,0.00172419650602462,0.011070889009638,0.00730123080104335
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMS1,PMS1 protein homolog 1,37572,0.0126515848337295,0.00471835352213994,0.00340361193033517,0.0218995577371237,0.00734162181446985
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.0118278203526912,0.00442339278718759,-0.0204976702155788,-0.00315797048980348,0.00750616829100781
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.0207885777149237,0.00782443853863395,-0.0361244772506462,-0.00545267817920114,0.00789494920976433
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM3,Intercellular adhesion molecule 3,40536,-0.00604205667733269,0.00227918103320114,-0.0105092515024069,-0.00157486185225844,0.00803379079761221
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.0158224171503785,0.0059699627411993,-0.0275235441231292,-0.00412129017762791,0.00805070775109067
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNGR1,Interferon gamma receptor 1,40422,0.00489175291160441,0.00184941300630055,0.00126690341925533,0.0085166024039535,0.00817636137159286
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,0.00910301905989054,0.00344433293631431,0.00235212650471449,0.0158539116150666,0.00822796514747899
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.0124830972383301,0.00473023611564711,0.00321183445166182,0.0217543600249985,0.0083249098151159
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA1,Annexin A1,37608,0.0098756381463633,0.0037527039915174,0.00252033832298919,0.0172309379697374,0.00850815132059067
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMEM132A,Transmembrane protein 132A,37628,0.0149633941065967,0.00569118419663272,0.00380867308119658,0.0261181151319968,0.00856795166071357
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,0.00820745067729876,0.00313311616302861,0.00206654299776269,0.0143483583568348,0.00881217899350188
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,0.00847813360247306,0.00323977677706562,0.00212817111942443,0.0148280960855217,0.00888372332838858
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MB,Myoglobin,40536,-0.0115603657288205,0.00443629767568144,-0.0202555091731561,-0.00286522228448483,0.00917286487284543
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,-0.0123076755725779,0.00473219053136123,-0.0215827690140459,-0.00303258213110988,0.00930999286200116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLMP,CXADR-like membrane protein,40489,0.00479074155508101,0.00184240988634892,0.00117961817783712,0.00840186493232489,0.00932390461264021
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL5A1,Collagen alpha-1(V) chain,37671,-0.00935288115834501,0.00359897179292758,-0.0164068658724831,-0.00229889644420696,0.00936637370227541
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PI3,Elafin,40074,0.0125654607456306,0.00483553174016575,0.00308781853490569,0.0220431029563554,0.00937012733899675
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,40305,0.0147571638164965,0.00569154008982417,0.00360174524044113,0.0259125823925519,0.00952787819097201
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,37562,0.00959292304399243,0.00370337205182303,0.0023343138224193,0.0168515322655656,0.0095992537285713
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,37482,0.0181693832465792,0.00702252763750491,0.00440522907706952,0.0319335374160888,0.00968386911279061
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNU13,NHP2-like protein 1,37562,0.0146528435511549,0.00566402521291213,0.00355135413384713,0.0257543329684627,0.00969217321203484
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,-0.0103320049681799,0.00400040000923379,-0.0181727889862782,-0.00249122095008168,0.0098106543088003
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,0.00730973695719984,0.00284700572053988,0.00172960574494168,0.012889868169458,0.0102520152181962
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH6,Cadherin-6,40359,-0.00875982913407834,0.00342488558617016,-0.0154726048829719,-0.00204705338518482,0.0105458878858166
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.0114996695341486,0.00450243323304097,0.00267490039738827,0.0203244386709089,0.0106574415651407
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG1B,Lithostathine-1-beta,40536,-0.0128775866351574,0.00504634866336533,-0.0227684300153534,-0.00298674325496135,0.0107240519008991
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCP2,Non-specific lipid-transfer protein,39980,0.0180058776391917,0.00705658366888859,0.00417497364817005,0.0318367816302133,0.0107311478206524
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SULT1A1,Sulfotransferase 1A1,40471,-0.029622667816731,0.0116153897453115,-0.0523888317175415,-0.0068565039159206,0.010772410142723
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA1,Carbonic anhydrase 1,40003,0.0143793105331906,0.00565242413756574,0.00330055922356179,0.0254580618428195,0.0109712328143436
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,40182,0.00658899449382041,0.00259291783969351,0.00150687552802112,0.0116711134596197,0.0110583543246676
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN7,Septin-7,37714,0.0120734947662908,0.00475665579036587,0.00275044941717368,0.0213965401154079,0.0111527579010223
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,37562,-0.00928659507937361,0.0036609499203184,-0.0164620569231977,-0.00211113323554955,0.0112029707547497
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,37628,0.0133120757218816,0.00524911907135245,0.00302380234203077,0.0236003491017324,0.011222234536847
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,37714,0.0135341663741561,0.00535802702285335,0.00303243340936353,0.0240358993389487,0.0115497787760094
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17RB,Interleukin-17 receptor B,40126,-0.0121865688056454,0.00482809702590022,-0.0216496389764098,-0.00272349863488092,0.0116094976832779
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.0112655776947843,0.00447073108841699,-0.0200282106280816,-0.002502944761487,0.0117501467068518
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,-0.00934406968247952,0.00371092760839191,-0.0166174877949277,-0.00207065157003138,0.011814560699665
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,0.0148176233152157,0.00588681184639518,0.00327947209628109,0.0263557745341502,0.011843059368427
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS5,Transmembrane protease serine 5,40159,0.00856977498859109,0.00341802504028212,0.00187044590963814,0.015269104067544,0.0121781617964552
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,40305,-0.010180797809181,0.00406150301847393,-0.0181413437253899,-0.00222025189297211,0.0121977954987566
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,0.0082972305976224,0.00331585462133326,0.0017981555398092,0.0147963056554356,0.0123513433746158
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,0.0129928205011647,0.00519395386122324,0.00281267093316712,0.0231729700691622,0.0123776587036299
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBC1D17,TBC1 domain family member 17,39961,0.010403715280402,0.00416306472163553,0.00224410842599634,0.0185633221348076,0.0124628609583633
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,0.00918217384189712,0.00368334435615774,0.00196281890382796,0.0164015287799663,0.012681087699366
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOX9,Transcription factor SOX-9,37572,0.0061356580044917,0.00246402749061557,0.00130616412288519,0.0109651518860982,0.012783240729026
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD5L,CD5 antigen-like,37934,0.0104676080893316,0.00422016157468795,0.00219609140294325,0.01873912477572,0.0131363225585258
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.00801161317406872,0.00323352178069755,0.00167391048390152,0.0143493158642359,0.0132362871310743
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP1,Caspase-1,39961,0.0150801991407295,0.0060873264362358,0.00314903932570736,0.0270113589557517,0.0132482329541687
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIMAP7,GTPase IMAP family member 7,37671,-0.00723642768358317,0.0029361979821097,-0.0129913757285182,-0.00148147963864815,0.0137308931712987
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.00423746834978725,0.00172031889903252,0.000865643307683506,0.00760929339189099,0.0137831090406788
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.00607873139575438,0.00246927575213305,0.00123895092157361,0.0109185118699352,0.0138366851368629
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.0125263619399672,0.00509140451525103,0.00254720909007515,0.0225055147898592,0.013894904746771
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,37987,0.00575361239809903,0.002344042166725,0.00115928975131802,0.01034793504488,0.014117870501492
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,0.00972218481697285,0.00396584034181965,0.00194913774700633,0.0174952318869394,0.0142398648254971
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRLF1,Cytokine receptor-like factor 1,40422,0.00581153327734195,0.00237321274214674,0.00116003630273433,0.0104630302519496,0.0143438088349433
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBR2,TGF-beta receptor type-2,40411,0.00697789773542509,0.00285142356636039,0.00138910754535872,0.0125666879254915,0.0144092825048449
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TERF1,Telomeric repeat-binding factor 1,37598,-0.00659791771507052,0.00269669039213793,-0.0118834308836609,-0.00131240454648017,0.0144311902385326
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOP56,Nucleolar protein 56,37562,0.0245408197368833,0.0100559627379587,0.00483113277048423,0.0442505067032824,0.0146831534368316
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,0.00641458733498313,0.00263423424001298,0.00125148822455768,0.0115776864454086,0.0149014503175024
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.0109704655510995,0.00450544166732223,0.00213979988314794,0.0198011312190511,0.0149055883370247
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,0.0193729458211062,0.00796327537092383,0.00376492609409554,0.0349809655481169,0.0149963945267273
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,40341,-0.014311325408089,0.00590366441420802,-0.0258825076599367,-0.00274014315624126,0.0153556558229976
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,39961,0.00898758410679037,0.0037081515169866,0.00171960713349663,0.0162555610800841,0.0153730870055557
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,QSOX1,Sulfhydryl oxidase 1,37761,0.00984493179071137,0.00406379702906736,0.00187988961373935,0.0178099739676834,0.0154233828079833
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECTIN2,Nectin-2,40330,0.0063143592132578,0.00260956861794013,0.00119960472209514,0.0114291137044204,0.0155447012085218
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,0.00592791002750179,0.00245623442807667,0.00111369054847151,0.0107421295065321,0.0158149828989069
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRCAM,Neuronal cell adhesion molecule,40359,0.00608820929986385,0.00252699442097018,0.00113530023476229,0.0110411183649654,0.015995798979273
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,39535,0.00826992914828117,0.00344068783201914,0.00152618099752365,0.0150136772990387,0.0162479127189678
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RETN,Resistin,40283,-0.00899227069281201,0.00374292828414058,-0.0163284101297276,-0.00165613125589647,0.0162962372183635
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.00887843525073971,0.00375014546188924,0.00152815014543679,0.0162287203560426,0.0179209252351173
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL12,Stromal cell-derived factor 1,40044,0.00869398111973219,0.00367367131482474,0.0014935853426757,0.0158943768967887,0.0179661820911827
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX3,Syntaxin-3,37942,0.00825916044549759,0.00350273752923663,0.00139379488819378,0.0151245260028014,0.0183920491684932
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUSP29,Dual specificity phosphatase 29,37572,-0.0142563194106978,0.00605241757446239,-0.0261190578566441,-0.00239358096475148,0.018513668336575
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,40228,-0.0076663777968966,0.00326298408025619,-0.0140618265941987,-0.00127092899959448,0.0188109547993142
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,0.011293639361069,0.00480710128191795,0.00187172084850983,0.0207155578736282,0.0188200078172631
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,37598,0.0137305775388866,0.00586402694814178,0.00223708472052868,0.0252240703572445,0.0192216449307241
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,0.0054011613003546,0.00230764035478099,0.000878186204983874,0.00992413639572533,0.0192674460330057
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCN15,Lipocalin-15,37959,-0.0134954597466674,0.00577616118785312,-0.0248167356748595,-0.00217418381847526,0.01948461758911
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.00782515877096305,0.00334937415801838,0.00126038542124703,0.0143899321206791,0.019487736559619
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,39980,0.0110455054810428,0.0047527104061123,0.0017301930850627,0.0203608178770229,0.0201360024304743
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,0.0130743378168156,0.00563668732096989,0.00202643066771458,0.0241222449659166,0.0203823963868774
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.0133866738062879,0.00577775717088188,0.0020622697513594,0.0247110778612164,0.0205200074530189
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR158,Probable G-protein coupled receptor 158,37959,0.00772378625526672,0.00333958154766042,0.0011782064218523,0.0142693660886811,0.0207485555239018
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGN,Mimecan,40332,-0.00850402091995438,0.00367938539872758,-0.0157156163014604,-0.00129242553844833,0.0208311682505177
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,0.00808739467104675,0.00350001572143546,0.00122736385703324,0.0149474254850602,0.0208636197506956
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,0.00741199949098189,0.00321584636654319,0.00110894061255724,0.0137150583694065,0.0211885979062984
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDRG1,Protein NDRG1,39961,0.0143061784672216,0.00622815370983282,0.00209899719594929,0.026513359738494,0.0216310255740321
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CENPJ,Centromere protein J,37714,0.0152376377997919,0.00664223469120212,0.00221885780503574,0.028256417794548,0.0218030162094811
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,37541,0.0189314486963268,0.00825931818253611,0.00274318505855604,0.0351197123340976,0.0219138149854197
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,40457,0.00541200293596101,0.00236280369728772,0.000780907689277076,0.0100430981826449,0.0220052638624536
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,40305,0.00640565595756775,0.002801411663262,0.000914889097574223,0.0118964228175613,0.0222333875799957
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DRAXIN,Draxin,40228,0.00895843308460377,0.00391910229106035,0.00127699259412548,0.0166398735750821,0.0222769334343519
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMCN2,Hemicentin-2,37648,-0.0118249465119978,0.00517685079104524,-0.0219715740624465,-0.00167831896154911,0.0223757692088954
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,0.0127805912830335,0.00561009046025796,0.0017848139809279,0.0237763685851391,0.0227340016391253
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,40044,0.0124073717620544,0.00544765593550433,0.00172996612846592,0.0230847773956429,0.0227661894637004
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP8,Neutrophil collagenase,40442,-0.0150589460969613,0.0066140986988961,-0.0280225795467976,-0.00209531264712491,0.0228116292924619
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TTN,Titin,37562,-0.0135677112670905,0.00596599918020305,-0.0252610696602885,-0.00187435287389255,0.0229717051791527
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,37572,0.0102045260896722,0.00448772818301889,0.00140857885095519,0.0190004733283892,0.0229896759447323
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,0.00571731507831424,0.00251719069372841,0.000783621318606554,0.0106510088380219,0.0231415777340847
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.0187037393874673,0.00823477307840712,0.00256358415378937,0.0348438946211453,0.0231443315270425
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK11,Kallikrein-11,40260,0.00609191634648633,0.00268598414411511,0.000827387424020707,0.0113564452689519,0.02334027169348
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,0.0136590529995595,0.00602708628769623,0.00184596387567483,0.0254721421234441,0.0234504095216212
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,0.00554706296568695,0.00245068387808859,0.000743722564633311,0.0103504033667406,0.0236200792908752
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300C,CMRF35-like molecule 6,40471,0.00696813826794831,0.00307970272188641,0.000931920933050941,0.0130043556028457,0.0236736335736821
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CENPF,Centromere protein F,37714,0.0111318384522451,0.00494161747232172,0.00144626820649455,0.0208174086979957,0.0242961778181671
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB2A2,Mammaglobin-A,37562,-0.00653533225139266,0.00291267071675091,-0.0122441668562244,-0.000826497646560877,0.0248645101984674
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,0.00759880980851284,0.00339013963408082,0.000954136125714444,0.0142434834913112,0.0250111447889453
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN2B,Sodium channel subunit beta-2,37572,-0.00602035124893708,0.00269281846371605,-0.0112982754378205,-0.000742427060053628,0.0253877663430213
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,0.0101771813052329,0.00456000146023664,0.00123957844316909,0.0191147841672967,0.0256421273314852
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,40357,0.0589576241855966,0.0264254715144053,0.00716370001736224,0.110751548353831,0.0256890049219642
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HLA_DRA,,40288,-0.00724935582214101,0.00325950793362614,-0.0136379913720483,-0.000860720272233773,0.0261581524710512
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.0275506396315105,0.0124686788428267,-0.0519892501634508,-0.0031120290995701,0.0271504527990999
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,40042,0.0110771712462518,0.00501370224898763,0.00125031483823602,0.0209040276542675,0.0271627341879
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFASC,Neurofascin,40516,0.00542544906048738,0.00245881018062231,0.000606181106467657,0.0102447170145071,0.0273607048359323
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAM,Integrin alpha-M,40332,-0.00631386025034073,0.00286210646436416,-0.0119235889204945,-0.000704131580186973,0.0273969594771924
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,40305,-0.00819532276416462,0.00371979678450107,-0.0154861244617867,-0.000904521066542515,0.0275975149952404
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKLR,Pyruvate kinase PKLR,40374,-0.0132310356679449,0.00600743098674244,-0.0250056004019601,-0.00145647093392973,0.0276481770954247
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF9,Fibroblast growth factor 9,37457,0.00810459962672181,0.00368983803510028,0.000872517077925262,0.0153366821755183,0.028076272819751
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,-0.00480248687023787,0.00219979646341132,-0.00911408793852406,-0.000490885801951675,0.0290392429049358
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD209,CD209 antigen,40382,0.00763050576110452,0.00350498394909905,0.000760737220870385,0.0145002743013387,0.0294918836008762
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,40332,-0.00852022954849158,0.00391630929402517,-0.0161961957647809,-0.000844263332202254,0.02960165691955
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,40311,0.017200434169675,0.00792112528921628,0.00167502860281107,0.0327258397365389,0.0299109305297611
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA6C,Semaphorin-6C,37598,0.00524494110119512,0.00241594248955491,0.000509693821667496,0.00998018838072274,0.0299511962292576
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,-0.00627573144492522,0.00289098351581265,-0.011942059135918,-0.000609403753932429,0.0299645854608735
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,0.00618139138628094,0.00284860394572966,0.000598127652650796,0.0117646551199111,0.0300268007472503
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.0112224523551809,0.0051897370852786,0.0010505676680349,0.021394337042327,0.0306029657189503
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3GL3,Endophilin-A3,37643,0.0162330144283315,0.00750932755726696,0.00151473241608822,0.0309512964405747,0.0306581970511641
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAG,S-arrestin,37541,-0.0104666088668382,0.00484265633020022,-0.0199582152740306,-0.000975002459645755,0.030687444940349
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN1,Contactin-1,40536,0.005380575868116,0.002493137032823,0.000494027283782925,0.0102671244524491,0.0309305431461001
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.0160487422827459,0.00747947898441489,-0.0307085210921991,-0.00138896347329272,0.0319148781283821
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,0.00678423503215338,0.00316539351577666,0.00058006374123112,0.0129884063230756,0.0321083222313198
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,0.011117703223905,0.00518909507317194,0.00094707688048799,0.021288329567322,0.0321676679988899
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,0.00499215095570624,0.00233206007362187,0.000421313211407373,0.00956298870000511,0.0323197457696048
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,37998,0.00408139646168431,0.00191648957340665,0.00032507689780727,0.00783771602556135,0.0332208918595944
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF12,Fibroblast growth factor 12,37598,0.00928136896619145,0.00437666663160689,0.000703102368241938,0.017859635564141,0.0339701140660894
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SATB1,DNA-binding protein SATB1,37959,0.00577714777443679,0.00272633517703935,0.000433530827439668,0.0111207647214339,0.0341073157883374
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,0.00782969969082459,0.00369902929223441,0.00057960227804514,0.015079797103604,0.0343017469007944
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00452306584409832,0.00213951973700258,-0.00871652452862338,-0.000329607159573261,0.0345287095659309
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOS1,"Nitric oxide synthase, brain",39961,-0.00951927869516411,0.00451652526917371,-0.0183716682227446,-0.000666889167583638,0.0350768170427042
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00863134260669269,0.00409839042196459,0.000598497379642099,0.0166641878337433,0.0352200314276869
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",37541,-0.0117167530563374,0.0055795654573446,-0.0226527013527328,-0.000780804759942005,0.0357532041638735
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMI,N-myc-interactor,37857,0.0135820164293205,0.00647880885835206,0.000883551066950419,0.0262804817916905,0.0360675869704173
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRND,Prion-like protein doppel,37942,-0.0101509045621437,0.00486071254463367,-0.0196779011496257,-0.000623907974661738,0.0367843193703582
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",37562,0.0109048906212031,0.00522976432029608,0.00065455255342277,0.0211552286889834,0.03707415883648
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE6,Ribonuclease K6,37917,0.00552686328766936,0.00266857775008066,0.000296450897511258,0.0107572756778275,0.0383694403547758
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RCC1,Regulator of chromosome condensation,37900,0.00958180146489367,0.00462715503885057,0.000512577588746543,0.0186510253410408,0.0383987706509741
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEDD9,Enhancer of filamentation 1,37598,0.006202374634558,0.00299690276352737,0.000328445218044365,0.0120763040510716,0.0385097869042761
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,-0.0129404770240976,0.00625709075291858,-0.025204374899818,-0.000676579148377151,0.0386468743416764
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOX2,Transcription factor SOX-2,37937,0.00436370740624809,0.00211217849364668,0.000223837558700607,0.00850357725379558,0.0388499198427969
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OPTC,Opticin,40305,0.00840964922527977,0.00407645041363891,0.000419806414547504,0.016399492036012,0.0391304595201242
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC16A1,Monocarboxylate transporter 1,39961,0.0112119686331127,0.00543803738516814,0.000553415358183132,0.0218705219080422,0.039246501941339
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GZMB,Granzyme B,40341,0.0117188431449605,0.0056876468807062,0.000571055258776307,0.0228666310311446,0.0393762996655355
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNR,Tenascin-R,40228,0.00789561278346555,0.00383972995080611,0.000369742079885571,0.0154214834870455,0.0397706208244894
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,39961,0.0104133471044732,0.00506720165684296,0.000481631857060997,0.0203450623518854,0.0398909948498479
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX1B,Syntaxin-1B,37572,0.00801462732306027,0.00390064927926636,0.000369354735698216,0.0156598999104223,0.0399286605666953
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PXDNL,Peroxidasin-like protein,37900,0.0108588754209847,0.00530793469733063,0.00045532341421663,0.0212624274277527,0.0407972693617829
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,-0.0137157613889726,0.00670689340693002,-0.0268612724665554,-0.000570250311389747,0.0408688890176763
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH23,Cadherin-23,37942,-0.00488353622137516,0.00239309499049651,-0.00957400240274832,-0.000193070040002007,0.0413022733553503
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,40465,0.0074682559820753,0.00366408617564246,0.000286647077816082,0.0146498648863345,0.0415431794566908
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD70,CD70 antigen,40341,0.00765912498597179,0.00375814072708509,0.00029316916088501,0.0150250808110586,0.0415655500171151
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD55,Complement decay-accelerating factor,39802,0.00483958174220184,0.00237652931168972,0.000181584291289979,0.00949757919311369,0.0417265965123367
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.00542473085177935,0.00266607137443936,-0.0106502307456805,-0.000199230957878202,0.0418977095146031
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GZMH,Granzyme H,40042,0.0136962096637206,0.00674594137231288,0.000474164573987336,0.0269182547534538,0.0423441268915085
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMNB1,Lamin-B1,37874,0.0104621922435449,0.00515586804587596,0.000356690873627982,0.0205676936134618,0.04245949795246
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN3,Neuronal-specific septin-3,37959,-0.0135112674039848,0.0066745269998392,-0.0265933403236697,-0.000429194484300009,0.0429585898694224
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JCHAIN,Immunoglobulin J chain,40044,-0.0112981645597128,0.00558778691692414,-0.0222502269168841,-0.000346102202541481,0.0431996934030382
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,0.0173486914992558,0.00859459057820002,0.000503293965983746,0.0341940890325278,0.0435528462400775
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,0.0163141682477149,0.00808331582232381,0.000470869235960222,0.0321574672594695,0.0435854746620711
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMBN,Ameloblastin,40044,-0.00541015804696449,0.00268593525611266,-0.0106745911489453,-0.000145724944983673,0.0439999260855575
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,0.0112916092726076,0.00560847491163485,0.000298998445803266,0.0222842200994119,0.0441021238397164
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,37714,0.00687483513433789,0.00341562321818501,0.000180213626695266,0.0135694566419805,0.0441598919436475
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,37598,0.00672894310413143,0.00335129217604337,0.000160410439086435,0.0132974757691764,0.0446780349261041
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTP1,Glutathione S-transferase P,39871,-0.012676034792766,0.00632495198862203,-0.0250729406904652,-0.000279128895066798,0.0450734458640132
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCN,Decorin,40042,-0.00412654083284654,0.00206184567217163,-0.00816775835030294,-8.5323315390142e-05,0.0453685376903977
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,0.00998646828462389,0.00500524659418864,0.000176184960014147,0.0197967516092336,0.0460385300966493
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,40332,0.00776517704716465,0.00389251430578425,0.000135849007827519,0.0153945050865018,0.0460708409244706
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCG3,Secretogranin-3,40379,-0.00599394880194144,0.00301225881156189,-0.0118979760726028,-8.99215312801255e-05,0.0466243260898395
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SBSN,Suprabasin,37977,-0.00604026243241817,0.00303950790126184,-0.0119976979188914,-8.28269459449598e-05,0.0469148233867853
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL14,C-X-C motif chemokine 14,40044,0.0110333824818464,0.00555940066973314,0.000136957169169484,0.0219298077945234,0.0472025669627633
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,-0.00892468620246457,0.00450442920665796,-0.0177533674475142,-9.60049574149791e-05,0.0475733267869754
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLIC5,Chloride intracellular channel protein 5,37572,-0.00578683322451487,0.00292904977675597,-0.0115277707869566,-4.58956620731782e-05,0.0482131840870065
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,40422,-0.00482113405777892,0.0024436983794873,-0.00961078288157403,-3.1485233983811e-05,0.0485259696100971
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,39980,0.00954000905688964,0.00486384986182799,6.86332770677076e-06,0.0190731547860725,0.0498489290376219
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCC,Netrin receptor DCC,37572,0.00414952668404177,0.00212036520138244,-6.38911066780379e-06,0.00830544247875134,0.0503701978448798
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,-0.010900221463464,0.00557040978188232,-0.0218182246359534,1.77817090253139e-05,0.0503912951023267
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,0.00605127233780139,0.00309783059732901,-2.04756329634714e-05,0.0121230203085663,0.0507908446268157
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSPN,Persephin,40341,0.0175248209332204,0.00898381107734261,-8.34487783711348e-05,0.0351330906448119,0.0511089646418892
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UNG,Uracil-DNA glycosylase,37900,0.00598316719003287,0.00306997133261117,-3.39766218850181e-05,0.0120003110019507,0.0513242396874954
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNL1,Interferon lambda-1,39961,-0.00799093988879504,0.00410522552775809,-0.0160371819232009,5.530214561081e-05,0.0516092789841333
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,0.0106491630844933,0.00548858994134572,-0.000108473200544336,0.0214067993695309,0.0523687380022331
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GH2,Growth hormone variant,39980,0.0295887027688126,0.0152708083605628,-0.000342081617890466,0.0595194871555157,0.0526902753006476
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAT1,Diamine acetyltransferase 1,37562,-0.00919700100108331,0.00474811499679816,-0.0185033063948077,0.000109304392641073,0.0527693168291406
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN3B,Sodium channel subunit beta-3,37541,0.00806240561655329,0.00416426930597633,-9.95622231603228e-05,0.0162243734562669,0.0528780215306023
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECTIN4,Nectin-4,40411,-0.00534367105081439,0.00276239702047092,-0.0107579692109374,7.06271093086153e-05,0.0530776060424034
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.0149404220324006,0.00772352138356157,-0.0300785239441813,0.000197679879380063,0.053084244246285
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STC2,Stanniocalcin-2,40309,-0.00471945004813393,0.00245320895063245,-0.00952773959137354,8.88394951056807e-05,0.0543992407814139
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,37942,-0.0123980178245811,0.00644967049553097,-0.0250393719958218,0.000243336346659564,0.0545926387675714
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,0.00649341812933637,0.00338025786075381,-0.000131887277741102,0.0131187235364138,0.0547524560593897
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,40341,0.00696806926971685,0.00362854342324513,-0.000143875839843605,0.0140800143792773,0.0548317264517239
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,37562,0.00571718338880652,0.0029815892826369,-0.000126731605161799,0.0115610983827748,0.055196744762389
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSPN,Claspin,39925,0.00591580612528629,0.00309124246607762,-0.000143029108225836,0.0119746413587984,0.0556729830044367
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.00614089705384612,0.00321083746752354,-0.000152344382500025,0.0124341384901923,0.0558270426782836
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00439436094022206,0.00231316227569757,-0.000139437120145174,0.00892815900058929,0.0574880179646831
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HIP1,Huntingtin-interacting protein 1,37562,0.00586632418805036,0.00309401110618843,-0.000197937580078951,0.0119305859561797,0.0579786302820712
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACHE,Acetylcholinesterase,37671,-0.00547474344319586,0.00289213881631683,-0.0111433355231768,0.00019384863678513,0.0583831560392215
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA11,Serpin A11,40536,0.00686438961024151,0.0036274685471924,-0.0002454487422556,0.0139742279627386,0.0584641580012879
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR101,Probable G-protein coupled receptor 101,37541,-0.0110505590022981,0.00585738396584673,-0.0225310315753577,0.000429913570761508,0.0592358378719519
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,0.0049990783942747,0.00265110493120664,-0.000197087270890319,0.0101952440594397,0.059359001725149
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUMF1,Formylglycine-generating enzyme,37598,0.01148578406235,0.00609129621904064,-0.000453156526969624,0.0234247246516697,0.0593701122665093
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,-0.0111158763230279,0.00591465004425507,-0.0227085904097678,0.000476837763712074,0.0602147926423603
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,40044,0.007860619899504,0.00418529073912248,-0.000342549949176062,0.0160637897481841,0.0603787681747917
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,0.00879481631486379,0.00468397096399525,-0.000385766774566896,0.0179753994042945,0.0604519063167084
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.0142473550464528,0.00759296787612069,-0.000634861990743786,0.0291295720836493,0.060624178442187
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,40451,-0.0072408863281833,0.00386454785755368,-0.0148154001289885,0.00033362747262191,0.0609941747098233
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,37541,0.0202957959421752,0.0108379560101954,-0.00094659783780765,0.0415381897221581,0.0611377620062534
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL9,C-X-C motif chemokine 9,40422,0.0113897529791254,0.00611441306960497,-0.000594496637300346,0.0233740025955511,0.0625128008669475
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HBQ1,Hemoglobin subunit theta-1,40489,-0.00994102451008481,0.00533943750626556,-0.0204063220223653,0.000524273002195678,0.0626479869382119
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,-0.00577417597396093,0.00310541333626349,-0.0118607861130374,0.0003124341651155,0.0629942331795634
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,37714,-0.00767107066690203,0.00412763403219489,-0.015761233370004,0.00041909203619996,0.0631248982715973
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FBLN2,Fibulin-2,37998,-0.00513944383365776,0.00279154177414758,-0.010610865710987,0.000331978043671511,0.0656321046055738
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,-0.00456129599962034,0.00248067992050272,-0.00942342864380566,0.000300836644564985,0.0659738936203275
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM26,Tripartite motif-containing protein 26,37482,0.00918577399581321,0.00499744969231895,-0.000609227401131937,0.0189807753927584,0.0660715503673604
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSTN,Osteocrin,37572,-0.0071485468845806,0.00390816515573074,-0.0148085505898128,0.000511456820651642,0.0674026388177639
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSM,Oncostatin-M,40268,-0.0119782156107311,0.00655413194374294,-0.0248243142204672,0.000867882999005091,0.0676310935002396
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,40379,0.00521420733562955,0.00286001078706942,-0.000391413807026514,0.0108198284782856,0.0683005407750471
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK15,Kallikrein-15,37880,0.00845443914174849,0.00464005906684754,-0.000640076629272693,0.0175489549127697,0.068468994369296
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VCAN,Versican core protein,40471,-0.00494672974108286,0.00271595571694064,-0.0102700029462865,0.00037654346412079,0.0685709821396072
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,-0.00528529666454814,0.00291629862887302,-0.0110012419771393,0.00043064864804299,0.0699580085324335
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00931601481037383,0.00514340670165721,-0.0007650623248743,0.019397091945622,0.0701244904241681
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD177,CD177 antigen,40316,-0.0208836648346399,0.0115464595164707,-0.0435147254869224,0.00174739581764267,0.070522155208914
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSB,Lupus La protein,39961,0.00989359774783864,0.00547188809205103,-0.000831302912581383,0.0206184984082587,0.070613802263192
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM2,Intercellular adhesion molecule 2,40536,-0.00507352790996699,0.00281439061898328,-0.0105897335231742,0.000442677703240241,0.0714526050754578
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENOPH1,Enolase-phosphatase E1,37900,0.00932008948192107,0.00519377717632235,-0.000859713783670739,0.0194998927475129,0.0727602611588384
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,39961,0.00621529873330273,0.00349237066233126,-0.000629747764866531,0.013060345231472,0.0751480851088809
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,39980,-0.00751000034999473,0.0042332529010623,-0.0158071760360768,0.000787175336087382,0.07607454857087
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYH4,Myosin-4,37562,-0.00766648938540311,0.00432514697767921,-0.0161437774616544,0.000810798690848143,0.0763284338186754
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADA2,Adenosine deaminase 2,40258,-0.00671005191672617,0.00378725227565436,-0.0141330663770087,0.00071296254355637,0.0764558681317293
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,-0.00611779067431464,0.00347153275366923,-0.0129219948715063,0.000686413522877044,0.0780463747126401
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18BP,Interleukin-18-binding protein,40403,0.00482841179536606,0.00275360167065106,-0.000568647479110011,0.0102254710698421,0.079537214687123
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,-0.00520273107869844,0.00296710722460931,-0.0110182612389327,0.000612799081535807,0.0795408292924495
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYH7B,Myosin-7B,37482,-0.00727579273236319,0.00415320650932078,-0.0154160774906319,0.000864492025905534,0.0798232139363197
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,-0.00666101327782048,0.00380318343166936,-0.0141152528038924,0.000793226248251463,0.0798910049520186
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,36973,0.00797814666689286,0.00455533210789842,-0.000950304264588038,0.0169065975983738,0.079903858537752
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAMDC2,MAM domain-containing protein 2,37990,-0.00537074822300469,0.003074827890967,-0.0113974108893,0.00065591444329064,0.0807150964533453
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,-0.0076772741399647,0.0044067628269884,-0.016314529280862,0.000959981000932556,0.0815043695992179
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNN,Tenascin-N,37998,0.0068968250635171,0.00396158895709814,-0.000867889292395264,0.0146615394194295,0.0817196157131768
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,37900,0.00905980231567966,0.00521100760457642,-0.00115377258929013,0.0192733772206494,0.0821299073072936
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM4,Intercellular adhesion molecule 4,40341,-0.00828427367153779,0.00476939698201295,-0.0176322917562832,0.0010637444132076,0.0824128006686218
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,-0.00414713139265115,0.0023911346932542,-0.00883375539142938,0.000539492606127076,0.0828704420730761
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTO1,Protein LTO1 homolog,40044,0.00645090092479255,0.00372476298189511,-0.000849634519721873,0.013751436369307,0.0833119154433718
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNPEP,Aspartyl aminopeptidase,37942,0.00926830588166959,0.00537832172900358,-0.00127320470717743,0.0198098164705166,0.0848624439544133
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FRMD7,FERM domain-containing protein 7,37572,0.00520192623046067,0.00302228864673796,-0.000721759517145722,0.0111256119780671,0.0852403326061432
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.00898530703382654,0.00525362618341815,-0.00131180028567304,0.0192824143533261,0.0872330485118163
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17A,Interleukin-17A,40028,-0.00659245774597958,0.00386022837329391,-0.0141585053576357,0.000973589865676492,0.0876953224089859
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,37562,-0.0111075906606892,0.00654030739679058,-0.0239265931583987,0.00171141183702037,0.0894695021179898
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F3,Tissue factor,40393,-0.00430219533865858,0.00253720057653635,-0.00927510846866983,0.00067071779135266,0.0899723690289291
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPEP2,Dipeptidase 2,40305,0.00439925195211604,0.00259454921647666,-0.00068606451217821,0.0094845684164103,0.0899860929791502
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHPK,Sedoheptulokinase,37714,-0.00658411970195614,0.00388511742024072,-0.0141989498456279,0.00103071044171566,0.0901552754418345
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FMR1,Synaptic functional regulator FMR1,39980,0.00537995043958841,0.0031769319672735,-0.000846836216267649,0.0116067370954445,0.0903913983534414
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA10,Annexin A10,39961,-0.0126521258528237,0.00747601959287931,-0.0273051242548671,0.00200087254921973,0.090597202843666
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,-0.00877734719596061,0.00519048333404655,-0.0189506945306918,0.00139600013877063,0.0908475661816553
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.0117395565158778,0.00694397875536444,-0.0253497548763921,0.00187064184463651,0.0909314771784448
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RALY,RNA-binding protein Raly,37900,0.00735757443684295,0.00436846262114786,-0.00120461230060685,0.0159197611742927,0.0921569562958989
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,0.00739997968159042,0.00439434466574197,-0.00121293586326383,0.0160128952264447,0.0922090293157813
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP6,Guanylate-binding protein 6,37562,-0.00726348205621129,0.00431528782489293,-0.0157214461930014,0.00119448208057885,0.0923606574790335
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD248,Endosialin,37998,-0.00608641709513118,0.0036241657099308,-0.0131897818865955,0.00101694769633318,0.0930975402459578
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCAM2,Neural cell adhesion molecule 2,40332,-0.00408163791285362,0.00243946841238125,-0.00886299600112087,0.000699720175413622,0.094314132056145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,37998,0.0046520415975504,0.00279477201813122,-0.000825711557986779,0.0101297947530876,0.0960254215625465
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,0.00428068763292214,0.00257478623753335,-0.000765893392643235,0.00932726865848751,0.0964276585256953
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,40373,0.00403746011189543,0.0024286904298245,-0.000722773130560597,0.00879769335435145,0.0964518599987353
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFD,Complement factor D,38013,0.00286396438305881,0.00172372046014191,-0.000514527718819338,0.00624245648493695,0.0966358531681758
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PADI4,Protein-arginine deiminase type-4,39934,0.0104365475997334,0.00628727647722749,-0.00188651429563253,0.0227596094950992,0.0969453073706322
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,37901,0.00734486606457854,0.00443728076897404,-0.00135220424261058,0.0160419363717677,0.0978945208536839
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,-0.00826016867908063,0.00499497463466003,-0.0180503189630143,0.00152998160485303,0.0982133121631942
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,40341,0.00791080987146933,0.00479557996639153,-0.00148852686265806,0.0173101466055967,0.0990436391132284
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,40403,-0.00494445597433457,0.00300190362531961,-0.010828187079961,0.00093927513129187,0.099555786721233
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,37482,0.00615973898440705,0.00374977485807579,-0.00118981973742151,0.0135092977062356,0.100470041230785
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,-0.00690387376573517,0.00420288541281595,-0.0151415291748544,0.00133378164338411,0.100475442986856
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,37942,-0.0097087852135202,0.00593960815494476,-0.0213504171972119,0.00193284677017153,0.102159731539813
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPM1B,Protein phosphatase 1B,37598,0.00939421903966171,0.00575800870779771,-0.00189147802762181,0.0206799161069452,0.102807793885702
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDHR1,Cadherin-related family member 1,39961,0.00648742223177332,0.00398124370234775,-0.00131581542482828,0.0142906598883749,0.103228287677497
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,-0.00291460286912808,0.00179877919181748,-0.00644021008509034,0.000611004346834194,0.105182851062446
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.00399931440171093,0.00247856799498284,-0.000858678868455436,0.00885730767187729,0.106642846790127
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,37572,0.00427553651787375,0.00267772269296597,-0.000972799960339553,0.00952387299608705,0.110355288818633
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB116,Beta-defensin 116,37541,-0.0114573988300946,0.00717613714558536,-0.0255226276354419,0.00260782997525274,0.110379715292966
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCL2,Phosducin-like protein 2,37482,0.00781222277492642,0.00490244581298274,-0.00179657101851976,0.0174210165683726,0.111064305060279
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA8,Carbonic anhydrase-related protein,37598,-0.00402216500460046,0.00252555674042994,-0.00897225621584314,0.000927926206642218,0.111277254580354
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.00621213963085966,0.00390419788617773,-0.00144008822604868,0.013864367487768,0.111597634768658
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,0.00982388937516797,0.00619510605145717,-0.00231851848568808,0.021966297236024,0.112819545678289
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,37987,0.00501788467634083,0.00316640885517422,-0.00118827667980065,0.0112240460324823,0.113052377703788
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB118,Beta-defensin 118,37541,0.00833988956548562,0.00528608354125765,-0.00202083417537937,0.0187006133063506,0.114657165862192
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00416298445711599,0.00264467954131593,-0.00102058744386323,0.0093465563580952,0.11548511198191
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,37598,0.00420013211810047,0.0026713005032849,-0.00103561686833794,0.00943588110453888,0.115901037758477
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP350,Centrosome-associated protein 350,37482,0.0053291227841959,0.00340706581524389,-0.00134872621368213,0.0120069717820739,0.117809332829146
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHRDL2,Chordin-like protein 2,40359,-0.00803548135286555,0.00514297784843957,-0.0181157179358071,0.00204475523007601,0.118209433719064
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMMD9,COMM domain-containing protein 9,37900,0.0055518169389914,0.00355513585847591,-0.00141624934362139,0.0125198832216042,0.118398037002513
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP152,Centrosomal protein of 152 kDa,37482,0.00588935864507971,0.00377490134091938,-0.00150944798312228,0.0132881652732817,0.118752083882686
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,0.00452230293157195,0.00290119322163566,-0.00116403578283393,0.0102086416459778,0.119070311440885
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP1,"Fatty acid-binding protein, liver",40357,-0.0130755939115281,0.00839028853136303,-0.0295205594329997,0.00336937160994341,0.119153601995026
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDN1,Endothelin-1,37628,0.00410057615367506,0.0026335026554966,-0.00106108905109828,0.00926224135844839,0.119475344461331
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMA1,Proteasome subunit alpha type-1,39980,-0.00653836768166663,0.00421264136972363,-0.0147951447663249,0.00171840940299168,0.12066282277887
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17RA,Interleukin-17 receptor A,40332,0.00614640800042219,0.00396458225861181,-0.00162417322645696,0.0139169892273013,0.121082428307869
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEX101,Testis-expressed protein 101,37572,0.00552811607776039,0.00356753189026431,-0.00146424642715766,0.0125204785826784,0.121270514770974
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,39980,0.00722066016617213,0.00466193379282136,-0.00191673006775774,0.016358050400102,0.121436923713791
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,0.00965140970058448,0.00627761608834192,-0.00265271783256568,0.0219555372337346,0.124207883489965
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDC1,Syndecan-1,40359,0.00554426856385138,0.00361447070543557,-0.00154009401880233,0.0126286311465051,0.125071968788862
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.0045791177479538,0.00299612285196874,-0.00129328304190492,0.0104515185378125,0.126449655559626
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B4,Protein ATP1B4,37482,-0.0058655737866444,0.00384336828491465,-0.0133985756250771,0.00166742805178832,0.126995664247831
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,40296,0.00659607294769139,0.0043317658725754,-0.00189418816255639,0.0150863340579392,0.127848358494494
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,40359,0.00435377751949401,0.00286526271719087,-0.00126213740620008,0.00996969244518811,0.128655612908434
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,-0.0116788064629388,0.00770180940079657,-0.0267743528885001,0.00341673996262251,0.129445263077311
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.0132391432924225,0.00878505391274515,-0.030457848961403,0.00397956237655801,0.131832795586666
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.00781078906219378,0.00518398085060682,-0.00234981340499559,0.0179713915293831,0.131907493896251
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OLFM4,Olfactomedin-4,37177,0.0168217661177264,0.0111653914394741,-0.00506240110364289,0.0387059333390956,0.131938330192963
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,37541,-0.00684775297138755,0.00454953240871574,-0.0157648364924704,0.00206933054969531,0.132308275310834
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",37562,-0.00669894231895118,0.00445505513316188,-0.0154308503799485,0.00203296574204612,0.132689892297407
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA6,Carbonic anhydrase 6,40295,-0.00865266685225419,0.00575941232155445,-0.0199411150025009,0.00263578129799254,0.133026056337707
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAP1,Antigen peptide transporter 1,37714,-0.00839189143393944,0.00558946406245344,-0.0193472409963482,0.0025634581284693,0.133281949165865
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A14,Protein S100-A14,37959,0.00729074037731092,0.00486669076542411,-0.00224797352292033,0.0168294542775422,0.13413325834286
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP290,Centrosomal protein of 290 kDa,37714,0.00722364043151555,0.00483035162650121,-0.00224384875642683,0.0166911296194579,0.134815915817502
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD4,Sushi domain-containing protein 4,37900,-0.0060390568869192,0.00404100173935117,-0.0139594202960475,0.00188130652220908,0.135082678111221
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YY1,Transcriptional repressor protein YY1,37598,0.00378955924339452,0.00254953934056708,-0.00120753786411695,0.00878665635090599,0.137205214797586
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DENND2B,DENN domain-containing protein 2B,37562,-0.00708791205036938,0.00477098309583556,-0.0164390389182071,0.00226321481746833,0.137401258341197
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,-0.00452002544836705,0.00304715168431709,-0.0104924427496286,0.00145239185289446,0.138002607682697
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,40411,-0.00364317161164087,0.00245625671624634,-0.00845743477548369,0.00117109155220196,0.138035443289741
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHP1,Calcineurin B homologous protein 1,37541,0.0098175317505417,0.00662279280594777,-0.00316314214911593,0.0227982056501993,0.138261835594309
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,0.0139775796245381,0.00945417881159583,-0.00455261084618972,0.0325077700952659,0.139305950175119
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.0152446354575355,0.0103116957955739,-0.00496628830178932,0.0354555592168603,0.139328619169673
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF8,SLAM family member 8,39980,0.00712113853778612,0.0048391893536873,-0.00236367259544099,0.0166059496710132,0.141161056916468
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRAL,GDNF family receptor alpha-like,37477,-0.00825283725353335,0.00561507666855613,-0.0192583875239034,0.00275271301683666,0.141649849685146
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.00839966842715262,0.00572128626945864,-0.00281405266098631,0.0196133895152916,0.142089277760206
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARG1,Arginase-1,40227,0.00699780469405362,0.00478155583111477,-0.00237404473493133,0.0163696541230386,0.143350667638746
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,40335,-0.00593006044690063,0.0040557541492965,-0.0138793385795218,0.0020192176857205,0.14372398031318
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZPR1,Zinc finger protein ZPR1,37541,0.0128706967608708,0.00881818475524802,-0.00441294535941536,0.0301543388811569,0.144434195208846
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,37598,0.00270381779885489,0.0018567775152047,-0.000935466130946312,0.0063431017286561,0.14536443876708
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00846089330914027,0.00584522433190378,-0.00299574638139114,0.0199175329996717,0.147783873339449
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,-0.00788249038358944,0.0054462652272503,-0.018557170229,0.00279218946182114,0.147831138566763
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",40293,-0.00752959157604724,0.00522329940733716,-0.0177672584144281,0.0027080752623336,0.14945213933165
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB5,Integrin beta-5,40411,0.00482515696208041,0.00334822529578147,-0.00173736461765128,0.0113876785418121,0.149573565542104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,37598,0.00891729194539412,0.00619822050025567,-0.00323122023510699,0.0210658041258952,0.150263365466454
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFF2,Trefoil factor 2,40396,-0.00739906358518762,0.00514700080976287,-0.0174871851723228,0.00268905800194761,0.150581810895166
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDAN1,Codanin-1,37942,0.00301234668521512,0.00210259531268456,-0.00110874012764662,0.00713343349807686,0.15197242090749
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,37482,-0.0042378759617896,0.00295817864319499,-0.0100359061024518,0.00156015417887259,0.151997211812491
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL19,Interleukin-19,39924,-0.00877549715461815,0.00613248910121958,-0.0207951757930085,0.00324418148377223,0.152454839952078
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD2,T-cell surface antigen CD2,37562,0.00495161942520191,0.00347107419587349,-0.00185168599871013,0.0117549248491139,0.153736904038113
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,0.0045467601443638,0.00318889769133636,-0.00170347933065547,0.0107969996193831,0.153947125467714
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TYMP,Thymidine phosphorylase,40257,0.00856935348327821,0.00602021575260607,-0.00323026939182969,0.0203689763583861,0.154631387380685
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.00819644224091731,0.00577453483242159,-0.00312164603062902,0.0195145305124636,0.155802840348889
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00464555692332488,0.00327424464759665,-0.00177196258596455,0.0110630764326143,0.155975866320827
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WNT9A,Protein Wnt-9a,40044,0.0036753074719089,0.00259422820914783,-0.00140937981802085,0.00875999476183865,0.156583378561416
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,40403,0.00351489779946291,0.00248534142608273,-0.00135637139565924,0.00838616699458507,0.157307594287364
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GKN1,Gastrokine-1,39602,0.00356163168159498,0.0025301009855216,-0.00139736625002735,0.00852062961321732,0.159239441075206
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFDN4,Prefoldin subunit 4,37482,0.00688469856480782,0.0049405585861793,-0.00279879626410361,0.0165681933937192,0.163490567199852
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A3,Protein S100-A3,37900,0.00578969129868204,0.00416126449328577,-0.00236638710815807,0.0139457697055221,0.164148456345254
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,40042,0.00796864378372569,0.00574676593784477,-0.00329501745445005,0.0192323050219014,0.165574138446013
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,37562,-0.00490671493375183,0.00353971419427586,-0.0118445547545325,0.00203112488702887,0.165712597087799
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPN1,Epsin-1,37714,0.00553773812378376,0.00400880109034265,-0.00231951201328783,0.0133949882608554,0.167180788632628
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,37541,0.013515988309811,0.00981304905808893,-0.00571758784404328,0.0327495644636653,0.168428081691329
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRN1,Neuritin,37959,-0.0045667769288367,0.00331710191025723,-0.0110682966729409,0.00193474281526747,0.16861639402415
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRING1,SREBP regulating gene protein,37482,0.00720766610627842,0.00523574332215365,-0.00305439080514274,0.0174697230176996,0.168651223497299
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABO,Histo-blood group ABO system transferase,37987,0.0178514091559689,0.0130664128132453,-0.00775875995799192,0.0434615782699298,0.171897070477288
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCUN1D2,DCN1-like protein 2,37482,0.0100203482650768,0.00735316078439578,-0.00439184687233892,0.0244325434024925,0.172992221784152
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,37628,0.00463754308034113,0.00340452142331963,-0.00203531890936535,0.0113104050700476,0.173166958198787
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROK1,Prokineticin-1,40341,-0.00847169310894416,0.00622590384692713,-0.0206744646489213,0.00373107843103302,0.173622445428602
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,0.00327117317901394,0.00240785087680007,-0.0014482145395142,0.00799056089754207,0.174314409738084
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC44A4,Choline transporter-like protein 4,37572,-0.00862346936057977,0.00636334793742506,-0.0210956313179329,0.00384869259677336,0.175384171315303
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.00403199552189699,0.00297767892178458,-0.00180425516480079,0.00986824620859477,0.175732620621696
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VIM,Vimentin,40042,0.0144126823760287,0.0107113422863843,-0.00658154850528458,0.0354069132573421,0.178466177394965
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMY2A,Pancreatic alpha-amylase,39695,0.00573294860718421,0.0042620291885779,-0.00262062860242847,0.0140865258167969,0.178605897865588
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFD,Vascular endothelial growth factor D,40483,-0.00404552452578744,0.00300886980522547,-0.00994290934402936,0.00185186029245449,0.178795139894399
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CADPS,Calcium-dependent secretion activator 1,37572,-0.00549062014161326,0.00409033805246382,-0.0135076827244423,0.00252644244121583,0.179509341478965
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB5,Serpin B5,40042,-0.00592462789891561,0.0044161940736169,-0.0145803682832047,0.00273111248537351,0.179755409959405
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,-0.00463035149298191,0.00346623963763497,-0.0114241811827465,0.00216347819678264,0.181619752253534
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAFB2,Scaffold attachment factor B2,37959,0.00334050974091927,0.00250641253859809,-0.00157205883473297,0.00825307831657152,0.18262475838882
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NLGN1,Neuroligin-1,37572,-0.00839585684895986,0.00633029242686342,-0.0208032300056122,0.00401151630769245,0.184763956582873
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,0.0106768549115948,0.00806179867894224,-0.005124270499132,0.0264779803223216,0.185401196741193
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00608581503216211,0.00459840605416971,-0.00292706083401052,0.0150986908983347,0.185705052101309
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD33,Myeloid cell surface antigen CD33,40411,0.00946092453074422,0.00717431289829703,-0.00460072874991796,0.0235225778114064,0.187280979235188
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,0.00503355126295928,0.00382921834971701,-0.00247171670248606,0.0125388192284046,0.188697037170223
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP73,Tumor protein p73,37572,0.004160063295376,0.00317572403062411,-0.00206435580464726,0.0103844823953993,0.190233171620331
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,37541,0.00732339216449573,0.00560060948052334,-0.00365380241733001,0.0183005867463215,0.191029850292115
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNL1,Thioredoxin-like protein 1,37525,0.0112964577810816,0.00864767726899578,-0.00565298966615014,0.0282459052283133,0.191473658547126
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH4,Cadherin-4,37541,0.00586717507341117,0.00449298107327224,-0.00293906783020242,0.0146734179770248,0.191625330958243
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD200,OX-2 membrane glycoprotein,40341,0.00306155097470433,0.00235085987501502,-0.00154613438032512,0.00766923632973377,0.192828926047975
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,40044,-0.0037502500220292,0.00288250438405953,-0.00939995861478589,0.00189945857072748,0.193264402627077
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MN1,Transcriptional activator MN1,37572,-0.00704165912264275,0.00541863482437594,-0.0176621833784196,0.0035788651331341,0.193786165193298
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOA1,Apolipoprotein A-I,38013,-0.00322637793244615,0.00249588138719221,-0.00811830545134287,0.00166554958645057,0.196143506909234
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,37598,0.00499741107037744,0.00387466388084126,-0.00259693013607143,0.0125917522768263,0.197154485605647
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBH,Dopamine beta-hydroxylase,37967,0.0121369382508398,0.00956036875380583,-0.00660138450661959,0.0308752610082993,0.204282781514915
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,-0.0136553429238341,0.0107658291755387,-0.0347563681078901,0.00744568226022177,0.20467488936809
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RELB,Transcription factor RelB,37598,0.00593683144517531,0.00468116684931869,-0.00323825557948932,0.0151119184698399,0.204735600216232
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.00792335301390366,0.00625406476534965,-0.00433461392618165,0.020181319953989,0.205208412455438
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALM3,Paralemmin-3,37562,0.00834580124666933,0.00659024884404842,-0.00457108648766557,0.0212626889810042,0.205397291920511
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRA3,GDNF family receptor alpha-3,40194,0.00327100459501918,0.00258354711285983,-0.00179274774618609,0.00833475693622444,0.205499399625344
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,0.0047978315134187,0.00379144291657171,-0.00263339660306185,0.0122290596298993,0.205733377202005
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAGLN3,Transgelin-3,37482,-0.00697996339656281,0.00554566477354355,-0.0178494663527082,0.00388953955958254,0.208185035000312
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA7A,Semaphorin-7A,40490,0.00305422871241488,0.00242995501069033,-0.00170848310853817,0.00781694053336792,0.208805431900758
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAPPA,Pappalysin-1,40044,0.00534652026784874,0.00425500868211275,-0.00299329674909224,0.0136863372847897,0.208944896840161
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDAC8,Histone deacetylase 8,37598,0.00710220475385845,0.00567960512660803,-0.00402982129429329,0.0182342308020102,0.211148304974108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",37562,0.00434791150442038,0.00348425548673643,-0.00248122924958302,0.0111770522584238,0.212099525440259
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNF75D,Zinc finger protein 75D,37714,0.00671988196260577,0.00539299115280177,-0.00385038069688571,0.0172901446220972,0.212771771102416
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXDC2,Plexin domain-containing protein 2,37942,0.00301094273782563,0.00241877023814175,-0.00172984692893221,0.00775173240458346,0.213218153487375
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP7,Retinoid-binding protein 7,37901,-0.00656130867403437,0.00528899800950938,-0.0169277447726728,0.00380512742460402,0.214790724582384
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00475183712291445,0.00383818212783163,-0.0122746740934644,0.00277099984763555,0.215722018391064
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,37901,0.00566996382896767,0.00458125672133875,-0.00330929934485628,0.0146492270027916,0.215869784546824
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNG,Interferon gamma,40044,0.0127057481860613,0.0102773590943635,-0.00743787563889115,0.0328493720110137,0.216371148427364
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,0.00294933449353779,0.00238891347526653,-0.00173293591798461,0.00763160490506018,0.217000526779291
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF20,Fibroblast growth factor 20,37598,0.00500817568987014,0.00405948634052799,-0.00294841753756472,0.012964768917305,0.217337928021013
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,37572,0.00402777541155479,0.00327125854276104,-0.00238389133225686,0.0104394421553664,0.218247065051347
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEG1,Protein LEG1 homolog,37231,-0.00775729060835046,0.00630888893164616,-0.0201227129143769,0.00460813169767601,0.218876647730677
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,-0.00552173754070383,0.00450163750183672,-0.0143449470443038,0.00330147196289614,0.219992712544751
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,0.00642416111935215,0.00523746344153569,-0.0038412672260578,0.0166895894647621,0.220003041447464
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL20,Interleukin-20,40044,0.00564947611731341,0.00461700093338164,-0.00339984571211461,0.0146987979467414,0.221112349912266
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,0.00398501567767807,0.00325983595565435,-0.00240426279540445,0.0103742941507606,0.22155583879603
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.00868476504054268,0.00712230634881309,-0.00527495540313098,0.0226444854842163,0.222723669293735
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDK1,Cyclin-dependent kinase 1,37482,0.0040486896457686,0.00332529394470563,-0.00246888648585443,0.0105662657773916,0.223419588715237
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.00554761744897895,0.00456667342445369,-0.00340306246295028,0.0144982973609082,0.224458676830833
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.00399940559499502,0.00329480739277252,-0.00245841689483911,0.0104572280848292,0.2248263937151
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,40042,-0.00361059508447334,0.00298939153290763,-0.0094698024889723,0.00224861232002562,0.227141494983419
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEZ6L2,Seizure 6-like protein 2,40305,0.00259090538935274,0.00214820375494199,-0.00161957397033356,0.00680138474903903,0.227804679928317
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.00450383117468755,0.00374306741548506,-0.0118402433090383,0.00283258095966317,0.228902837649891
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDSN,Corneodesmosin,40456,0.004673096661759,0.00390109693837431,-0.00297305333745463,0.0123192466609726,0.230976420670069
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEZ6,Seizure protein 6 homolog,37572,-0.00339289887346355,0.00283787293577352,-0.00895512982757964,0.00216933208065255,0.231882830955386
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL10,Interleukin-10,40044,-0.00929488601988985,0.00778358679841881,-0.0245507161447907,0.00596094410501102,0.232431643371306
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.00535437139498172,0.00451975128467993,-0.00350434112299093,0.0142130839129544,0.236173165324442
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCN2,Transcobalamin-2,40497,0.00318449285722942,0.00269695108822468,-0.00210153127569096,0.00847051699014979,0.237709556779706
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,40424,0.00223441173945862,0.00189696945730249,-0.00148364839685425,0.0059524718757715,0.238860032855975
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,0.00585998502653879,0.00497593625674956,-0.00389285003669034,0.0156128200897679,0.238951673283937
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRLB,Fc receptor-like B,39980,0.00649191349992376,0.0055182938148734,-0.0043239423772281,0.0173077693770756,0.239439161802139
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,37482,-0.00388385914428682,0.00330976173675938,-0.0103709921483352,0.00260327385976156,0.240634516438229
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.00345873851082106,0.00295298625819037,-0.00232911455523207,0.00924659157687419,0.241512329420885
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIL1,Nucleotide exchange factor SIL1,37628,0.00338120231911715,0.00289736254053871,-0.00229762826033872,0.00906003289857302,0.243234244127881
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,40341,0.00481533287621093,0.00412682483059893,-0.00327324379176298,0.0129039095441848,0.243293618388092
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.00345863069578599,0.00296580533469021,-0.00235434776020683,0.00927160915177881,0.24356716938715
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AZU1,Azurocidin,39809,0.00818756222338213,0.00702881286236755,-0.00558891098685827,0.0219640354336225,0.244094954907251
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.00539382885930705,0.00463831426459543,-0.0144849248179141,0.0036972670993,0.244897087804443
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,0.00213467145685041,0.00183575219268305,-0.00146340284080836,0.00573274575450919,0.244918822950999
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.00537170463179591,0.00461962732918315,-0.0144261741969949,0.00368276493340306,0.244931632984191
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL24,Interleukin-24,40044,0.00517351854659385,0.0044643657715479,-0.00357663836564003,0.0139236754588277,0.246536151344145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,0.00309060402961658,0.00267407966026005,-0.00215059210449312,0.00833180016372627,0.247798235609258
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRP2,Neuropilin-2,40332,-0.00303293678700199,0.00262512169417991,-0.00817817530759461,0.00211230173359064,0.247964131724912
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH3,Cadherin-3,40471,0.00368780059494093,0.00320211408414079,-0.00258834300997502,0.00996394419985688,0.249471085366187
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.00524492737849785,0.00458381097901685,-0.00373934214037518,0.0142291968973709,0.25254970034422
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPESP1,Sperm equatorial segment protein 1,37990,0.00285486361326995,0.0024985450459501,-0.00204228467679225,0.00775201190333216,0.253220582406668
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.00305187945479564,0.00267268209826922,-0.00829033636740331,0.00218657745781202,0.253524531242246
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,-0.00505183626061986,0.00445119325970069,-0.0137761750496332,0.0036725025283935,0.256421288297164
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,37714,0.00558596944482174,0.00492373335708933,-0.00406454793507335,0.0152364868247168,0.256605893851087
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BSND,Barttin,37482,-0.00353201735434964,0.00311752851976868,-0.00964237325309625,0.00257833854439697,0.257254289849319
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,0.00322192802310065,0.00284702883925348,-0.00235824850183617,0.00880210454803748,0.257785725501055
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP164,Centrosomal protein of 164 kDa,40044,0.00653599176295732,0.00578849244660972,-0.00480945343239773,0.0178814369583124,0.258858089298587
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,37959,0.00382355696052238,0.00339060279999216,-0.00282202452746225,0.010469138448507,0.259469885728608
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCUN1D1,DCN1-like protein 1,37541,-0.00764194604795343,0.00678377513515924,-0.0209381453128655,0.00565425321695869,0.259973136419142
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSL5,Insulin-like peptide INSL5,37901,0.00953290359440583,0.00849920271091255,-0.00712553371898278,0.0261913409077944,0.262042675795046
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AOC3,Membrane primary amine oxidase,40403,0.00306738960674363,0.00274591910153522,-0.0023146118322654,0.00844939104575267,0.263980325648416
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC1A4,Neutral amino acid transporter A,37572,-0.00532891121927422,0.00477120160350163,-0.0146804663621374,0.00402264392358898,0.264061467904096
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLR1,Folate receptor alpha,40299,0.00286122889404681,0.00256527477306162,-0.00216670966115397,0.0078891674492476,0.264709085475146
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,0.00303187386756436,0.00272025603435381,-0.00229982795976911,0.00836357569489783,0.265061800396652
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALMS1,Alstrom syndrome protein 1,37714,0.00453467262456806,0.0040854704535392,-0.00347284946436876,0.0125421947135049,0.267040202670665
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD7,T-cell antigen CD7,37567,0.0043138154003821,0.00389154942431655,-0.00331362147127833,0.0119412522720425,0.267662621514678
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,0.0030584402102994,0.00276204692777391,-0.00235517176813746,0.00847205218873625,0.268180491395489
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHIT1,Chitotriosidase-1,40398,0.0148374881118737,0.0134936824472328,-0.0116101294847026,0.0412851057084501,0.271528375804926
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100G,Protein S100-G,37959,0.00442033531874057,0.00402678610146767,-0.00347216544013607,0.0123128360776172,0.272340736343165
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOA4,Apolipoprotein A-IV,38013,0.00365760236558441,0.00333200775123067,-0.00287313282682771,0.0101883375579965,0.272347467784743
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KDM3A,Lysine-specific demethylase 3A,37598,-0.00922376655695781,0.00841010980386594,-0.0257075817725351,0.00726004865861944,0.272771893545337
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSLNL,Mesothelin-like protein,37572,-0.00373534796326224,0.00341468121354321,-0.0104281231418069,0.00295742721528245,0.274015301550048
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.0119793871385815,0.0109607507223975,-0.00950368427731774,0.0334624585544807,0.27443933316773
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,-0.00329192485112454,0.00301593836638755,-0.00920316404924415,0.00261931434699506,0.275065342067715
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,-0.00285156743088105,0.00261284547995301,-0.00797274457158896,0.00226960970982686,0.2751289787165
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C9orf40,Uncharacterized protein C9orf40,37901,-0.00813799673892734,0.00746082525205079,-0.0227612142329469,0.00648522075509221,0.27539645091199
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,40332,-0.00518135075976591,0.00476183197616227,-0.014514541433044,0.00415183991351215,0.276567348830904
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,0.00450969540933896,0.00415233971122811,-0.00362889042466814,0.0126482812433461,0.277471847445986
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLI2,Zinc finger protein GLI2,37598,-0.00331084601464433,0.00305632218230004,-0.00930123749195241,0.00267954546266375,0.278704997545351
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PODXL2,Podocalyxin-like protein 2,40411,0.00267205092345334,0.00246671457794186,-0.00216270964931271,0.00750681149621939,0.278717011407869
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH15,Cadherin-15,40435,0.00433506140303817,0.00400205555329953,-0.00350896748142891,0.0121790902875052,0.278732138449608
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,0.00661701985211534,0.00613245614436651,-0.00540259419084302,0.0186366338950737,0.280597262920667
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSMB,Beta-microseminoprotein,40236,0.00670809124466504,0.00625323202484231,-0.00554824352402588,0.018964426013356,0.283404251489843
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPSG1,Tryptase gamma,37598,0.0026584432818877,0.00247834640875336,-0.0021991156792689,0.00751600224304429,0.283439721416066
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,37572,0.00986968978990387,0.00922091576506384,-0.00820330510962126,0.027942684689429,0.284477455858408
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00358096220631603,0.00334600357726379,-0.00297720480512099,0.0101391292177531,0.284539678220611
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,0.00275258800415367,0.00258795434952767,-0.00231980252092055,0.0078249785292279,0.287522601700959
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CORO6,Coronin-6,37541,-0.00349567892203624,0.00330538158894293,-0.00997422683636439,0.00298286899229191,0.290270144166236
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UPK3A,Uroplakin-3a,37541,0.00478483076155008,0.004542093168885,-0.00411767184946451,0.0136873333725647,0.292158005180778
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC1,Sialoadhesin,40422,-0.00411879232837715,0.00391098412956325,-0.0117843212223211,0.00354673656556681,0.292295284937187
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MBL2,Mannose-binding protein C,37810,-0.0101418222161402,0.0096480794789428,-0.0290520579948681,0.00876841356258765,0.293197130528065
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUOX2,Dual oxidase 2,40042,0.00689150040933339,0.0065610697422392,-0.00596819628545543,0.0197511971041222,0.293567845818471
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNPO1,Transportin-1,37714,0.00337554976842331,0.00321646576452599,-0.00292872313004762,0.00967982266689425,0.293985921748964
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOS,Proto-oncogene c-Fos,37457,-0.00334334054166706,0.00319196325100894,-0.00959958851364459,0.00291290743031047,0.294923298366577
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.00717384751359865,0.00685557260594114,-0.00626307479404598,0.0206107698212433,0.295383845469706
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JUN,Transcription factor AP-1,40044,0.00490294734598006,0.00469028550620102,-0.00429001224617393,0.0140959069381341,0.295881639006617
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,0.00513609514010114,0.00491594791760731,-0.00449916277840918,0.0147713530586115,0.296142882582587
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,37541,0.00411732168340523,0.003941104653277,-0.00360724343701769,0.0118418868038281,0.296175113483323
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACTN4,Alpha-actinin-4,40044,0.00306664550466268,0.00294011639313883,-0.00269598262588942,0.00882927363521478,0.296948064875712
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCLN,Nicalin,40044,-0.00502772353552059,0.00483396520351473,-0.0145022953344095,0.00444684826336828,0.298317612267375
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00532547477829407,0.0051319407284278,-0.00473312904942442,0.0153840786060126,0.299423567051052
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIF20B,Kinesin-like protein KIF20B,37541,0.00734899280076237,0.00708758522403772,-0.00654267423835157,0.0212406598398763,0.299809794229824
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL5,Interleukin-5,40044,0.0136104340866293,0.0132019064041647,-0.0122653024655335,0.039486170638792,0.302582792253824
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM3D,Protein FAM3D,37901,-0.00763920314438158,0.00744840605865286,-0.0222380790193412,0.00695967273057802,0.30509115007525
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,0.00851419639935859,0.00830600946973041,-0.007765582161313,0.0247939749600302,0.30535139683097
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00544352439672833,0.00531822648007626,-0.00498019950422114,0.0158672482976778,0.306061936461665
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,37714,0.00720175940902305,0.00704394740218156,-0.00660437749925282,0.0210078963172989,0.306608416911809
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL6,Interleukin-6,40305,0.00669752870185007,0.00659929538878343,-0.00623709026016546,0.0196321476638656,0.310175935506889
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,-0.003530968506743,0.00347998130676232,-0.0103517318679971,0.00328979485451114,0.310290516683826
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL21R,Interleukin-21 receptor,37598,0.00515530730536466,0.005085755140778,-0.00481277277056022,0.0151233873812895,0.310756094176738
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EVI2B,Protein EVI2B,37482,0.00387461546415511,0.00383066107731877,-0.00363348024738967,0.0113827111756999,0.311808228284326
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGR2,Anterior gradient protein 2 homolog,39839,-0.00923563373877243,0.00916849824060932,-0.0272058902903667,0.00873462281282184,0.313795704341203
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,0.00397734785358707,0.00395579146815367,-0.00377600342399412,0.0117306991311683,0.314698551395747
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHH,Sonic hedgehog protein,37598,-0.00396190166797649,0.00394552851326036,-0.0116951375539668,0.00377133421801383,0.315324896790397
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FBN2,Fibrillin-2,37572,0.00552718275739328,0.0055335042762064,-0.00531848562397127,0.0163728511387578,0.317882103634503
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,37900,0.00349099865976164,0.00349929835769086,-0.00336762612131244,0.0103496234408357,0.318477639991643
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,0.00362348632392561,0.00364068443565267,-0.00351225516995362,0.0107592278178048,0.319620352013213
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFRC,Transferrin receptor protein 1,40391,-0.00355605164709838,0.00357312687807778,-0.0105593803281308,0.00344727703393407,0.319643797423597
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALLD,Palladin,37598,0.00373460950330934,0.00376978811558863,-0.00365417520324439,0.0111233942098631,0.321865818886575
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,40128,0.0156289632687081,0.0158256816702089,-0.0153893728049014,0.0466472993423176,0.323378687550242
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,-0.00514621596637838,0.0052265102583932,-0.0153901760728291,0.0050977441400723,0.324820553525017
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TK1,"Thymidine kinase, cytosolic",37714,0.00397762780338998,0.00405090154230144,-0.00396213921952084,0.0119173948263008,0.326161241051175
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,-0.00469958650806478,0.00479858383374075,-0.0141048108221967,0.00470563780606709,0.327415528201739
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.00731041811723827,0.00747481997657182,-0.021961065271319,0.00734022903684249,0.3280892403359
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,0.0079121531592328,0.00810031178312135,-0.00796445793568505,0.0237887642541506,0.328700489596977
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,0.00450011920171629,0.0046176903675072,-0.00455055391859783,0.0135507923220304,0.329806528565541
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,37901,-0.00455206762151448,0.00468764923326219,-0.0137398601187084,0.00463572487567942,0.331527477838101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNW1,Interferon omega-1,37562,-0.00324499117555873,0.00334576484460183,-0.00980269027097831,0.00331270791986086,0.332124088473041
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,37959,0.0027149110837311,0.00280410949419709,-0.00278114352489519,0.00821096569235738,0.332966768163896
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTLA,B- and T-lymphocyte attenuator,37482,0.00781508545822461,0.00807678980653289,-0.00801542256257986,0.0236455934790291,0.33326314808848
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,0.00316891324347976,0.00328194925360913,-0.00326370729359415,0.00960153378055366,0.334283026787732
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,40225,-0.00508642242907582,0.00527135530543851,-0.0154182788277353,0.00524543396958365,0.334600981429556
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY6D,Lymphocyte antigen 6D,40268,0.00325440800920448,0.00337805823312565,-0.0033665861277218,0.00987540214613076,0.335363529413101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTKN2,Rhotekin-2,37562,-0.00461087097675765,0.00478940464328805,-0.0139981040776022,0.00477636212408693,0.335704205948679
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOC,Myocilin,40332,0.00397923227723514,0.00414309039685102,-0.00414122490059287,0.0120996894550631,0.336843273007154
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,0.00373479497170223,0.00389533027878207,-0.00390005237471062,0.0113696423181151,0.337683346977231
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.0150296014423421,0.0157087486927656,-0.0458187488801627,0.0157595459954785,0.338702420682697
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSP90B1,Endoplasmin,39878,-0.00602921438446655,0.00635746735125699,-0.0184898503929303,0.00643142162399715,0.342957337683571
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL33,Interleukin-33,40044,0.00331662387765199,0.0035003511161201,-0.00354406430994341,0.0101773120652474,0.343392746350912
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.00541815033213285,0.00571995641954128,-0.00579296425016805,0.0166292649144338,0.343535642800451
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.00191820030043488,0.0020311537029934,-0.0020628609574322,0.00589926155830195,0.344987983580584
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFL4,Insulin growth factor-like family member 4,37598,-0.00674979278771116,0.00714736306987303,-0.0207586244046623,0.00725903882923998,0.34499528020795
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,40451,0.00254284332507994,0.00269636978072659,-0.00274204144514418,0.00782772809530406,0.345663536137408
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP4,Caspase-4,37714,-0.0145511085949735,0.0154864231561029,-0.0449044979809352,0.0158022807909883,0.347437721955792
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMPD3,AMP deaminase 3,37942,0.00616515509525557,0.00656244574905023,-0.00669723857288287,0.019027548763394,0.34751145532264
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRG3,Proteoglycan 3,37998,0.00425738359184169,0.0045344308829651,-0.00463010093876991,0.0131448681224533,0.347798101027946
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,-0.00547214761299605,0.00583346299229159,-0.0169057350778876,0.00596143985189546,0.348230142776657
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,40341,-0.00397197021768956,0.0042524514520431,-0.012306775063694,0.00436283462831491,0.350296184764813
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD58,Lymphocyte function-associated antigen 3,40335,0.00149091124244422,0.00159735622886518,-0.00163990696613153,0.00462172945101998,0.35064739877894
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPE,Carboxypeptidase E,40360,0.00321990375945231,0.00345632278265379,-0.00355448889454913,0.00999429641345374,0.351558399768715
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTR,Methionine synthase,37562,0.0055389343469282,0.0059492181753758,-0.00612153327680837,0.0171994019706648,0.351852255578312
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,-0.0034860742851958,0.00374444775189567,-0.0108251918789113,0.0038530433085197,0.351871642756701
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RALB,Ras-related protein Ral-B,37598,0.00249621137549323,0.00268776659770827,-0.00277181115601497,0.00776423390700143,0.353045714337411
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COPE,Coatomer subunit epsilon,39961,0.00404325195377802,0.00437852382269076,-0.00453865473869588,0.0126251586462519,0.355798517300058
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HCG22,Protein PBMUCL2,37562,0.0044741211900407,0.00485590549945208,-0.00504345358888538,0.0139916959689668,0.356870420632418
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN8,Septin-8,37921,0.002631394809904,0.00288189010730945,-0.00301710980042251,0.00827989942023052,0.361217068631248
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.00713740917655335,0.0078248796601267,-0.0224741733104017,0.00819935495729499,0.361710322308643
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCNA,Proliferating cell nuclear antigen,37482,0.00518143783385322,0.00568427193721745,-0.00595973516309298,0.0163226108307994,0.36202809868977
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTRK3,NT-3 growth factor receptor,40471,0.00178875044141929,0.00197087304664792,-0.00207416073001062,0.00565166161284921,0.364106984186721
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAST,Gastrin,37942,0.0106689014247085,0.0117730445048632,-0.0124062658048234,0.0337440686542404,0.364838614831952
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.00324526082279471,0.00361156173725299,-0.00383340018222115,0.0103239218278106,0.368894861783033
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HYAL1,Hyaluronidase-1,40214,0.00185912797171876,0.00207502404383699,-0.00220791915420175,0.00592617509763927,0.370290530481584
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,-0.00209724304199613,0.00234332720534712,-0.00669016436447649,0.00249567828048423,0.370810930378623
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RYR1,Ryanodine receptor 1,37562,-0.00280645234449493,0.00314150271223888,-0.00896379766048313,0.00335089297149327,0.371687719353956
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,40465,-0.00514537331395774,0.00577354488390811,-0.0164615212864176,0.00617077465850215,0.372836193174462
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.00560874712966416,0.00629609819267952,-0.00673160532798769,0.017949099587316,0.373037052021416
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00698068204675513,0.00786906854790863,-0.00844269230714578,0.022404056400656,0.375039180974282
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,0.00453419467178166,0.00511222088318301,-0.00548575825925703,0.0145541476028204,0.375131072825264
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00396532235956579,0.0044871711158078,-0.00482953302741749,0.0127601777465491,0.37687329877528
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NLGN2,Neuroligin-2,37541,-0.00386981381136279,0.00438189341573775,-0.0124583249062088,0.00471869728348319,0.377178276790229
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN7,Tetraspanin-7,37541,0.00731201288278812,0.0083112592722849,-0.00897805529089029,0.0236020810564665,0.378999007789641
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.0044798434666041,0.00510412871628519,-0.0144839357505231,0.00552424881731487,0.380128077363739
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUK1,Guanylate kinase,37562,-0.00320137416868432,0.00365059689998387,-0.0103565440926527,0.00395379575528405,0.380532362555877
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,-0.00584156453268037,0.00668627414862472,-0.0189466618639848,0.00726353279862408,0.382316468503166
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A16,Protein S100-A16,39934,-0.0049174841044826,0.0056307879235547,-0.0159538284346498,0.00611886022568462,0.382501801980978
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,37959,-0.00616799098375309,0.00710241529498985,-0.0200887249619332,0.00775274299442701,0.385171289199317
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,0.00162881525944068,0.00188992244172916,-0.00207543272634847,0.00533306324522982,0.388787514675346
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,-0.00378010730852687,0.00439942054971876,-0.0124029715859756,0.00484275696892189,0.390230112264957
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PYDC1,Pyrin domain-containing protein 1,37628,-0.00330899593686588,0.00386698086335776,-0.0108882784290471,0.00427028655531532,0.392176380020818
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX2,Peroxiredoxin-2,37763,-0.00486337727790299,0.00568700638075638,-0.0160099097841855,0.00628315522837952,0.39247048387942
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCNE1,G1/S-specific cyclin-E1,37598,0.00719271801022849,0.00850478257130576,-0.00947665582953081,0.0238620918499878,0.397720859633136
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.00519996825116913,0.00616171817403664,-0.00687699936994268,0.0172769358722809,0.398731958723108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,37942,-0.00215899382045476,0.00255911280759019,-0.00717485492333153,0.00285686728242201,0.398880345784638
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.00594607687524189,0.00704840660786536,-0.019760953826658,0.00786880007617421,0.398904712931378
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BOC,Brother of CDO,40042,0.00179924036465925,0.00213492689981104,-0.00238521635897039,0.00598369708828889,0.399373156872894
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BEX3,Protein BEX3,37482,-0.0036375615548636,0.00434237041153154,-0.0121486075614654,0.00487348445173822,0.402220029642022
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,-0.00723076343919067,0.00867401389706027,-0.0242318306774288,0.00977030379904747,0.404514853116536
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OMD,Osteomodulin,40422,0.00332857121134299,0.00400209637316961,-0.00451553768006945,0.0111726801027554,0.40558683439346
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,37562,-0.00288192043944537,0.00347828102845547,-0.00969935125521808,0.00393551037632734,0.407375688988072
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM171A2,Protein FAM171A2,37959,0.0120416702438215,0.0145657203868946,-0.016507141714492,0.0405904822021349,0.408414360848277
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL6B,Myosin light chain 6B,37572,-0.00691627708809964,0.00840311732444805,-0.0233863870440178,0.00955383286781853,0.410488336565279
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MKI67,Proliferation marker protein Ki-67,37598,0.00279969554378588,0.00342591390904988,-0.00391509571795188,0.00951448680552365,0.413822498316822
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,-0.00545008809584539,0.00669770333404915,-0.0185775866305817,0.00767741043889095,0.415817358326265
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL9,Interleukin-9,37714,0.00421118535175986,0.00521205239292114,-0.00600443733836557,0.0144268080418853,0.419121971050517
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HK2,Hexokinase-2,40042,-0.00202173712708518,0.00250365640088861,-0.00692890367282685,0.00288542941865648,0.419382839583684
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.00336013462892769,0.00416457691467918,-0.0115227053816989,0.0048024361238435,0.419775075093006
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OTOA,Otoancorin,37541,-0.00400620128309106,0.00497209785319489,-0.013751513075353,0.00573911050917092,0.420409371123969
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMY2B,Alpha-amylase 2B,39311,0.0035067233501556,0.00435719671759851,-0.00503338221633748,0.0120468289166487,0.420941165934608
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSLP,Thymic stromal lymphopoietin,40042,0.00443407830223514,0.00551259793508194,-0.00637061365052546,0.0152387702549957,0.421205023280179
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.00258615713304671,0.00322548484460411,-0.00373579316237734,0.00890810742847076,0.422687495730482
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,37482,-0.00185235152792506,0.00232180865122557,-0.00640309648432717,0.00269839342847705,0.424997953847732
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,-0.00370905337397259,0.00467097386310124,-0.012864162145651,0.00544605539770583,0.427172515141398
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB44,Ras-related protein Rab-44,37900,0.00285553236729377,0.00360809108666509,-0.00421632616256981,0.00992739089715736,0.428710165522128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.00233443395182014,0.00295166793207372,-0.00345083519504435,0.00811970309868462,0.429024629598158
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RSPO1,R-spondin-1,40228,0.00253358309865531,0.00320444736019839,-0.00374713372733354,0.00881429992464416,0.4291625516342
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCLRE1C,Protein artemis,37482,-0.00226996563557963,0.00288686209810165,-0.00792821534785887,0.0033882840766996,0.431700783312616
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.0047558772547423,0.00609872962961154,-0.00719763281929633,0.0167093873287809,0.435514189411105
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,37562,0.00688191351393047,0.00883547761853833,-0.0104356226184047,0.0241994496462656,0.436055349745775
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMIGO1,Amphoterin-induced protein 1,37572,0.003502894046842,0.00453651331500125,-0.00538867205056046,0.0123944601442445,0.44003619798206
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPSD1,Tryptase delta,37959,-0.00266278349672196,0.0034597381902188,-0.00944387034955082,0.0041183033561069,0.441521682426234
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MERTK,Tyrosine-protein kinase Mer,40516,0.00181244113431106,0.00236391263229484,-0.00282082762498682,0.00644570989360894,0.443263794914333
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EXOSC10,Exosome component 10,37562,0.0043725928887556,0.00571132600199992,-0.00682160607516425,0.0155667918526754,0.443927949896127
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANK2,Ankyrin-2,37562,0.00515958450378375,0.00674993034211312,-0.00807027896675797,0.0183894479743255,0.444648160534
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00417479339735522,0.00547372954981186,-0.00655371652027603,0.0149033033149865,0.445658268832024
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,0.00325438532057122,0.00431416832827274,-0.00520138460284335,0.0117101552439858,0.45065368718314
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MLLT1,Protein ENL,37482,0.00487633808255014,0.00651320746848168,-0.00788954855567395,0.0176422247207742,0.454060845981944
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSME2,Proteasome activator complex subunit 2,40152,0.00250353921692528,0.00335084695333637,-0.00406412081161402,0.00907119924546457,0.454992511311685
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPA,Apolipoprotein(a),37735,0.0118666083784744,0.0159077493591513,-0.0193125803654622,0.0430457971224111,0.455702361625898
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,37482,0.00227587420213726,0.00305372785594054,-0.00370943239550619,0.00826118079978072,0.456117513919
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAGE2A,G antigen 2A,37482,0.00420258928393296,0.00566194958670908,-0.00689483190601683,0.0153000104738828,0.457948488474951
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAX,Integrin alpha-X,37714,0.00371184582020461,0.00500773204992697,-0.00610330899765225,0.0135270006380615,0.458571407092022
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYBB2,Beta-crystallin B2,37942,-0.00459212730555605,0.00622530707261744,-0.0167937291678862,0.00760947455677413,0.460737109100859
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,0.00280391292052644,0.00382006290015009,-0.00468341036376773,0.0102912362048206,0.462963942185753
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,40042,-0.00329464654770422,0.00450598547903717,-0.0121263780866171,0.00553708499120864,0.464685613567552
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDI2,Protein DDI1 homolog 2,37671,0.00512954442306947,0.00708067616482859,-0.00874858085999456,0.0190076697061335,0.468806791626894
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,37598,0.0032184182187887,0.0044427814661275,-0.00548943345482121,0.0119262698923986,0.468823791311536
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAD1,Glutamate decarboxylase 1,37482,-0.00169781273280588,0.00235021705834389,-0.0063042381671599,0.00290861270154814,0.470057385689699
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRD2,Bromodomain-containing protein 2,37541,0.00225474466567874,0.00313378899396121,-0.00388748176248524,0.00839697109384271,0.47184899404932
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD82,CD82 antigen,37714,0.00272199840985675,0.00379629267005142,-0.00471873522344403,0.0101627320431575,0.473377530203104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGS8,Regulator of G-protein signaling 8,40044,0.00431226931360935,0.00601654954094199,-0.00748016778663695,0.0161047064138556,0.473548599094928
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STEAP4,Metalloreductase STEAP4,37541,0.00488461730160343,0.00683432711371495,-0.00851066384127786,0.0182798984444847,0.474795996589197
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA2,Ephrin type-A receptor 2,39759,-0.00198838982721793,0.002787802059338,-0.00745248186352041,0.00347570220908454,0.475704162156634
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G1B,Phospholipase A2,40514,0.00270008438869449,0.00378628003315929,-0.00472102447629771,0.0101211932536867,0.475779843020891
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBR1,TGF-beta receptor type-1,37598,0.00139404923126159,0.00195528436430104,-0.00243830812276846,0.00522640658529163,0.475880097396274
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARB1,Scavenger receptor class B member 1,39961,0.00382055281866024,0.00537080473264149,-0.00670622445731709,0.0143473300946376,0.476874512266864
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR1,Toll-like receptor 1,37598,-0.00168190153625227,0.00237620197431687,-0.00633925740591332,0.00297545433340879,0.47907527672828
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA5,Annexin A5,39896,-0.00194605409932111,0.0027690656369133,-0.00737342274767118,0.00348131454902896,0.482201170841718
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,37714,-0.00258916967159607,0.00370530979255641,-0.00985157686500664,0.0046732375218145,0.484706287554969
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC12A2,Solute carrier family 12 member 2,37562,-0.00181339768926339,0.00259918910983506,-0.0069078083445401,0.00328101296601331,0.485390810860827
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HBZ,Hemoglobin subunit zeta,37990,0.0066215900986513,0.00950645056753966,-0.0120110530137264,0.025254233211029,0.486104846711867
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRTN,Neurturin,40044,0.00308736495267536,0.00447995371945991,-0.00569334433746606,0.0118680742428168,0.49073845195574
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL25,Interleukin-25,37429,0.00218679349748968,0.00317368297328697,-0.00403362513015278,0.00840721212513214,0.490810616907135
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NENF,Neudesin,37900,0.006738554107395,0.00980856548614691,-0.012486234245453,0.0259633424602429,0.492090102218164
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,37959,0.00210451918154476,0.00306350513485984,-0.00389995088278053,0.00810898924587004,0.492116912264522
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.00172553201875684,0.00251343227611313,-0.00320079524242489,0.00665185927993857,0.4923925927802
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.00377952248518222,0.00551173003905272,-0.0145825133617255,0.0070234683913611,0.492899722209511
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,-0.00410068383670224,0.00598426739192738,-0.0158298479248799,0.00762848025147542,0.493202015077948
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2L15,Bcl-2-like protein 15,37598,0.00350733408828494,0.00512049917388747,-0.0065288442925345,0.0135435124691044,0.493381611791527
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA4,Ephrin type-A receptor 4,37671,0.00174783355137581,0.00255255373698049,-0.00325517177310596,0.00675083887585757,0.493520526150036
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNXB,Tenascin-X,40332,0.0015656816804659,0.0023023043700528,-0.00294683488483759,0.0060781982457694,0.496482827437865
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",39530,-0.00174384278082588,0.0025875808357791,-0.00681550121895291,0.00332781565730116,0.500367518105585
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,37482,-0.00184355744882146,0.00274426987431986,-0.00722232640248838,0.00353521150484546,0.501732927734383
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00307671457994571,0.00458425570983307,-0.0120618557712185,0.0059084266113271,0.50213807473129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,-0.00306714514263034,0.00465265983138389,-0.0121863584121428,0.00605206812688208,0.509761696912437
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,-0.00152578605986801,0.00232150888201121,-0.00607594346860997,0.00302437134887396,0.511038460149608
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1A,Interleukin-1 alpha,40044,0.00320275974650906,0.00487527981062534,-0.00635278868231659,0.0127583081753347,0.511230059947192
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00401026023863809,0.00610869847252237,-0.00796278876750576,0.0159833092447819,0.511524551852757
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,-0.00419545367534492,0.00641596425150487,-0.0167707436082945,0.00837983625760461,0.513182215216421
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,-0.00264150122509424,0.00405819212366365,-0.010595557787475,0.00531255533728652,0.515118705903734
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FZD8,Frizzled-8,37541,0.00264948534396123,0.00407281812438096,-0.00533323817982546,0.0106322088677479,0.515362145767691
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,40536,-0.00193973740468387,0.00298415586259774,-0.00778868289537543,0.00390920808600769,0.515693692300393
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HLA_A,,37959,0.00192024698616375,0.00296067859833744,-0.00388268306657762,0.00772317703890513,0.516618715407334
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.0034108197616183,0.00526568336703057,-0.00690991963776162,0.0137315591609982,0.517161344492133
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00373114383261376,0.00579013621141132,-0.00761752314175244,0.01507981080698,0.519329660804235
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,METAP1,Methionine aminopeptidase 1,39961,0.00179266466840903,0.00278283810743155,-0.0036616980221568,0.00724702735897486,0.519464513433656
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTNL10,Butyrophilin-like protein 10,37482,0.00242833951509623,0.00380513663213926,-0.00502972828389671,0.00988640731408918,0.523371592515783
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,37541,-0.00245881064176171,0.00385971743664183,-0.0100238568175797,0.00510623553405628,0.524107189007723
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,0.00374913367335799,0.00588731175338453,-0.00778999736327569,0.0152882647099917,0.524255614167734
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,37541,0.00452508077914375,0.00712856642879461,-0.00944690942129368,0.0184970709795812,0.52558214578229
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRR1B,Cornifin-B,37714,0.00485255019848426,0.00772636284405222,-0.0102911209758581,0.0199962213728266,0.529981321116228
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEB,Nebulin,37562,0.00207408331585333,0.00331057559951311,-0.00441464485919235,0.00856281149089902,0.530996419618993
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAG,Myelin-associated glycoprotein,37572,0.00264594781573086,0.00423363697806331,-0.00565198066127323,0.010943876292735,0.531993599980573
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,-0.00353080029872113,0.00569245671765479,-0.0146880154653245,0.00762641486788226,0.535097742179755
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGBL1,Integrin beta-like protein 1,37998,-0.00195886460202322,0.00315931741609965,-0.00815112673757852,0.00423339753353209,0.535249919284051
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,0.00336259071347201,0.00544018620383537,-0.00730017424604531,0.0140253556729893,0.536516910035823
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH22,Cadherin-22,37714,-0.00164882225897645,0.00267256348893649,-0.00688704669729197,0.00358940217933907,0.537282192715271
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,0.00211542340340912,0.00342901605026525,-0.00460544805511078,0.00883629486192901,0.537297241222883
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPT,Microtubule-associated protein tau,39961,0.00296528230979474,0.0048133422126749,-0.00646886842704806,0.0123994330466376,0.537867430020945
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL6,Fc receptor-like protein 6,40341,-0.00374430084244466,0.0061044780823462,-0.0157090778838432,0.00822047619895389,0.539640809579926
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,39980,-0.00274282789383219,0.00450667156283981,-0.0115759041569982,0.00609024836933385,0.542788565114108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,-0.00315117648913122,0.00518094321296784,-0.0133058251865482,0.00700347220828575,0.543049129689431
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,-0.0036396230850649,0.0059975527731313,-0.0153948265204023,0.00811558035027245,0.543960065789628
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBLN1,Cerebellin-1,37541,0.00539339490171258,0.00890445240418522,-0.0120593318104905,0.0228461216139156,0.544726867149673
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSCA,Prostate stem cell antigen,37901,0.0142629613713697,0.0235499200278392,-0.0318948818831953,0.0604208046259346,0.544758758032245
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL36A,Interleukin-36 alpha,37598,-0.00323806659802715,0.00536849863783998,-0.0137603239281935,0.0072841907321392,0.546412293589897
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,0.00232481512101031,0.00385965987261763,-0.00524011822932026,0.00988974847134087,0.546960090588807
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,0.00399777486501587,0.00663934365324506,-0.00901533869534445,0.0170108884253762,0.547094996808219
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KEL,Kell blood group glycoprotein,39961,-0.00193866927699336,0.00322562325419601,-0.00826089085521755,0.00438355230123082,0.547834377603366
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENG,Endoglin,40536,-0.00091967500685433,0.0015395912119119,-0.00393727378220165,0.00209792376849299,0.550282052578853
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,0.0025881937611543,0.00433470692357617,-0.00590783180905499,0.0110842193313636,0.550459871434093
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.0034440336399087,0.00578422256339916,-0.0147811098641711,0.00789304258435366,0.551573862473119
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBM25,RNA-binding protein 25,37482,0.0024963341319036,0.00421214613017752,-0.00575947228324434,0.0107521405470516,0.553424784211475
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAPN3,Calpain-3,37900,0.00199136953199179,0.00336419964703912,-0.00460246177620489,0.00858520084018848,0.553907646514077
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,37598,-0.00220406300970791,0.00372596931577501,-0.00950696286862694,0.00509883684921111,0.554168272769792
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMG4,Proteasome assembly chaperone 4,37598,-0.00302228083473554,0.00511757124676851,-0.0130527204784018,0.00700815880893075,0.554819144051612
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,37562,-0.00384087949493658,0.00651261837987564,-0.0166056115194928,0.00892385252961967,0.555361965836448
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXDC1,Plexin domain-containing protein 1,39980,-0.00177831076433231,0.00307091617127577,-0.00779730646003282,0.00424068493136819,0.562542577433729
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBR1,T-box brain protein 1,37572,0.00256440535962387,0.00443083794974777,-0.00612003702188176,0.0112488477411295,0.562758990265069
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,-0.00140917790867451,0.00247146357986419,-0.00625324652520832,0.00343489070785929,0.568565472288294
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,37482,-0.00242100267418265,0.00427107741289337,-0.0107923144034536,0.00595030905508835,0.570835017276568
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,H2AP,Huntingtin-interacting protein M,37482,-0.00267577956478386,0.00473743785363616,-0.0119611577579107,0.00660959862834301,0.5722088091729
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,-0.00265270834834238,0.00474037269493446,-0.0119438388304139,0.00663842213372916,0.575762463887713
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OMP,Olfactory marker protein,37541,0.0025696755713639,0.00459525285136379,-0.00643702001730914,0.0115763711600369,0.576033289445112
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSB,Cathepsin B,40353,0.00271761902884607,0.00487633219962464,-0.00683999208241822,0.0122752301401104,0.57732484365378
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN8,Tetraspanin-8,37901,-0.0052222859378462,0.00940689083625166,-0.0236597919768995,0.0132152201012071,0.578797627566421
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRP15,RRP15-like protein,37541,-0.00456248061580525,0.0082704630332166,-0.0207725881609098,0.0116476269292993,0.581190988063203
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC39A14,Zinc transporter ZIP14,39961,0.00166782743800661,0.00302562917209295,-0.00426240573929557,0.00759806061530878,0.581481722389675
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,37482,0.0027925825312115,0.00507428149226442,-0.00715300919362676,0.0127381742560498,0.582095295818201
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,37562,0.00597590226495905,0.010862905769096,-0.0153153930424691,0.0272671975723872,0.582246407538165
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,40044,0.00176173920893856,0.00322250829135398,-0.00455437704211525,0.00807785545999236,0.584593972635833
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGLON5,IgLON family member 5,37482,0.00464140505149818,0.00856406446436749,-0.0121441612986621,0.0214269714016585,0.587853344396796
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.012889844353107,0.0237917951516725,-0.0595217628503852,0.0337420741441712,0.58798138708101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,-0.00160746516325357,0.0029741074081698,-0.00743671568326637,0.00422178535675923,0.588870420341192
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA3,Carbonic anhydrase 3,40500,-0.00297546949170555,0.00551247008758053,-0.0137799108633634,0.00782897187995228,0.589362708393582
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53BP1,TP53-binding protein 1,37598,0.00434321421018757,0.00807169191223128,-0.0114773019377857,0.0201637303581609,0.590531080490508
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL4,Interleukin-4,40044,-0.00436912485745326,0.00813121042727096,-0.0203062972949043,0.0115680475799978,0.591048920663759
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,40536,-0.0014293228296585,0.00266415503047576,-0.00665106668939098,0.00379242103007398,0.591619507902827
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPP1,Osteopontin,40497,0.00230344841578521,0.00430141234324385,-0.00612731977697274,0.0107342166085432,0.592304812703423
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESPL1,Separin,37482,-0.0027725862118048,0.00521129674754767,-0.0129867278369982,0.00744155541338863,0.594711630143883
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERVV_1,,37562,-0.00233363893015058,0.00439478210265963,-0.0109474118513635,0.0062801339910623,0.59542625545289
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,-0.00195567536753394,0.0036847644006592,-0.00917781359282598,0.0052664628577581,0.595603486600454
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCP11,T-complex protein 11 homolog,37714,-0.00292269092727758,0.00551040728632512,-0.0137230892084748,0.00787770735391966,0.595847166804424
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,-0.0029102891813138,0.00552746515969142,-0.013744120894309,0.0079235425316814,0.598539860065128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TET2,Methylcytosine dioxygenase TET2,37697,-0.00480245927098386,0.00913194735744543,-0.0227010760915769,0.0130961575496092,0.598968916554697
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN4,Contactin-4,40332,0.00114310853817957,0.00219664799642722,-0.00316232153481778,0.00544853861117691,0.602800655217241
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLGAP5,Disks large-associated protein 5,37959,-0.00252765208178682,0.0048675768950042,-0.012068102795995,0.00701279863242141,0.603571607126734
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR2,Toll-like receptor 2,37714,0.00107974158223781,0.00208358603108108,-0.00300408703868111,0.00516357020315673,0.604318238810045
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,-0.00206204683775358,0.00398989751377122,-0.00988224596474517,0.00575815228923802,0.605292534304435
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,-0.00116202698605173,0.0022615559007179,-0.0055946765514588,0.00327062257935535,0.607387976579789
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL36G,Interleukin-36 gamma,37551,-0.0032078885328828,0.00626346086406158,-0.0154842718264435,0.0090684947606779,0.608548293768178
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00335916896766141,0.00662540196772319,-0.00962661888907603,0.0163449568243989,0.61215381059253
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,37900,0.00194625366419025,0.00386800991383168,-0.00563504576691986,0.00952755309530035,0.614855337430481
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLINT1,Clathrin interactor 1,37482,0.00208956868615737,0.00417530773702442,-0.0060940344784105,0.0102731718507252,0.61676064896757
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,-0.00295364551484623,0.00594344899960307,-0.0146028055540682,0.00869551452437578,0.619225596598523
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP15,Matrix metalloproteinase-15,37990,0.00223599731013941,0.00451756978289756,-0.0066184394643398,0.0110904340846186,0.620639362198513
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00260873458408367,0.00527227501110209,-0.0129423936058438,0.00772492443767643,0.620747867738692
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPEP1,Dipeptidase 1,40192,0.00227177000211325,0.0045976460206351,-0.00673961619833154,0.011283156202558,0.621231224599679
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,37942,-0.00130219253497021,0.00263742535440941,-0.00647154622961265,0.00386716115967223,0.621500490763839
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF3,Fibroblast growth factor 3,37598,0.00135831969426966,0.00276693651303691,-0.00406487587128269,0.00678151525982201,0.623497559522546
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,40042,-0.00149273538199164,0.00305286666862371,-0.00747635405249412,0.00449088328851084,0.624875573523966
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOH,Beta-2-glycoprotein 1,40332,0.00156727847300595,0.00320611304904474,-0.00471670310312174,0.00785126004913364,0.624961248331499
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ISM2,Isthmin-2,37998,-0.00196590404815507,0.0040370942059328,-0.00987860869178335,0.00594680059547322,0.626294442160175
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOS2,"Nitric oxide synthase, inducible",37562,-0.00173113690401874,0.00357150039671623,-0.00873127768158256,0.00526900387354508,0.627891173851178
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,37572,0.00218316442924875,0.0045074882803968,-0.00665151260032898,0.0110178414588265,0.628151488024021
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KITLG,Kit ligand,40359,-0.00158777717165566,0.00328680748458215,-0.00802991984143667,0.00485436549812535,0.629048561128481
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBQLN3,Ubiquilin-3,37562,-0.00196924251069274,0.00410258446826128,-0.0100103080684848,0.00607182304709937,0.631235060398984
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TG,Thyroglobulin,37900,0.00509018979014852,0.010639104154312,-0.015762454352303,0.0259428339326001,0.632343723746748
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLHL41,Kelch-like protein 41,37959,0.00205295024363506,0.00430038032095379,-0.00637579518543438,0.0104816956727045,0.633093535158445
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA10,Ephrin type-A receptor 10,39961,0.00279790928690422,0.00592072362547112,-0.00880670901901918,0.0144025275928276,0.636532313389341
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNF830,Zinc finger protein 830,37900,-0.00344970721774896,0.00732020960658374,-0.0177973180466531,0.0108979036111552,0.637464160900697
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD5,Sushi domain-containing protein 5,37604,-0.00145908989080889,0.00309971849642504,-0.00753453814380197,0.00461635836218419,0.63785071843769
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.00537145609247223,0.0114503766754944,-0.0170712821914968,0.0278141943764413,0.638999477170225
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF5,Fibroblast growth factor 5,40044,0.00136363617842497,0.00291820828812152,-0.00435605206629321,0.00708332442314315,0.640302218147165
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,0.00115581162084768,0.00247457976697569,-0.00369436472242467,0.00600598796412003,0.640453379512193
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD48,CD48 antigen,40396,0.00121253030775674,0.00264907720386453,-0.00397966101181774,0.00640472162733122,0.647161294806649
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,-0.00139870401199051,0.00305759399977461,-0.00739158825154874,0.00459418022756771,0.647352085658762
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,40203,0.00138859181244955,0.00303879810440172,-0.00456745247217782,0.00734463609707691,0.647710206638853
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUCL3,Mucin-like protein 3,37482,-0.00185869681586879,0.00409765170072067,-0.0098900941492813,0.00617270051754372,0.650123955485336
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,0.00147870736230819,0.00327169287350546,-0.00493381066976252,0.00789122539437889,0.65129791279309
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMA1,Laminin subunit alpha-1,37562,-0.00230333021154167,0.0051033063560347,-0.0123058106693697,0.00769915024628635,0.651751431798477
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HRAS,GTPase Hras,37697,-0.00401939067540675,0.00892536569346947,-0.0215131074346069,0.0134743260837934,0.652477397993173
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASET2,Ribonuclease T2,40465,0.00107055610318959,0.00238322215813556,-0.00360055932675611,0.00574167153313529,0.653289620092153
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,-0.00163860776463154,0.00365681590997892,-0.00880596694819023,0.00552875141892715,0.654090630336807
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,37541,-0.00288210354071025,0.00643798850115167,-0.0155005610029675,0.00973635392154703,0.654397749767342
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHC1,SHC-transforming protein 1,37482,0.00470823473708307,0.0106177863549741,-0.0161026265186662,0.0255190959928323,0.657462802155321
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EVPL,Envoplakin,37714,0.00138147069821846,0.00312832978467037,-0.00475005567973547,0.0075129970761724,0.658785822435452
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,37541,0.00322745944533551,0.00734036719224251,-0.0111596602514598,0.0176145791421308,0.660171530986069
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,37541,0.00282887952867637,0.00644258447112194,-0.00979858603472263,0.0154563450920754,0.660602997736143
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPB41L5,Band 4.1-like protein 5,37572,-0.00252958791000747,0.00578497540979368,-0.0138681397132031,0.00880896389318814,0.661923785233869
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKKL1,Dickkopf-like protein 1,40305,-0.00339054114823938,0.00795627599328532,-0.0189848420950786,0.0122037597985998,0.670006703028948
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,-0.00144510275847808,0.00339756678180621,-0.00810433365081826,0.00521412813386209,0.670599547963003
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL15,C-C motif chemokine 15,40536,0.00169168246802655,0.00401651938827148,-0.00618069553298555,0.00956406046903864,0.673628397115735
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK12,Kallikrein-12,39980,-0.00540146910210018,0.0129557055168228,-0.0307946519150728,0.0199917137108725,0.676744022206356
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMMR,Hyaluronan mediated motility receptor,37460,-0.00184324120634004,0.00442910343368752,-0.0105242839363676,0.0068378015236875,0.677295577090944
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,0.00190270969633607,0.00458556741667334,-0.00708500244034367,0.0108904218330158,0.678196646997446
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,0.00154965663721003,0.00375276506347545,-0.00580576288720185,0.00890507616162192,0.679659306980156
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.00317638429685578,0.00769627225787362,-0.0182610779222881,0.0119083093285765,0.679820459089385
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,0.0018830452278983,0.00458102802282539,-0.00709576969683946,0.0108618601526361,0.681040415088034
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASQ2,Calsequestrin-2,37562,-0.00187176471411425,0.00455897874099869,-0.0108073630464717,0.00706383361824318,0.68139701825818
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.0017424147665911,0.00428521921063797,-0.00665661488625933,0.0101414444194415,0.684299577828774
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLR3,Folate receptor gamma,40355,0.00669128315574877,0.0166604315007752,-0.0259631625857706,0.0393457288972682,0.687963774774622
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,-0.00160737589399043,0.00401226375812892,-0.00947141285992312,0.00625666107194225,0.688709605650773
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGM2,Phosphoglucomutase-2,37572,0.00216093977061608,0.00544834237744825,-0.00851781128918248,0.0128396908304147,0.69165168661138
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PADI2,Protein-arginine deiminase type-2,40044,0.002008665580948,0.00507423964559996,-0.00793684412442793,0.0119541752863239,0.69221706048465
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTNNA1,Catenin alpha-1,37541,-0.00129425250431595,0.00329127404857851,-0.00774514963952982,0.00515664463089792,0.694150451450283
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNF174,Zinc finger protein 174,37598,-0.00137822098122606,0.00352517373744605,-0.00828756150662032,0.00553111954416821,0.695829142632439
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PI16,Peptidase inhibitor 16,37987,-0.00086646708303435,0.00223115044768785,-0.00523952196050254,0.00350658779443384,0.697763212469316
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,-0.00202812791772196,0.00523215260752416,-0.0122831470284693,0.00822689119302539,0.698297808556798
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,-0.00196212957731176,0.00515660060223443,-0.0120690667576912,0.00814480760306772,0.703573176891
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOP1,DNA topoisomerase 1,37901,0.00366867586048698,0.00967059112280174,-0.0152856827402044,0.0226230344611784,0.704423436526307
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.00128241456534924,0.00339604252658847,-0.00537382878676416,0.00793865791746264,0.705717829214622
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRR5,Proline-rich protein 5,37598,0.00164003885039665,0.0043804531793427,-0.00694564938111504,0.0102257270819083,0.708113260609387
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBX2,Chromobox protein homolog 2,37562,0.00138501311636525,0.00373876024369055,-0.00594295696126823,0.00871298319399873,0.711055324908118
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,40516,0.00195542459569887,0.00529399620060054,-0.00842080795747818,0.0123316571488759,0.711859468404808
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARG2,"Arginase-2, mitochondrial",37900,-0.00146458436614974,0.00402825470264523,-0.0093599635833344,0.00643079485103491,0.716178950939082
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESR1,Estrogen receptor,37598,0.0019165574005566,0.00528622054115948,-0.00844443486011598,0.0122775496612292,0.716941503944017
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TJP3,Tight junction protein ZO-3,37541,-0.00144095223618739,0.00398699965436854,-0.00925547155874972,0.00637356708637495,0.717796802764986
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTF,Ciliary neurotrophic factor,37541,0.0011035937570646,0.00307276508784569,-0.00491902581511295,0.00712621332924214,0.719486194885628
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,0.00123895159451046,0.00346539855435774,-0.00555322957203072,0.00803113276105164,0.720707813195807
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAP1A,Ras-related protein Rap-1A,37598,0.00224218018157672,0.00632998974492075,-0.0101645997184679,0.0146489600816214,0.723183105152254
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP13,Collagenase 3,39961,-0.00103957456495521,0.00298607218958839,-0.00689227605654846,0.00481312692663803,0.727738917243638
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,0.00108857513066038,0.00312770990104266,-0.00504173627538324,0.007218886536704,0.727813047322272
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,0.00250620318285729,0.00724969491218804,-0.0117031988450313,0.0167156052107458,0.729574543629924
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDNRB,Endothelin receptor type B,37598,0.00147446314456058,0.00430314811238636,-0.00695970715571667,0.00990863344483784,0.731869106094499
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFNB2,Ephrin-B2,37572,-0.00175230111718235,0.00525916676508826,-0.0120602679767553,0.00855566574239063,0.738996284581633
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,0.00245869311265354,0.00746385896589909,-0.0121704704605087,0.0170878566858158,0.741848742758619
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPHS2,Podocin,37598,-0.00312342911294594,0.00952577384875572,-0.0217939458565071,0.0155470876306153,0.742998221088393
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPBGL,Trophoblast glycoprotein-like,37572,0.0012225830128911,0.00379291822428584,-0.00621153670670915,0.00865670273249135,0.747205511106707
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,40332,-0.000941887115519833,0.00293651388282082,-0.00669745432584863,0.00481368009480897,0.748403999475497
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMBS,Porphobilinogen deaminase,40489,0.00131303681197467,0.00410765190579836,-0.00673796092339011,0.00936403454733945,0.749233053983311
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL1A1,Collagen alpha-1(I) chain,40536,0.000744847188274668,0.00234622181491832,-0.00385374756896523,0.00534344194551457,0.750893659290448
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,0.00208442141744358,0.00660477922343892,-0.0108609458604967,0.0150297886953839,0.75231654845506
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.0013775377410735,0.00440658756406959,-0.00725937388450289,0.0100144493666499,0.754582903482562
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEL1L,Protein sel-1 homolog 1,37628,0.000907183511060032,0.00293785786666855,-0.00485101790761034,0.0066653849297304,0.757485542191915
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PITHD1,PITH domain-containing protein 1,37457,-0.00227140261663962,0.00746275487582027,-0.0168984021732473,0.0123555969399681,0.7608545740715
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,0.00413817613671431,0.0135992214874307,-0.0225162979786498,0.0307926502520784,0.760907081143093
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK3,Prostate-specific antigen,37998,0.00155646999160961,0.00517947042698234,-0.00859529204527578,0.011708232028495,0.763794646583199
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSL3,Insulin-like 3,37942,0.00162106912309403,0.00540439164310689,-0.00897153849739548,0.0122136767435835,0.76421683242027
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NXPE4,NXPE family member 4,37562,0.000982943745085718,0.00330646334444726,-0.00549772441003092,0.00746361190020235,0.76625784696776
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,37883,0.00113233368027649,0.00381466100195099,-0.00634440188354744,0.00860906924410043,0.766595315450398
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,0.000743226864035669,0.00255822914835126,-0.0042709022667328,0.00575735599480414,0.771420005783721
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,-0.000931961874301999,0.00328987840653534,-0.00738012355111127,0.00551619980250727,0.77696548748654
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,37572,0.00155012033431985,0.00548809413078127,-0.00920654416201144,0.0123067848306511,0.777601797876126
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHGB,Secretogranin-1,40406,-0.00102726404910576,0.00364374519522762,-0.0081690046317519,0.00611447653354038,0.778004426927497
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,-0.000933229029933066,0.00334243256832132,-0.00748439686384285,0.00561793880397672,0.780090600356782
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAND5,DAN domain family member 5,37598,-0.0013690888275545,0.00494395088982417,-0.0110592325716099,0.00832105491650087,0.781844344071561
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GJA8,Gap junction alpha-8 protein,37482,0.00156305898061648,0.00566236998098585,-0.00953518618211578,0.0126613041433487,0.782519229647465
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPT1,Translationally-controlled tumor protein,40044,0.00165900695997262,0.00601969425953315,-0.0101395937887123,0.0134576077086576,0.782861613214485
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB6B,Ras-related protein Rab-6B,39961,0.0012063385650082,0.00441913228873521,-0.00745516072091282,0.00986783785092921,0.784871557483664
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHISA5,Protein shisa-5,37998,-0.000612531686045227,0.00225031726295908,-0.00502315352144502,0.00379809014935457,0.785473987044587
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNLZ,DNL-type zinc finger protein,37541,0.00233709326190629,0.00863104680613477,-0.0145797584781179,0.0192539450019304,0.786566436935918
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL31,Interleukin-31,37598,0.00139736113853267,0.00528525386359458,-0.00896173643411272,0.0117564587111781,0.79148460044929
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,-0.000702639168425022,0.0026695695100772,-0.00593499540817633,0.00452971707132629,0.792398109449873
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,-0.000734388350790762,0.00279929716616407,-0.00622101079647234,0.00475223409489081,0.793057096786729
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXK,Tyrosine-protein kinase TXK,37714,0.0018028696967684,0.00687919982283658,-0.0116803619559913,0.0152861013495281,0.793267309361144
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFDN6,Prefoldin subunit 6,37572,0.00157380640234597,0.0060066190330671,-0.0101991669024655,0.0133467797071575,0.793316286455205
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF7,Fibroblast growth factor 7,37482,0.00192168793611979,0.00736743891160069,-0.0125184923306176,0.0163618682028572,0.794223664219688
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,37598,0.00102766222565569,0.00402044749840703,-0.00685241487122208,0.00890773932253346,0.798256832389787
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,0.00108997383616997,0.00447296602985661,-0.007677039582349,0.00985698725468893,0.807482221823596
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FZD10,Frizzled-10,37572,0.00133649928435547,0.00553253461542785,-0.00950726856188311,0.012180267130594,0.809116459501794
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.00118418320580324,0.00493128881131571,-0.010849509275982,0.00848114286437556,0.81022802944979
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEBP1,Heme-binding protein 1,40042,0.00116383335536468,0.00493078440053772,-0.00850050406968925,0.0108281707804186,0.813409295021157
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,37714,0.00159139990854516,0.00677135459375446,-0.0116804550952136,0.0148632549123039,0.814197279732941
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,0.000837612611188073,0.00373379595505561,-0.00648062746072093,0.00815585268309707,0.822501872096533
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,0.00161327001690092,0.00720635476036781,-0.01251118531342,0.0157377253472218,0.822863740481031
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNL2,Interferon lambda-2,37541,-0.00130861293276646,0.0058749825942589,-0.0128235788175139,0.010206352951981,0.823738785206001
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD160,CD160 antigen,40516,-0.000912339924140658,0.00412841981032021,-0.00900404275236828,0.00717936290408696,0.825102946854089
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,37714,0.000884068491628817,0.00407609901910381,-0.00710508558581464,0.00887322256907228,0.828296761840575
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,0.000473738909521595,0.00218642553988535,-0.00381165514865369,0.00475913296769689,0.828466107093076
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,39961,0.000939308048499603,0.00440335095372265,-0.00769125982079679,0.009569875917796,0.831082796048082
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPEP,Glutamyl aminopeptidase,37562,0.000899378988890388,0.00421645092232194,-0.00736486481886061,0.00916362279664139,0.831094439223694
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRX,Cone-rod homeobox protein,40042,0.00206442551253638,0.00972555715840537,-0.0169976665179381,0.0211265175430109,0.831900658069813
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMCH,Pro-MCH,37562,-0.00163829569634415,0.00772472551498312,-0.0167787577057111,0.0135021663130228,0.832044292966325
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPLX2,Complexin-2,37482,-0.000596613908979446,0.00281730992267317,-0.00611854135741886,0.00492531353945997,0.832291950062269
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL3,Interleukin-3,37482,0.00115753196134012,0.00547342275433882,-0.00957037663716398,0.0118854405598442,0.832514260108493
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF6,Fibroblast growth factor 6,37598,0.000824418295114533,0.00390621572697409,-0.00683176452975467,0.00848060111998374,0.832849236489916
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,0.000654382985362022,0.00313859984515878,-0.00549727271114918,0.00680603868187322,0.834845593262024
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGN,Cingulin,37572,0.000793827334037935,0.00381219386898624,-0.0066780726491751,0.00826572731725097,0.835049708384863
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK1,Kallikrein-1,40209,0.00235748045166668,0.0115313014175706,-0.0202438703267716,0.024958831230105,0.838010879310799
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RASA1,Ras GTPase-activating protein 1,39961,0.000596935421768681,0.00295120284422969,-0.00518742215292152,0.00638129299645888,0.839709464381791
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAD2,Glutamate decarboxylase 2,37598,0.000866893138581386,0.00430191958740976,-0.00756486925274175,0.00929865552990452,0.840300507497106
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FSTL3,Follistatin-related protein 3,40293,-0.000564229187958419,0.00282131964851376,-0.00609401569904538,0.00496555732312854,0.841492778842252
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RUVBL1,RuvB-like 1,39980,-0.00193258992292874,0.00972092748370146,-0.0209856077909836,0.0171204279451261,0.842416202792526
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FH,"Fumarate hydratase, mitochondrial",37541,0.00153870600152652,0.00776331687025702,-0.0136773950641772,0.0167548070672303,0.842889992892762
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,37688,0.00092444701905529,0.0047578704494495,-0.00840097906186572,0.0102498730999763,0.84594515384698
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,37562,-0.000902583385677444,0.00474567973013275,-0.0102041156567376,0.00839894888538274,0.849162769305814
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD99,CD99 antigen,40332,-0.000328503246578287,0.001755049994765,-0.00376840123631768,0.00311139474316111,0.851525028830832
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAGEA3,Melanoma-associated antigen 3,37714,-0.00142829886005589,0.00766483144994049,-0.0164513685019392,0.0135947707818275,0.852177495896544
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,37692,-0.000909567979065047,0.00505317437967717,-0.0108137897632323,0.0089946538051022,0.857155852544605
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TUBB3,Tubulin beta-3 chain,37541,-0.000437572242218537,0.00252249141998863,-0.00538165542539624,0.00450651094095917,0.862286043001014
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,37572,-0.00121288351095977,0.00709132294406404,-0.0151118764813253,0.0126861094594058,0.864196765738781
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNNI3,"Troponin I, cardiac muscle",40042,-0.00131049279416631,0.00766319415305304,-0.0163303533341503,0.0137093677458176,0.864217099717441
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHD,SH2 domain-containing adapter protein D,37531,0.00135755794167077,0.00798381615444325,-0.014290721721038,0.0170058376043795,0.864982309719005
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17F,Interleukin-17F,40044,-0.0011699541765017,0.0071997195632107,-0.0152814045203947,0.0129414961673913,0.870914261674579
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEX33,Testis-expressed protein 33,37714,-0.000578480978545855,0.00357968268374046,-0.00759465903867716,0.00643769708158545,0.871622382508868
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMOD2,Leiomodin-2,37541,0.000953158284575469,0.00589837345457461,-0.0106076536863908,0.0125139702555417,0.871625870381541
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,0.000460847030794149,0.00287079739763314,-0.00516591586856681,0.00608760993015511,0.872466638216865
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,40341,-0.000871423052953874,0.00553091792434054,-0.0117120221846613,0.00996917607875358,0.874809570066602
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,40044,0.000543083878006114,0.00351402310828927,-0.00634440141424085,0.00743056917025308,0.877179973938898
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD6,Programmed cell death protein 6,40359,-0.00095620225295031,0.00630545393033924,-0.0133148919564152,0.0114024874505146,0.879467399517478
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH1,Cadherin-1,39806,0.00054852650137968,0.00362913367050587,-0.00656457549281183,0.00766162849557119,0.879863083473456
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPGN,Epigen,37900,-0.000665945937204646,0.00448350905098189,-0.00945362367712915,0.00812173180271985,0.881924919434385
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDAC9,Histone deacetylase 9,37541,-0.000852506503904401,0.0057536755507679,-0.0121297105834095,0.0104246975756007,0.882213029384149
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B2M,Beta-2-microglobulin,38013,-0.00042115853180591,0.00287160476237308,-0.00604950386605714,0.00520718680244532,0.883400104895906
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLVRB,Flavin reductase,40332,-0.000853201571807341,0.00599445727098516,-0.0126023378229383,0.0108959346793236,0.886819777494302
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL21,C-C motif chemokine 21,40422,-0.000521844274894217,0.00383808614285221,-0.00804449311488454,0.00700080456509611,0.89185089175686
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP112,Centrosomal protein of 112 kDa,37562,-0.000563154067076812,0.00429072156380042,-0.00897296833212563,0.00784666019797201,0.895580136244083
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.000835187086125061,0.00636666672250304,-0.013313853862231,0.0116434796899809,0.895633965900164
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,0.00109606160377935,0.00851646687115487,-0.0155962134636842,0.0177883366712429,0.897597718002728
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPARCL1,SPARC-like protein 1,40346,0.000318291139692242,0.0024930405044184,-0.00456806824896783,0.00520465052835231,0.898410268654765
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,0.000935506138757228,0.00734168995865019,-0.0134542061801971,0.0153252184577116,0.898606620704911
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,37482,-0.000553301385652264,0.00448402043295521,-0.00934198143424447,0.00823537866293994,0.901796981533114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,37572,0.000476086822096192,0.00389830203127665,-0.00716458515920604,0.00811675880339842,0.902800534976256
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-0.000444007175346552,0.00364543478144143,-0.00758905934697176,0.00670104499627865,0.903060756915303
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORN4,MORN repeat-containing protein 4,37482,-0.000873362654558057,0.00717271680386302,-0.0149318875901296,0.0131851622810135,0.903089573701493
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,40009,-0.000566283608309274,0.00467234452095362,-0.00972407886937836,0.00859151165275982,0.903534960306567
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKAP12,A-kinase anchor protein 12,37671,-0.00023825456619928,0.00197495123798652,-0.00410915899265285,0.00363264986025429,0.903979442543758
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REST,RE1-silencing transcription factor,37482,-0.000392597092709912,0.00325935331920951,-0.00678092959836056,0.00599573541294073,0.904126601891138
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,37572,0.000393735087121856,0.00352359313823296,-0.00651250746381474,0.00729997763805846,0.911029293887654
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLIN3,Perilipin-3,40359,-0.000425012734543882,0.00383234291557193,-0.00793640484906486,0.0070863793799771,0.911695822839802
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL13,Interleukin-13,40044,0.000481002921628649,0.00434158729656608,-0.00802850817964087,0.00899051402289817,0.911784581698453
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RLN2,Prorelaxin H2,37643,0.00133509063351673,0.0127692950651408,-0.0236927276941593,0.0263629089611927,0.916730700499217
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.000323430517346626,0.00313316985278282,-0.0058175823941077,0.00646444342880095,0.917783690427477
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRC1,Protein regulator of cytokinesis 1,37900,-0.000433665975565559,0.00422774172041969,-0.00872003974758816,0.00785270779645704,0.918300806808092
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP1,Retinol-binding protein 1,37572,-0.000635104752476491,0.00625767855402967,-0.0129001547183746,0.0116299452134217,0.919161402859618
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,37541,-0.000545253565919033,0.00550247976282917,-0.0113301139010642,0.0102396067692261,0.921066475690648
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGR,Progesterone receptor,37598,0.000923111981652091,0.00940259628467928,-0.0175059767363193,0.0193522006996235,0.921793809332969
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLNS1A,Methylosome subunit pICln,37572,-0.000291886852046825,0.00305150472143457,-0.00627283610605857,0.00568906240196492,0.923797300301026
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE1,Ribonuclease pancreatic,37987,-0.000197014153089284,0.00218729447399106,-0.00448411132211175,0.00409008301593319,0.928231272261947
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,-0.000199924120823854,0.00239566611406383,-0.00489542970438896,0.00449558146274125,0.933492859991717
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCNIP4,Kv channel-interacting protein 4,39961,0.00038609901853289,0.00465057438725374,-0.00872902678048443,0.00950122481755021,0.933835283525565
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN15,Tetraspanin-15,37562,-0.000376781674483492,0.00464132324613815,-0.00947377523691426,0.00872021188794728,0.93530020610455
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,0.000246378634513068,0.0030736960342262,-0.00577806559257029,0.00627082286159642,0.936113515840199
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYTH3,Cytohesin-3,37482,0.000536739806713501,0.0067067653466003,-0.0126085202726231,0.0136819998860501,0.936214936141466
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,0.000402236877813187,0.00513233354770279,-0.00965713687568428,0.0104616106313107,0.937532476173712
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,0.000229947649308718,0.00303605278603305,-0.00572071581131606,0.0061806111099335,0.939627688705872
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KHDC3L,KH domain-containing protein 3,37482,0.000468980409718745,0.00620188752796666,-0.0116867191450959,0.0126246799645334,0.939723396647979
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC123,Cell division cycle protein 123 homolog,37482,-0.000419317952964541,0.0058283093727671,-0.011842804323588,0.011004168417659,0.942646750090991
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,0.000132447865420886,0.00185505288270962,-0.00350345578468996,0.00376835151553174,0.943081741864171
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA2,Protein disulfide-isomerase A2,37482,-0.000264372602002525,0.00378073483819844,-0.00767461288487146,0.00714586768086641,0.944253434430202
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DHODH,Dihydroorotate dehydrogenase,37562,-0.000305111084768464,0.00439489762660802,-0.00891911043292019,0.00830888826338326,0.944653236762321
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,37901,-0.000271449540332089,0.00393793397112832,-0.0079898001237436,0.00744690104307942,0.945044796659986
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,0.000313250447820879,0.00458384535977708,-0.0086710864573422,0.00929758735298396,0.945517670792991
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,37901,0.000336693239990237,0.00500486925856221,-0.00947285050679169,0.0101462369867722,0.946365264446988
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.000864658760740316,0.0128660536549257,-0.024352806402914,0.0260821239243947,0.946419806527876
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,37901,0.000749595354287031,0.0116632413812567,-0.0221103577529761,0.0236095484615502,0.948756275594618
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,-0.000262818739329259,0.00416671739907809,-0.00842958484152232,0.0079039473628638,0.949707159874663
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,37714,0.000338691048696908,0.00609324321879446,-0.0116040656601402,0.012281447757534,0.955673496839563
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST7,Cystatin-F,40376,-0.000401868940981222,0.00831236654199731,-0.0166941073632959,0.0158903694813335,0.961441171164582
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,-0.000205230482560353,0.00442153044187722,-0.00887143014863971,0.008460969183519,0.96297926029353
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCIN,Adseverin,37541,0.000282842175795193,0.00666160803955624,-0.012773909581735,0.0133395939333254,0.966133806922327
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SKIV2L,Helicase SKI2W,37562,-0.000154634531845102,0.00368975392295558,-0.00738655222083805,0.00707728315714784,0.96657174282308
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,0.000179545375303417,0.0044161890369041,-0.00847618513702863,0.00883527588763546,0.96757051679448
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,0.000135856478158139,0.00343983985446467,-0.00660622963659261,0.00687794259290888,0.968496340496784
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IKZF2,Zinc finger protein Helios,39980,0.000322935736605911,0.00847691450213144,-0.0162918166875717,0.0169376881607835,0.969611705343352
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOD3,Extracellular superoxide dismutase,37987,-0.000192640260377948,0.00535582924060903,-0.0106900655719716,0.0103047850512157,0.971308138029335
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,-0.000171272805471388,0.00498615927245277,-0.00994414497947882,0.00960159936853604,0.972598857999615
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCARE,Photoreceptor cilium actin regulator,37541,0.000253656741970999,0.0078155086483358,-0.0150647402087672,0.0155720536927092,0.974109246914655
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,0.000163446130825162,0.00545253656876404,-0.0105235255439523,0.0108504178056027,0.97608651923007
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,40306,-8.51515088497241e-05,0.00325541088217768,-0.00646575683791798,0.00629545382021853,0.979132509409153
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",37562,-0.000123871325496692,0.00571305972089654,-0.0113214683784539,0.0110737257274605,0.982701845526946
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,-9.79075884563195e-05,0.00604472820064836,-0.0119455748617271,0.0117497596848145,0.987077327091301
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC25A,M-phase inducer phosphatase 1,37482,-4.04225212214071e-05,0.00372397764413631,-0.00733941870372857,0.00725857366128576,0.991339568469569
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,37482,6.01590707132666e-05,0.00577255682849374,-0.0112540523131345,0.011374370454561,0.991685105008056
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2,Interleukin-2,40044,1.92565368981544e-05,0.00283554968758208,-0.00553842085076272,0.00557693392455903,0.994581604724453
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP2BP,LRP2-binding protein,37572,-2.59866283221354e-05,0.00789020927407905,-0.0154907968055171,0.0154388235488728,0.997372199363598
